

<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/CollaborationsContractsAndLicensingAgreements" xlink:href="abus-20161231.xsd#CollaborationsContractsAndLicensingAgreements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/CollaborationsContractsAndLicensingAgreementsDeferredCollaborationsAndContractsRevenueDetails" xlink:href="abus-20161231.xsd#CollaborationsContractsAndLicensingAgreementsDeferredCollaborationsAndContractsRevenueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/CollaborationsContractsAndLicensingAgreementsDetails" xlink:href="abus-20161231.xsd#CollaborationsContractsAndLicensingAgreementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/CollaborationsContractsAndLicensingAgreementsRevenueRecognizedUnderCollaborationsContractsAndLicensingAgreementsDetails" xlink:href="abus-20161231.xsd#CollaborationsContractsAndLicensingAgreementsRevenueRecognizedUnderCollaborationsContractsAndLicensingAgreementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/CollaborationsContractsAndLicensingAgreementsTables" xlink:href="abus-20161231.xsd#CollaborationsContractsAndLicensingAgreementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ConcentrationsOfBusinessRisk" xlink:href="abus-20161231.xsd#ConcentrationsOfBusinessRisk" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ConcentrationsOfBusinessRiskDetails" xlink:href="abus-20161231.xsd#ConcentrationsOfBusinessRiskDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ConcentrationsOfBusinessRiskForeignCurrencyExposureDetails" xlink:href="abus-20161231.xsd#ConcentrationsOfBusinessRiskForeignCurrencyExposureDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ConcentrationsOfBusinessRiskNetLiquidityOfCompanyDetails" xlink:href="abus-20161231.xsd#ConcentrationsOfBusinessRiskNetLiquidityOfCompanyDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ConcentrationsOfBusinessRiskTables" xlink:href="abus-20161231.xsd#ConcentrationsOfBusinessRiskTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ConsolidatedBalanceSheets" xlink:href="abus-20161231.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="abus-20161231.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ConsolidatedStatementOfStockholdersEquity" xlink:href="abus-20161231.xsd#ConsolidatedStatementOfStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ConsolidatedStatementOfStockholdersEquityParenthetical" xlink:href="abus-20161231.xsd#ConsolidatedStatementOfStockholdersEquityParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="abus-20161231.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="abus-20161231.xsd#ConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ContingenciesAndCommitments" xlink:href="abus-20161231.xsd#ContingenciesAndCommitments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ContingenciesAndCommitmentsDetails" xlink:href="abus-20161231.xsd#ContingenciesAndCommitmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ContingenciesAndCommitmentsMinimumRentAndEstimatedOperatingCostCommitmentNetLeaseInducementsDetails" xlink:href="abus-20161231.xsd#ContingenciesAndCommitmentsMinimumRentAndEstimatedOperatingCostCommitmentNetLeaseInducementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ContingenciesAndCommitmentsTables" xlink:href="abus-20161231.xsd#ContingenciesAndCommitmentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/DocumentAndEntityInformation" xlink:href="abus-20161231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/GovernmentGrantsAndRefundableInvestmentTaxCredits" xlink:href="abus-20161231.xsd#GovernmentGrantsAndRefundableInvestmentTaxCredits" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/GovernmentGrantsAndRefundableInvestmentTaxCreditsDetails" xlink:href="abus-20161231.xsd#GovernmentGrantsAndRefundableInvestmentTaxCreditsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ImpairmentEvaluationsForIntangibleAssetsAndGoodwill" xlink:href="abus-20161231.xsd#ImpairmentEvaluationsForIntangibleAssetsAndGoodwill" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ImpairmentEvaluationsForIntangibleAssetsAndGoodwillNarrativeDetails" xlink:href="abus-20161231.xsd#ImpairmentEvaluationsForIntangibleAssetsAndGoodwillNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ImpairmentEvaluationsForIntangibleAssetsAndGoodwillSummaryOfCarryingValueOfIntangibleAssetsDetails" xlink:href="abus-20161231.xsd#ImpairmentEvaluationsForIntangibleAssetsAndGoodwillSummaryOfCarryingValueOfIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ImpairmentEvaluationsForIntangibleAssetsAndGoodwillTables" xlink:href="abus-20161231.xsd#ImpairmentEvaluationsForIntangibleAssetsAndGoodwillTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/IncomeTaxes" xlink:href="abus-20161231.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="abus-20161231.xsd#IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/IncomeTaxesDetails" xlink:href="abus-20161231.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/IncomeTaxesIncomeTaxReconciliationDetails" xlink:href="abus-20161231.xsd#IncomeTaxesIncomeTaxReconciliationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/IncomeTaxesTables" xlink:href="abus-20161231.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/InterimFinancialDataUnaudited" xlink:href="abus-20161231.xsd#InterimFinancialDataUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/InterimFinancialDataUnauditedDetails" xlink:href="abus-20161231.xsd#InterimFinancialDataUnauditedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/InterimFinancialDataUnauditedTables" xlink:href="abus-20161231.xsd#InterimFinancialDataUnauditedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/LoanPayable" xlink:href="abus-20161231.xsd#LoanPayable" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/LoanPayableDetails" xlink:href="abus-20161231.xsd#LoanPayableDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/NatureOfBusinessAndFutureOperations" xlink:href="abus-20161231.xsd#NatureOfBusinessAndFutureOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/PropertyAndEquipment" xlink:href="abus-20161231.xsd#PropertyAndEquipment" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/PropertyAndEquipmentDetails" xlink:href="abus-20161231.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/PropertyAndEquipmentPropertyAndEquipmentSummaryDetails" xlink:href="abus-20161231.xsd#PropertyAndEquipmentPropertyAndEquipmentSummaryDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/PropertyAndEquipmentTables" xlink:href="abus-20161231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapital" xlink:href="abus-20161231.xsd#ShareCapital" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapitalLocationOfExpensesForStockBasedCompensationDetails" xlink:href="abus-20161231.xsd#ShareCapitalLocationOfExpensesForStockBasedCompensationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapitalNarrativeDetails" xlink:href="abus-20161231.xsd#ShareCapitalNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapitalNonVestedLiabilityStockOptionActivityDetails" xlink:href="abus-20161231.xsd#ShareCapitalNonVestedLiabilityStockOptionActivityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapitalNonVestedStockOptionActivityEquityOptionsDetails" xlink:href="abus-20161231.xsd#ShareCapitalNonVestedStockOptionActivityEquityOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapitalNonVestedStockOptionActivityOncoreOptionPlanDetails" xlink:href="abus-20161231.xsd#ShareCapitalNonVestedStockOptionActivityOncoreOptionPlanDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapitalOutstandingOptionsUnderOncoreOptionPlanDetails" xlink:href="abus-20161231.xsd#ShareCapitalOutstandingOptionsUnderOncoreOptionPlanDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapitalOutstandingOptionsUnderProtivaOptionPlanDetails" xlink:href="abus-20161231.xsd#ShareCapitalOutstandingOptionsUnderProtivaOptionPlanDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapitalStockOptionActivityForLiabilityClassifiedOptionsDetails" xlink:href="abus-20161231.xsd#ShareCapitalStockOptionActivityForLiabilityClassifiedOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapitalStockOptionsOutstandingEquityOptionsDetails" xlink:href="abus-20161231.xsd#ShareCapitalStockOptionsOutstandingEquityOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapitalSummaryOfInformationEquityOptionsDetails" xlink:href="abus-20161231.xsd#ShareCapitalSummaryOfInformationEquityOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapitalSummaryOfInformationLiabilityClassifiedOptionsDetails" xlink:href="abus-20161231.xsd#ShareCapitalSummaryOfInformationLiabilityClassifiedOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapitalSummaryOfWarrantActivityDetails" xlink:href="abus-20161231.xsd#ShareCapitalSummaryOfWarrantActivityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapitalTables" xlink:href="abus-20161231.xsd#ShareCapitalTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapitalValuationAssumptionsAssumptionsWarrantsDetails" xlink:href="abus-20161231.xsd#ShareCapitalValuationAssumptionsAssumptionsWarrantsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapitalValuationAssumptionsEquityOptionsDetails" xlink:href="abus-20161231.xsd#ShareCapitalValuationAssumptionsEquityOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareCapitalValuationAssumptionsLiabilityClassifiedOptionsDetails" xlink:href="abus-20161231.xsd#ShareCapitalValuationAssumptionsLiabilityClassifiedOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SignificantAccountingPolicies" xlink:href="abus-20161231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="abus-20161231.xsd#SignificantAccountingPoliciesAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesChangesInFairValueOfCompanysWarrantsDetails" xlink:href="abus-20161231.xsd#SignificantAccountingPoliciesChangesInFairValueOfCompanysWarrantsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesChangesInFairValueOfContingentConsiderationDetails" xlink:href="abus-20161231.xsd#SignificantAccountingPoliciesChangesInFairValueOfContingentConsiderationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesChangesInFairValueOfLiabilityClassifiedStockOptionsDetails" xlink:href="abus-20161231.xsd#SignificantAccountingPoliciesChangesInFairValueOfLiabilityClassifiedStockOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesComputationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" xlink:href="abus-20161231.xsd#SignificantAccountingPoliciesComputationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesEstimatedUsefulLivesDetails" xlink:href="abus-20161231.xsd#SignificantAccountingPoliciesEstimatedUsefulLivesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:href="abus-20161231.xsd#SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesPolicies" xlink:href="abus-20161231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesTables" xlink:href="abus-20161231.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SubsequentEvents" xlink:href="abus-20161231.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SubsequentEventsSubsequentEventsDetails" xlink:href="abus-20161231.xsd#SubsequentEventsSubsequentEventsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SupplementaryInformation" xlink:href="abus-20161231.xsd#SupplementaryInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SupplementaryInformationDetails" xlink:href="abus-20161231.xsd#SupplementaryInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SupplementaryInformationTables" xlink:href="abus-20161231.xsd#SupplementaryInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/CollaborationsContractsAndLicensingAgreements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueDisclosureAbstract" xlink:label="loc_us-gaap_DeferredRevenueDisclosureAbstract_131526527BB1CFC0DC88FE9957549541" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_5D01D73DDD1A516021A0FE9957545D04" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueDisclosureAbstract_131526527BB1CFC0DC88FE9957549541" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_5D01D73DDD1A516021A0FE9957545D04" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/CollaborationsContractsAndLicensingAgreementsDeferredCollaborationsAndContractsRevenueDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueDisclosureAbstract" xlink:label="loc_us-gaap_DeferredRevenueDisclosureAbstract_2001D7CDAC6D006C45B88B375C26B46D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementByTypeTable" xlink:label="loc_us-gaap_DeferredRevenueArrangementByTypeTable_9E00E6E186FA3AA004738B375C26D704" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueDisclosureAbstract_2001D7CDAC6D006C45B88B375C26B46D" xlink:to="loc_us-gaap_DeferredRevenueArrangementByTypeTable_9E00E6E186FA3AA004738B375C26D704" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="loc_us-gaap_CounterpartyNameAxis_15D6686BCA33470E2A518B375C26585B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_9E00E6E186FA3AA004738B375C26D704" xlink:to="loc_us-gaap_CounterpartyNameAxis_15D6686BCA33470E2A518B375C26585B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_B645A9F7346CAF83600A8B375C263538" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CounterpartyNameAxis_15D6686BCA33470E2A518B375C26585B" xlink:to="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_B645A9F7346CAF83600A8B375C263538" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_DoDMember" xlink:label="loc_abus_DoDMember_DF9ECC37869AB6A8670C8B375C26967B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_B645A9F7346CAF83600A8B375C263538" xlink:to="loc_abus_DoDMember_DF9ECC37869AB6A8670C8B375C26967B" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_MonsantoMember" xlink:label="loc_abus_MonsantoMember_3711F30F94C440B7D5DB8B375C26CA46" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_B645A9F7346CAF83600A8B375C263538" xlink:to="loc_abus_MonsantoMember_3711F30F94C440B7D5DB8B375C26CA46" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_DicernaMember" xlink:label="loc_abus_DicernaMember_8362B5779D51CB7669EB8B375C261909" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_B645A9F7346CAF83600A8B375C263538" xlink:to="loc_abus_DicernaMember_8362B5779D51CB7669EB8B375C261909" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementLineItems" xlink:label="loc_us-gaap_DeferredRevenueArrangementLineItems_3C3B78A2475E020F69EE8B375C26165B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_9E00E6E186FA3AA004738B375C26D704" xlink:to="loc_us-gaap_DeferredRevenueArrangementLineItems_3C3B78A2475E020F69EE8B375C26165B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_1D92C92519307A55C9868B375C26C718" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_3C3B78A2475E020F69EE8B375C26165B" xlink:to="loc_us-gaap_DeferredRevenueCurrent_1D92C92519307A55C9868B375C26C718" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_0BE001490BCDE71699798B375C260739" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_3C3B78A2475E020F69EE8B375C26165B" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_0BE001490BCDE71699798B375C260739" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaap_DeferredRevenue_06AB1980F9C44D7F8ED08B375C26C1D3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_3C3B78A2475E020F69EE8B375C26165B" xlink:to="loc_us-gaap_DeferredRevenue_06AB1980F9C44D7F8ED08B375C26C1D3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/CollaborationsContractsAndLicensingAgreementsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueDisclosureAbstract" xlink:label="loc_us-gaap_DeferredRevenueDisclosureAbstract_2F727B7C079CA842829DA5432EBEBE95" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_82DA32B5AC240E92E9F2A5432EBE4B27" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueDisclosureAbstract_2F727B7C079CA842829DA5432EBEBE95" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_82DA32B5AC240E92E9F2A5432EBE4B27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_E87784DE0BE329208AF8A5432EBE0F4B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_82DA32B5AC240E92E9F2A5432EBE4B27" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_E87784DE0BE329208AF8A5432EBE0F4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C54075122025034EEF47A5432EBE7C97" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_E87784DE0BE329208AF8A5432EBE0F4B" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C54075122025034EEF47A5432EBE7C97" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_PADCo.Member" xlink:label="loc_abus_PADCo.Member_A45015DAEA2112754B8DA5432EBEB93B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C54075122025034EEF47A5432EBE7C97" xlink:to="loc_abus_PADCo.Member_A45015DAEA2112754B8DA5432EBEB93B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_2A0FA3419035EF314996A5432EBE6B37" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_82DA32B5AC240E92E9F2A5432EBE4B27" xlink:to="loc_dei_LegalEntityAxis_2A0FA3419035EF314996A5432EBE6B37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_CFDE54FCBEFEF82C09F2A5432EBE3D0C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2A0FA3419035EF314996A5432EBE6B37" xlink:to="loc_dei_EntityDomain_CFDE54FCBEFEF82C09F2A5432EBE3D0C" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_MonsantoMember" xlink:label="loc_abus_MonsantoMember_2038F5B7A9713891BE97A5432EBE4F65" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_CFDE54FCBEFEF82C09F2A5432EBE3D0C" xlink:to="loc_abus_MonsantoMember_2038F5B7A9713891BE97A5432EBE4F65" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ContractModificationsAxis" xlink:label="loc_abus_ContractModificationsAxis_9DF4757E1D8495A12CD9A5432EBECB96" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_82DA32B5AC240E92E9F2A5432EBE4B27" xlink:to="loc_abus_ContractModificationsAxis_9DF4757E1D8495A12CD9A5432EBECB96" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ContractModificationsDomain" xlink:label="loc_abus_ContractModificationsDomain_2BE6B62846657954613CA5432EBEDEC6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContractModificationsAxis_9DF4757E1D8495A12CD9A5432EBECB96" xlink:to="loc_abus_ContractModificationsDomain_2BE6B62846657954613CA5432EBEDEC6" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_IncreaseToSupportDevelopmentPlansMember" xlink:label="loc_abus_IncreaseToSupportDevelopmentPlansMember_E4B5E8F420061FF13076A5432EBE1718" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContractModificationsDomain_2BE6B62846657954613CA5432EBEDEC6" xlink:to="loc_abus_IncreaseToSupportDevelopmentPlansMember_E4B5E8F420061FF13076A5432EBE1718" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_IncreasedFundingForStageOneMember" xlink:label="loc_abus_IncreasedFundingForStageOneMember_3F1F57AB917B18AA8264A5432EBEA3DF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContractModificationsDomain_2BE6B62846657954613CA5432EBEDEC6" xlink:to="loc_abus_IncreasedFundingForStageOneMember_3F1F57AB917B18AA8264A5432EBEA3DF" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_StageOneMember" xlink:label="loc_abus_StageOneMember_B83758A5B4DC630025A4A5432EBE8199" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContractModificationsDomain_2BE6B62846657954613CA5432EBEDEC6" xlink:to="loc_abus_StageOneMember_B83758A5B4DC630025A4A5432EBE8199" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_85A60964EF00E567152EA5432EBE441E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_82DA32B5AC240E92E9F2A5432EBE4B27" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_85A60964EF00E567152EA5432EBE441E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_953A3304C0A3698CE363A5432EBE398C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_85A60964EF00E567152EA5432EBE441E" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_953A3304C0A3698CE363A5432EBE398C" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ContractExtensionMember" xlink:label="loc_abus_ContractExtensionMember_8910107499980C9E34ACA5432EBEA140" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_953A3304C0A3698CE363A5432EBE398C" xlink:to="loc_abus_ContractExtensionMember_8910107499980C9E34ACA5432EBEA140" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_MarqiboCommercialSalesMember" xlink:label="loc_abus_MarqiboCommercialSalesMember_BFDBFDAD673E3141A795A5432EBE6006" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_953A3304C0A3698CE363A5432EBE398C" xlink:to="loc_abus_MarqiboCommercialSalesMember_BFDBFDAD673E3141A795A5432EBE6006" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_MarqiboMember" xlink:label="loc_abus_MarqiboMember_A36FFA94B21DD84D1F58A5432EBEE605" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_953A3304C0A3698CE363A5432EBE398C" xlink:to="loc_abus_MarqiboMember_A36FFA94B21DD84D1F58A5432EBEE605" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_A70C2D04F42AC8DD702DA5432EBE031F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_82DA32B5AC240E92E9F2A5432EBE4B27" xlink:to="loc_us-gaap_RangeAxis_A70C2D04F42AC8DD702DA5432EBE031F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_F81069F92AB58443354CA5432EBEF5CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_A70C2D04F42AC8DD702DA5432EBE031F" xlink:to="loc_us-gaap_RangeMember_F81069F92AB58443354CA5432EBEF5CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_FA5436CE42C15B8EC014A5432EBE60B4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_F81069F92AB58443354CA5432EBEF5CD" xlink:to="loc_us-gaap_MaximumMember_FA5436CE42C15B8EC014A5432EBE60B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="loc_us-gaap_CounterpartyNameAxis_E72EDA0ADD8BBFDB5BF2A5432EBE4381" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_82DA32B5AC240E92E9F2A5432EBE4B27" xlink:to="loc_us-gaap_CounterpartyNameAxis_E72EDA0ADD8BBFDB5BF2A5432EBE4381" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_30DAB202A93FCCA5F355A5432EBEDC4C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CounterpartyNameAxis_E72EDA0ADD8BBFDB5BF2A5432EBE4381" xlink:to="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_30DAB202A93FCCA5F355A5432EBEDC4C" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_DoDMember" xlink:label="loc_abus_DoDMember_6D7F6B02B7CFDBB44FCEA5432EBE40B8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_30DAB202A93FCCA5F355A5432EBEDC4C" xlink:to="loc_abus_DoDMember_6D7F6B02B7CFDBB44FCEA5432EBE40B8" xlink:type="arc" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_30DAB202A93FCCA5F355A5432EBEDC4C" xlink:to="loc_abus_MonsantoMember_2038F5B7A9713891BE97A5432EBE4F65" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_BMSMember" xlink:label="loc_abus_BMSMember_D912E59A1D6C807EA4D7A5432EBEB004" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_30DAB202A93FCCA5F355A5432EBEDC4C" xlink:to="loc_abus_BMSMember_D912E59A1D6C807EA4D7A5432EBEB004" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_DicernaMember" xlink:label="loc_abus_DicernaMember_18824AE4EA2DF24A9266A5432EBEDB36" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_30DAB202A93FCCA5F355A5432EBEDC4C" xlink:to="loc_abus_DicernaMember_18824AE4EA2DF24A9266A5432EBEDB36" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_TalonTherapeuticsMember" xlink:label="loc_abus_TalonTherapeuticsMember_A9297C1E61EBCA636B80A5432EBE5D4C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_30DAB202A93FCCA5F355A5432EBEDC4C" xlink:to="loc_abus_TalonTherapeuticsMember_A9297C1E61EBCA636B80A5432EBE5D4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_82DA32B5AC240E92E9F2A5432EBE4B27" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_PotentialContractFundingAmount" xlink:label="loc_abus_PotentialContractFundingAmount_54B2C264E20257F80661A5432EBECFB0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:to="loc_abus_PotentialContractFundingAmount_54B2C264E20257F80661A5432EBECFB0" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_OptionalExcercisedContractualOptionAmount" xlink:label="loc_abus_OptionalExcercisedContractualOptionAmount_718153DA85C3DDA5CC99A5432EBE80F7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:to="loc_abus_OptionalExcercisedContractualOptionAmount_718153DA85C3DDA5CC99A5432EBE80F7" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ApproximateOptionPeriod" xlink:label="loc_abus_ApproximateOptionPeriod_106FE2B0DEE3A87C5F35A5432EBECA14" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:to="loc_abus_ApproximateOptionPeriod_106FE2B0DEE3A87C5F35A5432EBECA14" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_MaximumPotentialTransactionValue" xlink:label="loc_abus_MaximumPotentialTransactionValue_9DCEEC68BEC59E49B2E4A5432EBEE95E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:to="loc_abus_MaximumPotentialTransactionValue_9DCEEC68BEC59E49B2E4A5432EBEE95E" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_OptionPeriodExtension" xlink:label="loc_abus_OptionPeriodExtension_649DCC039D27F1176EE0A5432EBE7622" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:to="loc_abus_OptionPeriodExtension_649DCC039D27F1176EE0A5432EBE7622" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_NearTermContractPayments" xlink:label="loc_abus_NearTermContractPayments_C98451F084E3187F7DF3A5432EBE98E6" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:to="loc_abus_NearTermContractPayments_C98451F084E3187F7DF3A5432EBE98E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_C7520F9E995B75B796FCA5432EBEA61A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:to="loc_us-gaap_Revenues_C7520F9E995B75B796FCA5432EBEA61A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9639B544A207303A3334A5432EBE4B4C" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9639B544A207303A3334A5432EBE4B4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaap_DeferredRevenue_145FC8C265489D304E40A5432EBEB134" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:to="loc_us-gaap_DeferredRevenue_145FC8C265489D304E40A5432EBEB134" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_LengthOfAgreementWithBristolMyersSquibb" xlink:label="loc_abus_LengthOfAgreementWithBristolMyersSquibb_BD4F8753812766D5D72EA5432EBEC7B5" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:to="loc_abus_LengthOfAgreementWithBristolMyersSquibb_BD4F8753812766D5D72EA5432EBEC7B5" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_MilestonePayment" xlink:label="loc_abus_MilestonePayment_D21893899A0FE9231616A5432EBE66DE" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:to="loc_abus_MilestonePayment_D21893899A0FE9231616A5432EBE66DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LicensesRevenue" xlink:label="loc_us-gaap_LicensesRevenue_FBDEE465392CAFA678BCA5432EBE810B" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:to="loc_us-gaap_LicensesRevenue_FBDEE465392CAFA678BCA5432EBE810B" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_NumberOfChemotherapyProductsWithWorldwideLicenses" xlink:label="loc_abus_NumberOfChemotherapyProductsWithWorldwideLicenses_4BDE1F80F074BDBA3587A5432EBEE929" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:to="loc_abus_NumberOfChemotherapyProductsWithWorldwideLicenses_4BDE1F80F074BDBA3587A5432EBEE929" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContractsRevenue" xlink:label="loc_us-gaap_ContractsRevenue_1BA7F8E407127E965797A5432EBE5279" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:to="loc_us-gaap_ContractsRevenue_1BA7F8E407127E965797A5432EBE5279" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="loc_us-gaap_RoyaltyRevenue_DAA66C90B6BAF23E23FDA5432EBE570F" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:to="loc_us-gaap_RoyaltyRevenue_DAA66C90B6BAF23E23FDA5432EBE570F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_D377880CE18D52867081A5432EBED95D" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0F05B0B9EDC44E6B7B77A5432EBE37B2" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_D377880CE18D52867081A5432EBED95D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/CollaborationsContractsAndLicensingAgreementsRevenueRecognizedUnderCollaborationsContractsAndLicensingAgreementsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueDisclosureAbstract" xlink:label="loc_us-gaap_DeferredRevenueDisclosureAbstract_98F2C0FBDD11AD4399C591DE2B038018" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_43AD9C3A24B1898D866691DE2B03721C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueDisclosureAbstract_98F2C0FBDD11AD4399C591DE2B038018" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_43AD9C3A24B1898D866691DE2B03721C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="loc_us-gaap_CounterpartyNameAxis_50A35DC360BFB718916691DE2B037C5A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_43AD9C3A24B1898D866691DE2B03721C" xlink:to="loc_us-gaap_CounterpartyNameAxis_50A35DC360BFB718916691DE2B037C5A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_CCFC7A7664895AB712B691DE2B0376EF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CounterpartyNameAxis_50A35DC360BFB718916691DE2B037C5A" xlink:to="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_CCFC7A7664895AB712B691DE2B0376EF" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_DoDMember" xlink:label="loc_abus_DoDMember_4C4BB8FB9CB5CFC68C0791DE2B041F9C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_CCFC7A7664895AB712B691DE2B0376EF" xlink:to="loc_abus_DoDMember_4C4BB8FB9CB5CFC68C0791DE2B041F9C" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_MonsantoMember" xlink:label="loc_abus_MonsantoMember_9D4137A68942D2CC0B2591DE2B043B1D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_CCFC7A7664895AB712B691DE2B0376EF" xlink:to="loc_abus_MonsantoMember_9D4137A68942D2CC0B2591DE2B043B1D" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_BMSMember" xlink:label="loc_abus_BMSMember_7E95F9E17F954D40468991DE2B0461BA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_CCFC7A7664895AB712B691DE2B0376EF" xlink:to="loc_abus_BMSMember_7E95F9E17F954D40468991DE2B0461BA" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_DicernaMember" xlink:label="loc_abus_DicernaMember_7AACEA6F6D4F21C3AF9791DE2B04BD5B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_CCFC7A7664895AB712B691DE2B0376EF" xlink:to="loc_abus_DicernaMember_7AACEA6F6D4F21C3AF9791DE2B04BD5B" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_OtherMilestoneandRoyaltyPaymentsMember" xlink:label="loc_abus_OtherMilestoneandRoyaltyPaymentsMember_7B1B608EBF0B964BE30891DE2B04D8F4" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_CCFC7A7664895AB712B691DE2B0376EF" xlink:to="loc_abus_OtherMilestoneandRoyaltyPaymentsMember_7B1B608EBF0B964BE30891DE2B04D8F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_CEAF9E182E0902EF49D591DE2B04F6AF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_43AD9C3A24B1898D866691DE2B03721C" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_CEAF9E182E0902EF49D591DE2B04F6AF" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_CollaborationsAndContractsAbstract" xlink:label="loc_abus_CollaborationsAndContractsAbstract_D25CBBB8556FE4FE11B591DE2B049489" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_CEAF9E182E0902EF49D591DE2B04F6AF" xlink:to="loc_abus_CollaborationsAndContractsAbstract_D25CBBB8556FE4FE11B591DE2B049489" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContractsRevenue" xlink:label="loc_us-gaap_ContractsRevenue_E922B6EBA4681A0F974191DE2B0441FC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_CollaborationsAndContractsAbstract_D25CBBB8556FE4FE11B591DE2B049489" xlink:to="loc_us-gaap_ContractsRevenue_E922B6EBA4681A0F974191DE2B0441FC" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_LicensingFeesMilestoneAndRoyaltyPaymentsAbstract" xlink:label="loc_abus_LicensingFeesMilestoneAndRoyaltyPaymentsAbstract_984B45A082903C1195EC91DE2B04E6C5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_CEAF9E182E0902EF49D591DE2B04F6AF" xlink:to="loc_abus_LicensingFeesMilestoneAndRoyaltyPaymentsAbstract_984B45A082903C1195EC91DE2B04E6C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LicensesRevenue" xlink:label="loc_us-gaap_LicensesRevenue_CD0AEAE113C60D039E0B91DE2B050188" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_LicensingFeesMilestoneAndRoyaltyPaymentsAbstract_984B45A082903C1195EC91DE2B04E6C5" xlink:to="loc_us-gaap_LicensesRevenue_CD0AEAE113C60D039E0B91DE2B050188" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_B92DE55E6432CC448E0C91DE2B058BF8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_CEAF9E182E0902EF49D591DE2B04F6AF" xlink:to="loc_us-gaap_Revenues_B92DE55E6432CC448E0C91DE2B058BF8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/CollaborationsContractsAndLicensingAgreementsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueDisclosureAbstract" xlink:label="loc_us-gaap_DeferredRevenueDisclosureAbstract_4F8A09763E3A5A4C8368A5432EBE5DFD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_7FF191F6CE057DAA11E8A5432ECD0E15" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueDisclosureAbstract_4F8A09763E3A5A4C8368A5432EBE5DFD" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_7FF191F6CE057DAA11E8A5432ECD0E15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueByArrangementDisclosureTextBlock" xlink:label="loc_us-gaap_DeferredRevenueByArrangementDisclosureTextBlock_B08C42317CF50EE6CDFCA5432ECDD2D3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueDisclosureAbstract_4F8A09763E3A5A4C8368A5432EBE5DFD" xlink:to="loc_us-gaap_DeferredRevenueByArrangementDisclosureTextBlock_B08C42317CF50EE6CDFCA5432ECDD2D3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ConcentrationsOfBusinessRisk" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_4DAD4319CDA311A400E4879247F4D379" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_7A81AC44BB5514E91963879247F42EB5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_4DAD4319CDA311A400E4879247F4D379" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_7A81AC44BB5514E91963879247F42EB5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ConcentrationsOfBusinessRiskDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_9810DBB5248E0F48BAB8877B8C9C481A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_1B699BE3B7E703A4A42E877B8C9C78CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_9810DBB5248E0F48BAB8877B8C9C481A" xlink:to="loc_us-gaap_AccountsReceivableNet_1B699BE3B7E703A4A42E877B8C9C78CB" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ThresholdPeriodToPayAccountsPayables" xlink:label="loc_abus_ThresholdPeriodToPayAccountsPayables_C3628CC206550958F6A7877B8C9C13A4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_9810DBB5248E0F48BAB8877B8C9C481A" xlink:to="loc_abus_ThresholdPeriodToPayAccountsPayables_C3628CC206550958F6A7877B8C9C13A4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ConcentrationsOfBusinessRiskForeignCurrencyExposureDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_CADF55EF18A26752800F877B8C94F05F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:label="loc_us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable_9D6410234BA77A46B6EA877B8C9473DE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_CADF55EF18A26752800F877B8C94F05F" xlink:to="loc_us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable_9D6410234BA77A46B6EA877B8C9473DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1E9F921B42ECF478D90B877B8C94D6FF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable_9D6410234BA77A46B6EA877B8C9473DE" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1E9F921B42ECF478D90B877B8C94D6FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_D9A31A8031BA34BE417C877B8C94570A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1E9F921B42ECF478D90B877B8C94D6FF" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_D9A31A8031BA34BE417C877B8C94570A" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ForeignCurrencyExposureMember" xlink:label="loc_abus_ForeignCurrencyExposureMember_CD2B3D3D0F81A29C7A6E877B8C9456E3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_D9A31A8031BA34BE417C877B8C94570A" xlink:to="loc_abus_ForeignCurrencyExposureMember_CD2B3D3D0F81A29C7A6E877B8C9456E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceLineItems" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceLineItems_D78B8AA906190F180472877B8C94B5ED" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable_9D6410234BA77A46B6EA877B8C9473DE" xlink:to="loc_us-gaap_IntercompanyForeignCurrencyBalanceLineItems_D78B8AA906190F180472877B8C94B5ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_A97E631F85E98E1A7664877B8C9483C2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceLineItems_D78B8AA906190F180472877B8C94B5ED" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_A97E631F85E98E1A7664877B8C9483C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_9E52AD5F89C787D29E12877B8C94CA78" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceLineItems_D78B8AA906190F180472877B8C94B5ED" xlink:to="loc_us-gaap_AccountsReceivableNet_9E52AD5F89C787D29E12877B8C94CA78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent_F04F11B61B93C292FCCA877B8C94546E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceLineItems_D78B8AA906190F180472877B8C94B5ED" xlink:to="loc_us-gaap_UnbilledReceivablesCurrent_F04F11B61B93C292FCCA877B8C94546E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_8BE73E618786EFA86550877B8C94C244" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceLineItems_D78B8AA906190F180472877B8C94B5ED" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_8BE73E618786EFA86550877B8C94C244" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ExposuretoCanadianDollar" xlink:label="loc_abus_ExposuretoCanadianDollar_62D3FC3B7A7AE714984C878CC805EEBF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceLineItems_D78B8AA906190F180472877B8C94B5ED" xlink:to="loc_abus_ExposuretoCanadianDollar_62D3FC3B7A7AE714984C878CC805EEBF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ConcentrationsOfBusinessRiskNetLiquidityOfCompanyDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_6AAD7DF15BDACD706093877B8C98EF81" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_0E26421734218DAF8161877B8C986B38" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_6AAD7DF15BDACD706093877B8C98EF81" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_0E26421734218DAF8161877B8C986B38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_7C6A12782C49D401CD2F877B8C990880" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_6AAD7DF15BDACD706093877B8C98EF81" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_7C6A12782C49D401CD2F877B8C990880" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_NetLiquidity" xlink:label="loc_abus_NetLiquidity_E487263E7C8B985200C9877B8C99FAEF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_6AAD7DF15BDACD706093877B8C98EF81" xlink:to="loc_abus_NetLiquidity_E487263E7C8B985200C9877B8C99FAEF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ConcentrationsOfBusinessRiskTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_E6CBDCEF4A75C9F1B7EBFE99583364C5" xlink:type="locator" />
    <link:loc xlink:href="abus-20161231.xsd#abus_NetLiquidityDisclosureTableTextBlock" xlink:label="loc_abus_NetLiquidityDisclosureTableTextBlock_60075A449EB2EF057BEDFE9958336CFD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_E6CBDCEF4A75C9F1B7EBFE99583364C5" xlink:to="loc_abus_NetLiquidityDisclosureTableTextBlock_60075A449EB2EF057BEDFE9958336CFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock" xlink:label="loc_us-gaap_ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock_AC91EDE0296FD80BE3FBFE995834FEF9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_E6CBDCEF4A75C9F1B7EBFE99583364C5" xlink:to="loc_us-gaap_ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock_AC91EDE0296FD80BE3FBFE995834FEF9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_FB154785E414A0CFECF98F837E91EEC1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_BF6853BAAF1E6DCA24758F837E91938E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_FB154785E414A0CFECF98F837E91EEC1" xlink:to="loc_us-gaap_AssetsAbstract_BF6853BAAF1E6DCA24758F837E91938E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_3598C2587BAD3E35995D8F837E91439F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_BF6853BAAF1E6DCA24758F837E91938E" xlink:to="loc_us-gaap_AssetsCurrentAbstract_3598C2587BAD3E35995D8F837E91439F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_F2F14DFBF9CDD93DB68D8F837E91C561" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3598C2587BAD3E35995D8F837E91439F" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_F2F14DFBF9CDD93DB68D8F837E91C561" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaap_ShortTermInvestments_5139C9FCCB48A984317D8F837E91DC70" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3598C2587BAD3E35995D8F837E91439F" xlink:to="loc_us-gaap_ShortTermInvestments_5139C9FCCB48A984317D8F837E91DC70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_9F563B748214831CB0FA8F837E9168AE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3598C2587BAD3E35995D8F837E91439F" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_9F563B748214831CB0FA8F837E9168AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent_C01131002AB98A22CAAF8F837E916D0F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3598C2587BAD3E35995D8F837E91439F" xlink:to="loc_us-gaap_UnbilledReceivablesCurrent_C01131002AB98A22CAAF8F837E916D0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="loc_us-gaap_IncomeTaxesReceivable_26886F3A2B55B94697498F837E912B96" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3598C2587BAD3E35995D8F837E91439F" xlink:to="loc_us-gaap_IncomeTaxesReceivable_26886F3A2B55B94697498F837E912B96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_95C1208919D040F0D70D8F837E925A85" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3598C2587BAD3E35995D8F837E91439F" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_95C1208919D040F0D70D8F837E925A85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_53A8BA9DDB7C69D1C5998F837E92B273" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3598C2587BAD3E35995D8F837E91439F" xlink:to="loc_us-gaap_AssetsCurrent_53A8BA9DDB7C69D1C5998F837E92B273" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedInvestmentsNoncurrent" xlink:label="loc_us-gaap_RestrictedInvestmentsNoncurrent_6EF792061080E50E869B8F837E92DA16" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_BF6853BAAF1E6DCA24758F837E91938E" xlink:to="loc_us-gaap_RestrictedInvestmentsNoncurrent_6EF792061080E50E869B8F837E92DA16" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermInvestments" xlink:label="loc_us-gaap_LongTermInvestments_675206D3ADD3717DB5268F837E92000E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_BF6853BAAF1E6DCA24758F837E91938E" xlink:to="loc_us-gaap_LongTermInvestments_675206D3ADD3717DB5268F837E92000E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_14E90FA2A4164B367B358F837E92638D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_BF6853BAAF1E6DCA24758F837E91938E" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_14E90FA2A4164B367B358F837E92638D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_EE3165B894A7C96FEB108F837E92007C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_BF6853BAAF1E6DCA24758F837E91938E" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_EE3165B894A7C96FEB108F837E92007C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_41EB57394506C28E96A98F837E923818" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_BF6853BAAF1E6DCA24758F837E91938E" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_41EB57394506C28E96A98F837E923818" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_A35EE4B5DBAA7F21F09A8F837E927962" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_BF6853BAAF1E6DCA24758F837E91938E" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_A35EE4B5DBAA7F21F09A8F837E927962" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_A3050FFAD2C7A1D696A98F837E92CB74" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_BF6853BAAF1E6DCA24758F837E91938E" xlink:to="loc_us-gaap_Goodwill_A3050FFAD2C7A1D696A98F837E92CB74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_2C069653FD54C5E721EC8F837E924FC8" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_BF6853BAAF1E6DCA24758F837E91938E" xlink:to="loc_us-gaap_Assets_2C069653FD54C5E721EC8F837E924FC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_F8E4B21DE5B2516A40438F837E9201C1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_FB154785E414A0CFECF98F837E91EEC1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_F8E4B21DE5B2516A40438F837E9201C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9F17271CF5DEC30874C78F837E92807B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_F8E4B21DE5B2516A40438F837E9201C1" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_9F17271CF5DEC30874C78F837E92807B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3C0C7E002045CDD93D9C8F837E929FBD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9F17271CF5DEC30874C78F837E92807B" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3C0C7E002045CDD93D9C8F837E929FBD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_E26D3E625346DAB12DF08F837E9294C3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9F17271CF5DEC30874C78F837E92807B" xlink:to="loc_us-gaap_DeferredRevenueCurrent_E26D3E625346DAB12DF08F837E9294C3" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EmployeeStockOptionsLiabilityClassifiedOutstanding" xlink:label="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstanding_3ABE6CFD3609C70B1F7A8F837E92A9A3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9F17271CF5DEC30874C78F837E92807B" xlink:to="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstanding_3ABE6CFD3609C70B1F7A8F837E92A9A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_6CF05A1682E3EC671BDC8F837E92B643" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9F17271CF5DEC30874C78F837E92807B" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_6CF05A1682E3EC671BDC8F837E92B643" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_3D332BCF0C5F4E0CEC388F837E92645D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9F17271CF5DEC30874C78F837E92807B" xlink:to="loc_us-gaap_LiabilitiesCurrent_3D332BCF0C5F4E0CEC388F837E92645D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_5494644D00EB7121950E8F837E924B7C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_F8E4B21DE5B2516A40438F837E9201C1" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_5494644D00EB7121950E8F837E924B7C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaap_LongTermLoansPayable_65F39A363AA0A19961798F837E92D16D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_F8E4B21DE5B2516A40438F837E9201C1" xlink:to="loc_us-gaap_LongTermLoansPayable_65F39A363AA0A19961798F837E92D16D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_F2181652D7657D08EDA68F837E929FB5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_F8E4B21DE5B2516A40438F837E9201C1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_F2181652D7657D08EDA68F837E929FB5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_FA37D069F1787231A0C38F837E925EA9" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_F8E4B21DE5B2516A40438F837E9201C1" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_FA37D069F1787231A0C38F837E925EA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_6530FED89171FABE3C978F837E9363B0" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_F8E4B21DE5B2516A40438F837E9201C1" xlink:to="loc_us-gaap_Liabilities_6530FED89171FABE3C978F837E9363B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_496BA5798D7C6475D6EF8F837E93F909" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_F8E4B21DE5B2516A40438F837E9201C1" xlink:to="loc_us-gaap_StockholdersEquityAbstract_496BA5798D7C6475D6EF8F837E93F909" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_64C052226CCA88A590068F837E93BF78" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_496BA5798D7C6475D6EF8F837E93F909" xlink:to="loc_us-gaap_CommonStockValue_64C052226CCA88A590068F837E93BF78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_A1B5946804127B2D915A8F837E93DBF5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_496BA5798D7C6475D6EF8F837E93F909" xlink:to="loc_us-gaap_AdditionalPaidInCapital_A1B5946804127B2D915A8F837E93DBF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6D9BB63BBE4A654A00B68F837E930AFB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_496BA5798D7C6475D6EF8F837E93F909" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6D9BB63BBE4A654A00B68F837E930AFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_486B40478DE43CDEAF158F837E93B04E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_496BA5798D7C6475D6EF8F837E93F909" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_486B40478DE43CDEAF158F837E93B04E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_9FD599E9AD635DBC12328F837E93B389" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_496BA5798D7C6475D6EF8F837E93F909" xlink:to="loc_us-gaap_StockholdersEquity_9FD599E9AD635DBC12328F837E93B389" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_D883764958F1A2C8C0C58F837E930666" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_FB154785E414A0CFECF98F837E91EEC1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_D883764958F1A2C8C0C58F837E930666" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9711C4018CBDD70BB505FE9957CDF764" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaap_CommonStockNoParValue_3F2DB91E904D47A0A5EDFE9957CE0E81" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9711C4018CBDD70BB505FE9957CDF764" xlink:to="loc_us-gaap_CommonStockNoParValue_3F2DB91E904D47A0A5EDFE9957CE0E81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_D42F2E00363FCFC5C598FE9957CE0959" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9711C4018CBDD70BB505FE9957CDF764" xlink:to="loc_us-gaap_CommonStockSharesIssued_D42F2E00363FCFC5C598FE9957CE0959" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_16EF6E1AEE83BC7DBB07FE9957CEFC88" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9711C4018CBDD70BB505FE9957CDF764" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_16EF6E1AEE83BC7DBB07FE9957CEFC88" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ConsolidatedStatementOfStockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_FEF3959818AB9888F219CF89C8D7229E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_8A2637DB96D4B479D7D8CF89C8D7DB94" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_FEF3959818AB9888F219CF89C8D7229E" xlink:to="loc_us-gaap_StatementTable_8A2637DB96D4B479D7D8CF89C8D7DB94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_763BA5681DC76C8D74D1CF89C8D7191C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8A2637DB96D4B479D7D8CF89C8D7DB94" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_763BA5681DC76C8D74D1CF89C8D7191C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_B01544B0F2CEBE53FB7CCF89C8D74B09" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_763BA5681DC76C8D74D1CF89C8D7191C" xlink:to="loc_us-gaap_EquityComponentDomain_B01544B0F2CEBE53FB7CCF89C8D74B09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_DE8FEAE21B0F1CB182B9CF89C8D7DC49" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_B01544B0F2CEBE53FB7CCF89C8D74B09" xlink:to="loc_us-gaap_CommonStockMember_DE8FEAE21B0F1CB182B9CF89C8D7DC49" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_DF02EE494528C78E5777CF89C8D77FF2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_B01544B0F2CEBE53FB7CCF89C8D74B09" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_DF02EE494528C78E5777CF89C8D77FF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_B370A5CD3AB45C279A87CF89C8D7A6BA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_B01544B0F2CEBE53FB7CCF89C8D74B09" xlink:to="loc_us-gaap_RetainedEarningsMember_B370A5CD3AB45C279A87CF89C8D7A6BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_859FF73FBAECEC0874CACF89C8D79C1C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_B01544B0F2CEBE53FB7CCF89C8D74B09" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_859FF73FBAECEC0874CACF89C8D79C1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8A2637DB96D4B479D7D8CF89C8D7DB94" xlink:to="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_6FDD8804F9EF6683A42CCF89C8D9863E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_us-gaap_SharesIssued_6FDD8804F9EF6683A42CCF89C8D9863E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_0B2B982E7E1FDD29C6A3CF89C8D9FD90" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_us-gaap_StockholdersEquity_0B2B982E7E1FDD29C6A3CF89C8D9FD90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_B048A6B8330F9B7AED20CF89C8D9ACBD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_B048A6B8330F9B7AED20CF89C8D9ACBD" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_AdjustmentstoAdditionalPaidinCapitalReclassificationofEquitytoLiabilityStockOptionAwards" xlink:label="loc_abus_AdjustmentstoAdditionalPaidinCapitalReclassificationofEquitytoLiabilityStockOptionAwards_E47A121E6F580518E459CF89C8D9D367" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_abus_AdjustmentstoAdditionalPaidinCapitalReclassificationofEquitytoLiabilityStockOptionAwards_E47A121E6F580518E459CF89C8D9D367" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_AdjustmentstoAdditionalPaidinCapitalCertainFairValueAdjustmentstoLiabilityStockOptionAwards" xlink:label="loc_abus_AdjustmentstoAdditionalPaidinCapitalCertainFairValueAdjustmentstoLiabilityStockOptionAwards_50D2E0AAD9534FD3255ECF89C8D9E182" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_abus_AdjustmentstoAdditionalPaidinCapitalCertainFairValueAdjustmentstoLiabilityStockOptionAwards_50D2E0AAD9534FD3255ECF89C8D9E182" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_310BAD9754652A09FB96CF89C8D9170E" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_310BAD9754652A09FB96CF89C8D9170E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2FA59BAF5045622C2AC7CF89C8D9B926" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2FA59BAF5045622C2AC7CF89C8D9B926" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_B88C1E3341784373BBE9CF89C8D97152" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_B88C1E3341784373BBE9CF89C8D97152" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_D9E0197A5A1A43874A23CF89C8D9CF2A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_D9E0197A5A1A43874A23CF89C8D9CF2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_52FCD7E5A28EDAFA1B5ECF89C8D9F1E5" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_52FCD7E5A28EDAFA1B5ECF89C8D9F1E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_FE32543FB07BB5EBCD27CF89C8D9C26D" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_FE32543FB07BB5EBCD27CF89C8D9C26D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_CFA6DD895B3EAD61076DCF89C8D94998" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_CFA6DD895B3EAD61076DCF89C8D94998" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_5F0168EDE16974332A38CF89C8D9EC9C" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_5F0168EDE16974332A38CF89C8D9EC9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_C67A7F3B673717A08B53CF89C8D99AFC" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_C67A7F3B673717A08B53CF89C8D99AFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_F9183AAE04EB65E832A9CF89C8D970ED" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_us-gaap_NetIncomeLoss_F9183AAE04EB65E832A9CF89C8D970ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_AEEBB673DDD97CF70BC6CF89C8D92BD9" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_us-gaap_SharesIssued_AEEBB673DDD97CF70BC6CF89C8D92BD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_8CD3709EEA03238B0848CF89C8D9A449" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7487B8BDC628C86E910FCF89C8D9F094" xlink:to="loc_us-gaap_StockholdersEquity_8CD3709EEA03238B0848CF89C8D9A449" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ConsolidatedStatementOfStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_67C7B4CBF76F1FD2A5BCCED59F48AFC9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_4923B32725C4F04A36D3CED59F48CA97" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_67C7B4CBF76F1FD2A5BCCED59F48AFC9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_4923B32725C4F04A36D3CED59F48CA97" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_B7DA4B758E1CE4BC83ABB50A1DBC8AFE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_7D2F4635BE41A75F6F8BB50A1DBC5012" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_B7DA4B758E1CE4BC83ABB50A1DBC8AFE" xlink:to="loc_us-gaap_StatementTable_7D2F4635BE41A75F6F8BB50A1DBC5012" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_E6410DD45959A7E1F63AB50A1DBDC3C5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7D2F4635BE41A75F6F8BB50A1DBC5012" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_E6410DD45959A7E1F63AB50A1DBDC3C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_F1CF762C66CEC38F1AB4B50A1DBDD505" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_E6410DD45959A7E1F63AB50A1DBDC3C5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_F1CF762C66CEC38F1AB4B50A1DBDD505" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_B3F4FA9144A43C339E79B50A1DBD3B60" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F1CF762C66CEC38F1AB4B50A1DBDD505" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_B3F4FA9144A43C339E79B50A1DBD3B60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_57FDF281C6759E875305B50A1DBDAEDC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F1CF762C66CEC38F1AB4B50A1DBDD505" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_57FDF281C6759E875305B50A1DBDAEDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_4755B28794C233CEEBDDB50A1DBDA68F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7D2F4635BE41A75F6F8BB50A1DBC5012" xlink:to="loc_us-gaap_StatementLineItems_4755B28794C233CEEBDDB50A1DBDA68F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0F0E9FFFD91D75DA8DBFB50A1DBD5E10" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4755B28794C233CEEBDDB50A1DBDA68F" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0F0E9FFFD91D75DA8DBFB50A1DBD5E10" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_2482F77E738435FFF1F6B50A1DBDDD53" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0F0E9FFFD91D75DA8DBFB50A1DBD5E10" xlink:to="loc_us-gaap_NetIncomeLoss_2482F77E738435FFF1F6B50A1DBDDD53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_115A564989FB382AEBD0B50A1DBD4520" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0F0E9FFFD91D75DA8DBFB50A1DBD5E10" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_115A564989FB382AEBD0B50A1DBD4520" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_83A47DF0246EEBFEBE1AB50A1DBD64F8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_115A564989FB382AEBD0B50A1DBD4520" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_83A47DF0246EEBFEBE1AB50A1DBD64F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_C02636330118C7F1DD88B50A1DBDD21C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_115A564989FB382AEBD0B50A1DBD4520" xlink:to="loc_us-gaap_Depreciation_C02636330118C7F1DD88B50A1DBDD21C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1C889624E1D1E919A574B50A1DBD2282" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_115A564989FB382AEBD0B50A1DBD4520" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1C889624E1D1E919A574B50A1DBD2282" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_31AFF83D55F1707E0314B50A1DBEA56E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_115A564989FB382AEBD0B50A1DBD4520" xlink:to="loc_us-gaap_ShareBasedCompensation_31AFF83D55F1707E0314B50A1DBEA56E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_456D60AE91010DDEECADB50A1DBEC4D5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_115A564989FB382AEBD0B50A1DBD4520" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_456D60AE91010DDEECADB50A1DBEC4D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_BBFEF3DC363E7279218BB50A1DBE8A63" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_115A564989FB382AEBD0B50A1DBD4520" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_BBFEF3DC363E7279218BB50A1DBE8A63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6ED93AA6221E2B3E82ECB50A1DBE95A4" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_115A564989FB382AEBD0B50A1DBD4520" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6ED93AA6221E2B3E82ECB50A1DBE95A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_C3A823E7D30D8D434375B50A1DBEFFF1" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_115A564989FB382AEBD0B50A1DBD4520" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_C3A823E7D30D8D434375B50A1DBEFFF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_A85CF6CAEB09ECD5334BB50A1DBE57DF" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_115A564989FB382AEBD0B50A1DBD4520" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_A85CF6CAEB09ECD5334BB50A1DBE57DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_F1ED604D097A287F4D0AB50A1DBECF39" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0F0E9FFFD91D75DA8DBFB50A1DBD5E10" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_F1ED604D097A287F4D0AB50A1DBECF39" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8B9515A9EAA0F6E6FF67B50A1DBEB60C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_F1ED604D097A287F4D0AB50A1DBECF39" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8B9515A9EAA0F6E6FF67B50A1DBEB60C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInUnbilledReceivables_AC43EA72CAE2CCA86E93B50A1DBEB94E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_F1ED604D097A287F4D0AB50A1DBECF39" xlink:to="loc_us-gaap_IncreaseDecreaseInUnbilledReceivables_AC43EA72CAE2CCA86E93B50A1DBEB94E" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_IncreaseDecreaseOtherDeferredCostsNet" xlink:label="loc_abus_IncreaseDecreaseOtherDeferredCostsNet_38162CCACE2DAA96419AB50A1DBE42D0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_F1ED604D097A287F4D0AB50A1DBECF39" xlink:to="loc_abus_IncreaseDecreaseOtherDeferredCostsNet_38162CCACE2DAA96419AB50A1DBE42D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_5519E1EF9CD228B22A53B50A1DBE268C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_F1ED604D097A287F4D0AB50A1DBECF39" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_5519E1EF9CD228B22A53B50A1DBE268C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1899A74A07C73F23347CB50A1DBEF03B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_F1ED604D097A287F4D0AB50A1DBECF39" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1899A74A07C73F23347CB50A1DBEF03B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_376ADD92BC15B6721E4FB50A1DBE29F2" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_F1ED604D097A287F4D0AB50A1DBECF39" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_376ADD92BC15B6721E4FB50A1DBE29F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_1E8B13B57B1806092D86B50A1DC3ECB2" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_F1ED604D097A287F4D0AB50A1DBECF39" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_1E8B13B57B1806092D86B50A1DC3ECB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5BC9C03CAD0115130F08B50A1DC34A87" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4755B28794C233CEEBDDB50A1DBDA68F" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5BC9C03CAD0115130F08B50A1DC34A87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0E77C5D77E86CCB0BDD2B50A1DC48A12" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4755B28794C233CEEBDDB50A1DBDA68F" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0E77C5D77E86CCB0BDD2B50A1DC48A12" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromInvestments" xlink:label="loc_us-gaap_PaymentsForProceedsFromInvestments_E16FC3EBC1D9CB8DF21AB50A1DC465F3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0E77C5D77E86CCB0BDD2B50A1DC48A12" xlink:to="loc_us-gaap_PaymentsForProceedsFromInvestments_E16FC3EBC1D9CB8DF21AB50A1DC465F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireRestrictedInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireRestrictedInvestments_F7F31253ECD0D5450789B50A1DC49AC0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0E77C5D77E86CCB0BDD2B50A1DC48A12" xlink:to="loc_us-gaap_PaymentsToAcquireRestrictedInvestments_F7F31253ECD0D5450789B50A1DC49AC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_8ED44757FE557710C3E1B50A1DC4208D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0E77C5D77E86CCB0BDD2B50A1DC48A12" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_8ED44757FE557710C3E1B50A1DC4208D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_E6C88649732D2CC37FF5B50A1DC4F323" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0E77C5D77E86CCB0BDD2B50A1DC48A12" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_E6C88649732D2CC37FF5B50A1DC4F323" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7EF891392E9E1214EAD0B50A1DC4BF67" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0E77C5D77E86CCB0BDD2B50A1DC48A12" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7EF891392E9E1214EAD0B50A1DC4BF67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5D7AC30AAF4AA4A3815EB50A1DC43209" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4755B28794C233CEEBDDB50A1DBDA68F" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5D7AC30AAF4AA4A3815EB50A1DC43209" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_AAA61781A91AA79832CEB50A1DC4A4F6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4755B28794C233CEEBDDB50A1DBDA68F" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_AAA61781A91AA79832CEB50A1DC4A4F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_C9B2C83EDE376055B34CB50A1DC4AB79" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_AAA61781A91AA79832CEB50A1DC4A4F6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_C9B2C83EDE376055B34CB50A1DC4AB79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_FD5787E5CB9FDF4D0519B50A1DC4B166" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_AAA61781A91AA79832CEB50A1DC4A4F6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_FD5787E5CB9FDF4D0519B50A1DC4B166" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_D67759A57D5D6D28C817B50A1DC4DE5C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_AAA61781A91AA79832CEB50A1DC4A4F6" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_D67759A57D5D6D28C817B50A1DC4DE5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_0F416DD56682EAE6C048B50A1DC47610" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_AAA61781A91AA79832CEB50A1DC4A4F6" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_0F416DD56682EAE6C048B50A1DC47610" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_C4010160043141834230B50A1DC4BEAE" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4755B28794C233CEEBDDB50A1DBDA68F" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_C4010160043141834230B50A1DC4BEAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_DD8724DC903B4E571853B50A1DC42179" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4755B28794C233CEEBDDB50A1DBDA68F" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_DD8724DC903B4E571853B50A1DC42179" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_A326A51A71449792AAB7B50A1DC47C9B" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4755B28794C233CEEBDDB50A1DBDA68F" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_A326A51A71449792AAB7B50A1DC47C9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_656272E467EA7F5F254CB50A1DC45876" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4755B28794C233CEEBDDB50A1DBDA68F" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_656272E467EA7F5F254CB50A1DC45876" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_E55F0B7535C99A363ECEB50A1DC5576B" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4755B28794C233CEEBDDB50A1DBDA68F" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_E55F0B7535C99A363ECEB50A1DC5576B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_E1FB62C9E01CB8716D56B50A1DC5CABD" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4755B28794C233CEEBDDB50A1DBDA68F" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_E1FB62C9E01CB8716D56B50A1DC5CABD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_4449301C73FA2B5D87DBB50A1DC57E70" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_E1FB62C9E01CB8716D56B50A1DC5CABD" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_4449301C73FA2B5D87DBB50A1DC57E70" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_FairValueofWarrantsExercisedonaCashlessBasis" xlink:label="loc_abus_FairValueofWarrantsExercisedonaCashlessBasis_9CA4D66B52C064FA3740B50A1DC5C8AA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_E1FB62C9E01CB8716D56B50A1DC5CABD" xlink:to="loc_abus_FairValueofWarrantsExercisedonaCashlessBasis_9CA4D66B52C064FA3740B50A1DC5C8AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIncomeTaxRefunds" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds_AC7140DB396D41A7041DB50A1DC57233" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_E1FB62C9E01CB8716D56B50A1DC5CABD" xlink:to="loc_us-gaap_ProceedsFromIncomeTaxRefunds_AC7140DB396D41A7041DB50A1DC57233" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_78A6740BE6708D578119B50A1DC5E228" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_E1FB62C9E01CB8716D56B50A1DC5CABD" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_78A6740BE6708D578119B50A1DC5E228" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_FBDE5F546141BB838E6AAF7881C76711" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_2CF7FC95B1EFADEF0C18AF7881C7DE0B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FBDE5F546141BB838E6AAF7881C76711" xlink:to="loc_us-gaap_RevenuesAbstract_2CF7FC95B1EFADEF0C18AF7881C7DE0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContractsRevenue" xlink:label="loc_us-gaap_ContractsRevenue_56D2AF6C5E2960015A22AF7881C75BBA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_2CF7FC95B1EFADEF0C18AF7881C7DE0B" xlink:to="loc_us-gaap_ContractsRevenue_56D2AF6C5E2960015A22AF7881C75BBA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LicensesRevenue" xlink:label="loc_us-gaap_LicensesRevenue_F8EA5FC501DC99EC0ECDAF7881C77CD0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_2CF7FC95B1EFADEF0C18AF7881C7DE0B" xlink:to="loc_us-gaap_LicensesRevenue_F8EA5FC501DC99EC0ECDAF7881C77CD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_3B9EF734EB1F5A06A2D4AF7881C77544" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_2CF7FC95B1EFADEF0C18AF7881C7DE0B" xlink:to="loc_us-gaap_Revenues_3B9EF734EB1F5A06A2D4AF7881C77544" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_7CF35460C0E5EF0B7BA5AF7881C7876B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FBDE5F546141BB838E6AAF7881C76711" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_7CF35460C0E5EF0B7BA5AF7881C7876B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_105AE8219D4F4585DB32AF7881C7A0EF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_7CF35460C0E5EF0B7BA5AF7881C7876B" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_105AE8219D4F4585DB32AF7881C7A0EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_D1611926CA54ACC38B25AF7881C78236" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_7CF35460C0E5EF0B7BA5AF7881C7876B" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_D1611926CA54ACC38B25AF7881C78236" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_683D783BDD6F6ACB98F1AF7881C71417" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_7CF35460C0E5EF0B7BA5AF7881C7876B" xlink:to="loc_us-gaap_Depreciation_683D783BDD6F6ACB98F1AF7881C71417" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_05B72FB2EA8DBDE5575EAF7881C7FDBA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_7CF35460C0E5EF0B7BA5AF7881C7876B" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_05B72FB2EA8DBDE5575EAF7881C7FDBA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_8E1997E5D334FA9605C7AF7881C82199" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_7CF35460C0E5EF0B7BA5AF7881C7876B" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_8E1997E5D334FA9605C7AF7881C82199" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_821AB0B18FB8382D0185AF7D827FA781" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_7CF35460C0E5EF0B7BA5AF7881C7876B" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_821AB0B18FB8382D0185AF7D827FA781" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_8FD31802B139613BB230AF7881C83A03" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_7CF35460C0E5EF0B7BA5AF7881C7876B" xlink:to="loc_us-gaap_OperatingExpenses_8FD31802B139613BB230AF7881C83A03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_8DDE51C2A540608C49BCAF7881C85ED5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FBDE5F546141BB838E6AAF7881C76711" xlink:to="loc_us-gaap_OperatingIncomeLoss_8DDE51C2A540608C49BCAF7881C85ED5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_689677F622DF757AD135AF7881C87D5E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FBDE5F546141BB838E6AAF7881C76711" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_689677F622DF757AD135AF7881C87D5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_EA6B113438AFD49A1551AF7881C80848" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_689677F622DF757AD135AF7881C87D5E" xlink:to="loc_us-gaap_InvestmentIncomeInterest_EA6B113438AFD49A1551AF7881C80848" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_E2994FD0B2C3792E81B4AF7881C84687" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_689677F622DF757AD135AF7881C87D5E" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_E2994FD0B2C3792E81B4AF7881C84687" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_OptionExercisedContractualOptionRevenueAmount" xlink:label="loc_abus_OptionExercisedContractualOptionRevenueAmount_792E1B57CC69A7A78FBEAF7881C87987" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_689677F622DF757AD135AF7881C87D5E" xlink:to="loc_abus_OptionExercisedContractualOptionRevenueAmount_792E1B57CC69A7A78FBEAF7881C87987" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_3D15830765299FD46F9AAF7881C8F3A9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_689677F622DF757AD135AF7881C87D5E" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_3D15830765299FD46F9AAF7881C8F3A9" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_IncreaseDecreaseInFairValueOfContingentConsiderationLiability" xlink:label="loc_abus_IncreaseDecreaseInFairValueOfContingentConsiderationLiability_701425E1A6E9C418072DAF7881C8DA2E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_689677F622DF757AD135AF7881C87D5E" xlink:to="loc_abus_IncreaseDecreaseInFairValueOfContingentConsiderationLiability_701425E1A6E9C418072DAF7881C8DA2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2E82F4A49E421AAC5B82AF7881C8DFDE" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_689677F622DF757AD135AF7881C87D5E" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2E82F4A49E421AAC5B82AF7881C8DFDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0ED16BA0F625F5EE06B7AF7881C86676" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FBDE5F546141BB838E6AAF7881C76711" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0ED16BA0F625F5EE06B7AF7881C86676" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_F6B3CB54FF24F5380820AF7881C8BA17" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FBDE5F546141BB838E6AAF7881C76711" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_F6B3CB54FF24F5380820AF7881C8BA17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_DFDF3CC0C0460F8A6BEBAF7881C8C55F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FBDE5F546141BB838E6AAF7881C76711" xlink:to="loc_us-gaap_NetIncomeLoss_DFDF3CC0C0460F8A6BEBAF7881C8C55F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_241F46ACD43D23122A91AF7881C85BA8" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FBDE5F546141BB838E6AAF7881C76711" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_241F46ACD43D23122A91AF7881C85BA8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_16FFF84FFE59C8A69059AF7881C811E4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_241F46ACD43D23122A91AF7881C85BA8" xlink:to="loc_us-gaap_EarningsPerShareBasic_16FFF84FFE59C8A69059AF7881C811E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2B1DF23F5B64E4607A81AF7881C8F821" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_241F46ACD43D23122A91AF7881C85BA8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2B1DF23F5B64E4607A81AF7881C8F821" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0F2BCEE2A64B03BF705EAF7881C9ADB2" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FBDE5F546141BB838E6AAF7881C76711" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0F2BCEE2A64B03BF705EAF7881C9ADB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7951BCE6D7E21127C098AF7881C9E3BD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0F2BCEE2A64B03BF705EAF7881C9ADB2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7951BCE6D7E21127C098AF7881C9E3BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_354E8BFD7E107251B2AAAF7881C96D7A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0F2BCEE2A64B03BF705EAF7881C9ADB2" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_354E8BFD7E107251B2AAAF7881C96D7A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_20064EB69193BB96BB48AF7881C90358" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FBDE5F546141BB838E6AAF7881C76711" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_20064EB69193BB96BB48AF7881C90358" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_A259CF717EFE296032D3AF7881C99691" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_20064EB69193BB96BB48AF7881C90358" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_A259CF717EFE296032D3AF7881C99691" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5B362C8244D862406640AF7881C9E22D" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_FBDE5F546141BB838E6AAF7881C76711" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_5B362C8244D862406640AF7881C9E22D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ContingenciesAndCommitments" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6094333B282980BD028B87924812F9AC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2E87ED395317D724B215879248123673" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6094333B282980BD028B87924812F9AC" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2E87ED395317D724B215879248123673" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ContingenciesAndCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7CADD1E93059443946DF87BCC45D5BFD" xlink:type="locator" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ContingenciesandCommitmentsTable" xlink:label="loc_abus_ContingenciesandCommitmentsTable_AE4E878093A8882F885287BCC45DA7B0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7CADD1E93059443946DF87BCC45D5BFD" xlink:to="loc_abus_ContingenciesandCommitmentsTable_AE4E878093A8882F885287BCC45DA7B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3D33E83AA68E7A65971B87BCC46DC120" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_AE4E878093A8882F885287BCC45DA7B0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3D33E83AA68E7A65971B87BCC46DC120" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2215B6517F5C9FFA02A687BCC46DB7D1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3D33E83AA68E7A65971B87BCC46DC120" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2215B6517F5C9FFA02A687BCC46DB7D1" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_LaboratoryFacilitiesandOfficeSpaceMember" xlink:label="loc_abus_LaboratoryFacilitiesandOfficeSpaceMember_EB8C2AAA5ADBA510EFC187BCC46D32E5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2215B6517F5C9FFA02A687BCC46DB7D1" xlink:to="loc_abus_LaboratoryFacilitiesandOfficeSpaceMember_EB8C2AAA5ADBA510EFC187BCC46D32E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaap_ProductOrServiceAxis_E956E4C561D873268CBC87BCC46D1103" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_AE4E878093A8882F885287BCC45DA7B0" xlink:to="loc_us-gaap_ProductOrServiceAxis_E956E4C561D873268CBC87BCC46D1103" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaap_ProductsAndServicesDomain_A6960CEBC512FED29FCA87BCC46DF2FE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductOrServiceAxis_E956E4C561D873268CBC87BCC46D1103" xlink:to="loc_us-gaap_ProductsAndServicesDomain_A6960CEBC512FED29FCA87BCC46DF2FE" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_MarqiboMember" xlink:label="loc_abus_MarqiboMember_84A6CEEE973BD839978087BCC46DFC83" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductsAndServicesDomain_A6960CEBC512FED29FCA87BCC46DF2FE" xlink:to="loc_abus_MarqiboMember_84A6CEEE973BD839978087BCC46DFC83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="loc_us-gaap_CounterpartyNameAxis_B2A67957A022320EAA2A87BCC46D23BD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_AE4E878093A8882F885287BCC45DA7B0" xlink:to="loc_us-gaap_CounterpartyNameAxis_B2A67957A022320EAA2A87BCC46D23BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_126E433CE96D195F545587BCC46DB7A6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CounterpartyNameAxis_B2A67957A022320EAA2A87BCC46D23BD" xlink:to="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_126E433CE96D195F545587BCC46DB7A6" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_BlumbergandDrexelMember" xlink:label="loc_abus_BlumbergandDrexelMember_9DD01684F9A531C194B787BCC46DACF9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_126E433CE96D195F545587BCC46DB7A6" xlink:to="loc_abus_BlumbergandDrexelMember_9DD01684F9A531C194B787BCC46DACF9" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_BlumbergMember" xlink:label="loc_abus_BlumbergMember_0AEBB7136B77241EA1FE87BCC46DA14E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_126E433CE96D195F545587BCC46DB7A6" xlink:to="loc_abus_BlumbergMember_0AEBB7136B77241EA1FE87BCC46DA14E" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_CytosMember" xlink:label="loc_abus_CytosMember_0606A59825903FEAF59787BCC46D71FE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_126E433CE96D195F545587BCC46DB7A6" xlink:to="loc_abus_CytosMember_0606A59825903FEAF59787BCC46D71FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LitigationCaseAxis" xlink:label="loc_us-gaap_LitigationCaseAxis_D8D38EE19E57438F648287BCC46DCE41" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_AE4E878093A8882F885287BCC45DA7B0" xlink:to="loc_us-gaap_LitigationCaseAxis_D8D38EE19E57438F648287BCC46DCE41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LitigationCaseTypeDomain" xlink:label="loc_us-gaap_LitigationCaseTypeDomain_76FD6AA47DC8A577B03C87BCC46D5B94" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationCaseAxis_D8D38EE19E57438F648287BCC46DCE41" xlink:to="loc_us-gaap_LitigationCaseTypeDomain_76FD6AA47DC8A577B03C87BCC46D5B94" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ArbitrationWithTheUniversityOfBritishColumbiaMember" xlink:label="loc_abus_ArbitrationWithTheUniversityOfBritishColumbiaMember_7A5BA0AC317EFE486A9087BCC46D01ED" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationCaseTypeDomain_76FD6AA47DC8A577B03C87BCC46D5B94" xlink:to="loc_abus_ArbitrationWithTheUniversityOfBritishColumbiaMember_7A5BA0AC317EFE486A9087BCC46D01ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_88D25B1D94C442E9879687BCC46D3E9A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_AE4E878093A8882F885287BCC45DA7B0" xlink:to="loc_dei_LegalEntityAxis_88D25B1D94C442E9879687BCC46D3E9A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_DEECA7B051F00A96FC5E87BCC46D8BB4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_88D25B1D94C442E9879687BCC46D3E9A" xlink:to="loc_dei_EntityDomain_DEECA7B051F00A96FC5E87BCC46D8BB4" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ArbutusInc.Member" xlink:label="loc_abus_ArbutusInc.Member_62223CA045937AC201A287BCC46D14E0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_DEECA7B051F00A96FC5E87BCC46D8BB4" xlink:to="loc_abus_ArbutusInc.Member_62223CA045937AC201A287BCC46D14E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_68C342F063CEFB287DCC87BCC46D6F15" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_AE4E878093A8882F885287BCC45DA7B0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_68C342F063CEFB287DCC87BCC46D6F15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_29FEF56954FBBA4E508187BCC46DAA91" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_68C342F063CEFB287DCC87BCC46D6F15" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_29FEF56954FBBA4E508187BCC46DAA91" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EnantigenMember" xlink:label="loc_abus_EnantigenMember_F1EB8B3A13C465A97D6787BCC46D252E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_29FEF56954FBBA4E508187BCC46DAA91" xlink:to="loc_abus_EnantigenMember_F1EB8B3A13C465A97D6787BCC46D252E" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ContingenciesandCommitmentsLineItems" xlink:label="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_AE4E878093A8882F885287BCC45DA7B0" xlink:to="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_9385035C5F65341091A387BCC46DCEEF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_9385035C5F65341091A387BCC46DCEEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:label="loc_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract_AE4641C732C21141D63187BCC46DE6D1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract_AE4641C732C21141D63187BCC46DE6D1" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_LesseeLeasingArrangementsOperatingLeasesNumberofRenewalOptions" xlink:label="loc_abus_LesseeLeasingArrangementsOperatingLeasesNumberofRenewalOptions_C69CE351ED9F5CD542A487BCC46DB23C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_LesseeLeasingArrangementsOperatingLeasesNumberofRenewalOptions_C69CE351ED9F5CD542A487BCC46DB23C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm" xlink:label="loc_us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm_BA22134EEDA4F6B24B2887BCC46DBDFD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm_BA22134EEDA4F6B24B2887BCC46DBDFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_7B667849B0021DDA677987BCC46D5CCC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_7B667849B0021DDA677987BCC46D5CCC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_8EC08ED02B81C214D9E787BCC46D24C6" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_8EC08ED02B81C214D9E787BCC46D24C6" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_PercentOfCostsFundedByTPC" xlink:label="loc_abus_PercentOfCostsFundedByTPC_1B722D6D7D181A9123B587BCC46D0127" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_PercentOfCostsFundedByTPC_1B722D6D7D181A9123B587BCC46D0127" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_MaximumContributionForProduct" xlink:label="loc_abus_MaximumContributionForProduct_019D41837B8C486317A287BCC46DD8C9" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_MaximumContributionForProduct_019D41837B8C486317A287BCC46DD8C9" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_CumulativeContributionforProduct" xlink:label="loc_abus_CumulativeContributionforProduct_3B5D7EA7BE288A5D584787BCC46DE46E" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_CumulativeContributionforProduct_3B5D7EA7BE288A5D584787BCC46DE46E" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_RoyaltyGuaranteesCommitmentsPercentage" xlink:label="loc_abus_RoyaltyGuaranteesCommitmentsPercentage_3986E4A71F9F04BF2A6A87BCC46D9848" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_RoyaltyGuaranteesCommitmentsPercentage_3986E4A71F9F04BF2A6A87BCC46D9848" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="loc_us-gaap_RoyaltyRevenue_A43B9AC6878F328434DD87BCC46D197C" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_us-gaap_RoyaltyRevenue_A43B9AC6878F328434DD87BCC46D197C" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_RoyaltyPayable" xlink:label="loc_abus_RoyaltyPayable_D8DA4CBBF722C3D8FCC187BCC46D7AA5" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_RoyaltyPayable_D8DA4CBBF722C3D8FCC187BCC46D7AA5" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_RoyaltiesPaidOrAccrued" xlink:label="loc_abus_RoyaltiesPaidOrAccrued_A4C43130AE513C39D27287BCC46D62E5" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_RoyaltiesPaidOrAccrued_A4C43130AE513C39D27287BCC46D62E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContractualObligation" xlink:label="loc_us-gaap_ContractualObligation_61842A2235FAB64AD67487BCC46DB37E" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_us-gaap_ContractualObligation_61842A2235FAB64AD67487BCC46DB37E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_FE2C054B58B0DB819F3287BCC46D7B2C" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_FE2C054B58B0DB819F3287BCC46D7B2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_0580A3EE63E0E7622FE187BCC46D9BE5" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_0580A3EE63E0E7622FE187BCC46D9BE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_74B63AE4C9C539C828BD87BCC46D65B6" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_74B63AE4C9C539C828BD87BCC46D65B6" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_IncreaseDecreaseInFairValueOfContingentConsiderationLiability" xlink:label="loc_abus_IncreaseDecreaseInFairValueOfContingentConsiderationLiability_1F2546BBB5C35FF715C687BCC46D1A88" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_IncreaseDecreaseInFairValueOfContingentConsiderationLiability_1F2546BBB5C35FF715C687BCC46D1A88" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_Numberofseriesofcompounds" xlink:label="loc_abus_Numberofseriesofcompounds_9DA58A3559928E94ECB987BCC46DBA53" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_Numberofseriesofcompounds_9DA58A3559928E94ECB987BCC46DBA53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LicenseCosts" xlink:label="loc_us-gaap_LicenseCosts_F57B5A54D6F0DD9ADC6887BCC46D2289" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_us-gaap_LicenseCosts_F57B5A54D6F0DD9ADC6887BCC46D2289" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerLicense" xlink:label="loc_abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerLicense_B51F5CEA87D33EAA712687BCC46D9224" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerLicense_B51F5CEA87D33EAA712687BCC46D9224" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_LicenseAgreementMaximumSalesPerformanceMilestonePaymentsPerLicense" xlink:label="loc_abus_LicenseAgreementMaximumSalesPerformanceMilestonePaymentsPerLicense_2EE7A7A8B7BF4B913DB087BCC46D80D2" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_LicenseAgreementMaximumSalesPerformanceMilestonePaymentsPerLicense_2EE7A7A8B7BF4B913DB087BCC46D80D2" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ContractualObligationAmountOfResearchFundingPerYear" xlink:label="loc_abus_ContractualObligationAmountOfResearchFundingPerYear_D27C6202D4B4E25FC4BC87BCC46DCE0F" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_ContractualObligationAmountOfResearchFundingPerYear_D27C6202D4B4E25FC4BC87BCC46DCE0F" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ResearchFundingPeriod" xlink:label="loc_abus_ResearchFundingPeriod_3A5C60A1259C192609A287BCC46DA646" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_ResearchFundingPeriod_3A5C60A1259C192609A287BCC46DA646" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ResearchFundingPeriodRenewableOption" xlink:label="loc_abus_ResearchFundingPeriodRenewableOption_638EBDFD6D2BC5238C1387BCC46D59B4" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_ResearchFundingPeriodRenewableOption_638EBDFD6D2BC5238C1387BCC46D59B4" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ResearchFundingAgreementRightToObtainExclusiveLicenseUpfrontPayment" xlink:label="loc_abus_ResearchFundingAgreementRightToObtainExclusiveLicenseUpfrontPayment_43FB3030B3B191B7853087BCC46DA097" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_ResearchFundingAgreementRightToObtainExclusiveLicenseUpfrontPayment_43FB3030B3B191B7853087BCC46DA097" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ResearchFundingAgreementRightToObtainExclusiveLicenseMaximumDevelopmentAndRegulatoryMilestonePayments" xlink:label="loc_abus_ResearchFundingAgreementRightToObtainExclusiveLicenseMaximumDevelopmentAndRegulatoryMilestonePayments_F5B0185C98FA1363210087BCC46DFF4D" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_ResearchFundingAgreementRightToObtainExclusiveLicenseMaximumDevelopmentAndRegulatoryMilestonePayments_F5B0185C98FA1363210087BCC46DFF4D" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ResearchFundingAgreementRightToObtainExclusiveLicenseMaximumCommercializationMilestonePayments" xlink:label="loc_abus_ResearchFundingAgreementRightToObtainExclusiveLicenseMaximumCommercializationMilestonePayments_F33BB15B9401E6E1F26F87BCC46D415B" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_ResearchFundingAgreementRightToObtainExclusiveLicenseMaximumCommercializationMilestonePayments_F33BB15B9401E6E1F26F87BCC46D415B" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ResearchFundingPeriodNumberofRenewableOptions" xlink:label="loc_abus_ResearchFundingPeriodNumberofRenewableOptions_2BB53A526DE2D28E149587D1ACAE0E25" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_B8713EB1582D3A411E9587BCC46D3022" xlink:to="loc_abus_ResearchFundingPeriodNumberofRenewableOptions_2BB53A526DE2D28E149587D1ACAE0E25" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ContingenciesAndCommitmentsMinimumRentAndEstimatedOperatingCostCommitmentNetLeaseInducementsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_835249DADD1B1F38CEEC94DF9CB17A4C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1B500C920F5BA65F11A894DF9CB13A2C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_835249DADD1B1F38CEEC94DF9CB17A4C" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1B500C920F5BA65F11A894DF9CB13A2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_45E18D966703DBE30B9B94DF9CB1C350" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_835249DADD1B1F38CEEC94DF9CB17A4C" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_45E18D966703DBE30B9B94DF9CB1C350" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_AB43C1F3702C20C8F36294DF9CB1FBA5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_835249DADD1B1F38CEEC94DF9CB17A4C" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_AB43C1F3702C20C8F36294DF9CB1FBA5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_739EC916D1893CD4B94494DF9CB17ED6" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_835249DADD1B1F38CEEC94DF9CB17A4C" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_739EC916D1893CD4B94494DF9CB17ED6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_D3FCA7C136E0F7D8326294DF9CB12277" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_835249DADD1B1F38CEEC94DF9CB17A4C" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_D3FCA7C136E0F7D8326294DF9CB12277" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2655B27A3C0276DE6C8294DF9CB28B55" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_835249DADD1B1F38CEEC94DF9CB17A4C" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2655B27A3C0276DE6C8294DF9CB28B55" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ContingenciesAndCommitmentsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_D76CE53407A65CFF0D15877B8CBDAE6A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_D07BC129128BA3A7EC22877B8CBE398F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_D76CE53407A65CFF0D15877B8CBDAE6A" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_D07BC129128BA3A7EC22877B8CBE398F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:href="abus-20161231.xsd#abus_DocumentAndEntityInformationAbstract" xlink:label="loc_abus_DocumentAndEntityInformationAbstract_1FB310AA36060C92DF89FE9957645166" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1B52B5EF98115D31A21EFE9957642866" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_DocumentAndEntityInformationAbstract_1FB310AA36060C92DF89FE9957645166" xlink:to="loc_dei_EntityRegistrantName_1B52B5EF98115D31A21EFE9957642866" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_EBBBE45CD941092380A3FE9957647884" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_DocumentAndEntityInformationAbstract_1FB310AA36060C92DF89FE9957645166" xlink:to="loc_dei_DocumentType_EBBBE45CD941092380A3FE9957647884" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_DF49B3FA240426C81C69FE995764142E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_DocumentAndEntityInformationAbstract_1FB310AA36060C92DF89FE9957645166" xlink:to="loc_dei_CurrentFiscalYearEndDate_DF49B3FA240426C81C69FE995764142E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_C66C77209B012A01E2F1FE995764121E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_DocumentAndEntityInformationAbstract_1FB310AA36060C92DF89FE9957645166" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_C66C77209B012A01E2F1FE995764121E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_3422AC57F819DC42AA03FE9957640C58" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_DocumentAndEntityInformationAbstract_1FB310AA36060C92DF89FE9957645166" xlink:to="loc_dei_EntityPublicFloat_3422AC57F819DC42AA03FE9957640C58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_1988FC3EA7D816E30882FE995764E383" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_DocumentAndEntityInformationAbstract_1FB310AA36060C92DF89FE9957645166" xlink:to="loc_dei_AmendmentFlag_1988FC3EA7D816E30882FE995764E383" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_7BEBE1DF93D06528F149FE995764575C" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_DocumentAndEntityInformationAbstract_1FB310AA36060C92DF89FE9957645166" xlink:to="loc_dei_EntityCentralIndexKey_7BEBE1DF93D06528F149FE995764575C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_36C360BC0CA95737A0FDFE995764B0C7" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_DocumentAndEntityInformationAbstract_1FB310AA36060C92DF89FE9957645166" xlink:to="loc_dei_EntityCurrentReportingStatus_36C360BC0CA95737A0FDFE995764B0C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_2CA41F192236137E0D3BFE9957649341" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_DocumentAndEntityInformationAbstract_1FB310AA36060C92DF89FE9957645166" xlink:to="loc_dei_EntityVoluntaryFilers_2CA41F192236137E0D3BFE9957649341" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_DA8413A828E803CE989EFE995764EF9B" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_DocumentAndEntityInformationAbstract_1FB310AA36060C92DF89FE9957645166" xlink:to="loc_dei_EntityFilerCategory_DA8413A828E803CE989EFE995764EF9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_8F60FEC562F76A6DACCDFE9957646FF0" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_DocumentAndEntityInformationAbstract_1FB310AA36060C92DF89FE9957645166" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_8F60FEC562F76A6DACCDFE9957646FF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_C574B6D4EAA97121CD2BFE995764DDF9" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_DocumentAndEntityInformationAbstract_1FB310AA36060C92DF89FE9957645166" xlink:to="loc_dei_DocumentPeriodEndDate_C574B6D4EAA97121CD2BFE995764DDF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_FE84ADAF6AD39DCFE32AFE99576442F3" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_DocumentAndEntityInformationAbstract_1FB310AA36060C92DF89FE9957645166" xlink:to="loc_dei_DocumentFiscalYearFocus_FE84ADAF6AD39DCFE32AFE99576442F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_94BFDEAE9A492F1B3869FE995765C09F" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_DocumentAndEntityInformationAbstract_1FB310AA36060C92DF89FE9957645166" xlink:to="loc_dei_DocumentFiscalPeriodFocus_94BFDEAE9A492F1B3869FE995765C09F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/GovernmentGrantsAndRefundableInvestmentTaxCredits" xlink:type="extended">
    <link:loc xlink:href="abus-20161231.xsd#abus_GovernmentGrantsAndRefundableInvestmentTaxCreditsAbstract" xlink:label="loc_abus_GovernmentGrantsAndRefundableInvestmentTaxCreditsAbstract_9CE97E4D8BA2780E5E38FE99571A3A2D" xlink:type="locator" />
    <link:loc xlink:href="abus-20161231.xsd#abus_GovernmentGrantsAndRefundableInvestmentTaxCreditsTextBlock" xlink:label="loc_abus_GovernmentGrantsAndRefundableInvestmentTaxCreditsTextBlock_3D6CE12C646D15631776FE99571AF420" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_GovernmentGrantsAndRefundableInvestmentTaxCreditsAbstract_9CE97E4D8BA2780E5E38FE99571A3A2D" xlink:to="loc_abus_GovernmentGrantsAndRefundableInvestmentTaxCreditsTextBlock_3D6CE12C646D15631776FE99571AF420" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/GovernmentGrantsAndRefundableInvestmentTaxCreditsDetails" xlink:type="extended">
    <link:loc xlink:href="abus-20161231.xsd#abus_GovernmentGrantsAndRefundableInvestmentTaxCreditsAbstract" xlink:label="loc_abus_GovernmentGrantsAndRefundableInvestmentTaxCreditsAbstract_2E266435D4BE54AF72878714984D192D" xlink:type="locator" />
    <link:loc xlink:href="abus-20161231.xsd#abus_GovernmentGrantsandRefundableInvestmentTaxCreditsTable" xlink:label="loc_abus_GovernmentGrantsandRefundableInvestmentTaxCreditsTable_14945C500077E6B757D38714984D6236" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_GovernmentGrantsAndRefundableInvestmentTaxCreditsAbstract_2E266435D4BE54AF72878714984D192D" xlink:to="loc_abus_GovernmentGrantsandRefundableInvestmentTaxCreditsTable_14945C500077E6B757D38714984D6236" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_09CBEC4985E67AF1DFF18714984D8BD6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_GovernmentGrantsandRefundableInvestmentTaxCreditsTable_14945C500077E6B757D38714984D6236" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_09CBEC4985E67AF1DFF18714984D8BD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3E6BBB04A9A41F1B48FE8714984DD552" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_09CBEC4985E67AF1DFF18714984D8BD6" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3E6BBB04A9A41F1B48FE8714984DD552" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ISARICMember" xlink:label="loc_abus_ISARICMember_43E6E0A7D937AFAD79AA8714984D5AEC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3E6BBB04A9A41F1B48FE8714984DD552" xlink:to="loc_abus_ISARICMember_43E6E0A7D937AFAD79AA8714984D5AEC" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_GovernmentGrantsandRefundableInvestmentTaxCreditsLineItems" xlink:label="loc_abus_GovernmentGrantsandRefundableInvestmentTaxCreditsLineItems_1F0B86239F73BE8053F08714984D304C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_GovernmentGrantsandRefundableInvestmentTaxCreditsTable_14945C500077E6B757D38714984D6236" xlink:to="loc_abus_GovernmentGrantsandRefundableInvestmentTaxCreditsLineItems_1F0B86239F73BE8053F08714984D304C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContractsRevenue" xlink:label="loc_us-gaap_ContractsRevenue_A2F9BB8AD829B87E63EB8714984DEBCE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_GovernmentGrantsandRefundableInvestmentTaxCreditsLineItems_1F0B86239F73BE8053F08714984D304C" xlink:to="loc_us-gaap_ContractsRevenue_A2F9BB8AD829B87E63EB8714984DEBCE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueFromGrants" xlink:label="loc_us-gaap_RevenueFromGrants_C8710B13C0E00A1838BB8714984DE43E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_GovernmentGrantsandRefundableInvestmentTaxCreditsLineItems_1F0B86239F73BE8053F08714984D304C" xlink:to="loc_us-gaap_RevenueFromGrants_C8710B13C0E00A1838BB8714984DE43E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentTaxCredit" xlink:label="loc_us-gaap_InvestmentTaxCredit_A770339A671FD0E5AFF98714984D8ECB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_GovernmentGrantsandRefundableInvestmentTaxCreditsLineItems_1F0B86239F73BE8053F08714984D304C" xlink:to="loc_us-gaap_InvestmentTaxCredit_A770339A671FD0E5AFF98714984D8ECB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ImpairmentEvaluationsForIntangibleAssetsAndGoodwill" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5FD7DB84F800C852AF20861C08417251" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_40CF9F245A99D1336768861C084193B6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5FD7DB84F800C852AF20861C08417251" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_40CF9F245A99D1336768861C084193B6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ImpairmentEvaluationsForIntangibleAssetsAndGoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_72E15D3D50E0ED07535ADE7BD257E19B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_A089E6B0DE43EFA48DB9DE7BD2589920" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_72E15D3D50E0ED07535ADE7BD257E19B" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_A089E6B0DE43EFA48DB9DE7BD2589920" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B57857BC8D89BC1DBCD5DE7BD2588CEC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_A089E6B0DE43EFA48DB9DE7BD2589920" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B57857BC8D89BC1DBCD5DE7BD2588CEC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6C66BDA604E3999E20EBDE7BD258E843" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B57857BC8D89BC1DBCD5DE7BD2588CEC" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6C66BDA604E3999E20EBDE7BD258E843" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_CyclophilinDrugCandidateOCB030Member" xlink:label="loc_abus_CyclophilinDrugCandidateOCB030Member_75DA13F43174E326CDC9DE7BD2588735" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6C66BDA604E3999E20EBDE7BD258E843" xlink:to="loc_abus_CyclophilinDrugCandidateOCB030Member_75DA13F43174E326CDC9DE7BD2588735" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_736E43C9ECA196B7BACCDE7BD2586A44" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_A089E6B0DE43EFA48DB9DE7BD2589920" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_736E43C9ECA196B7BACCDE7BD2586A44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_BC01B99BACC08AE5FA40DE7BD258601F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_736E43C9ECA196B7BACCDE7BD2586A44" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_BC01B99BACC08AE5FA40DE7BD258601F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_844AB10EF426668461F1DE7BD2584354" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_736E43C9ECA196B7BACCDE7BD2586A44" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_844AB10EF426668461F1DE7BD2584354" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_41B1A494EB15F7F89CC3DE7BD258F204" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_736E43C9ECA196B7BACCDE7BD2586A44" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_41B1A494EB15F7F89CC3DE7BD258F204" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfReportingUnits" xlink:label="loc_us-gaap_NumberOfReportingUnits_FB8E4396C30D3B147A6BDE7BD25877AA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_736E43C9ECA196B7BACCDE7BD2586A44" xlink:to="loc_us-gaap_NumberOfReportingUnits_FB8E4396C30D3B147A6BDE7BD25877AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_53A7C6FC52B1102422C3DE7BD258E3FD" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_736E43C9ECA196B7BACCDE7BD2586A44" xlink:to="loc_us-gaap_Goodwill_53A7C6FC52B1102422C3DE7BD258E3FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_4994DBD358F26D09C23BDE7BD258B7A9" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_736E43C9ECA196B7BACCDE7BD2586A44" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_4994DBD358F26D09C23BDE7BD258B7A9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ImpairmentEvaluationsForIntangibleAssetsAndGoodwillSummaryOfCarryingValueOfIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DED31ED109B8B8AFCA6E861C0955C20C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F201FF88DB9805F4DDED861C09569BC8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DED31ED109B8B8AFCA6E861C0955C20C" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F201FF88DB9805F4DDED861C09569BC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B5164E764D5EE64AB2AD861C09566293" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F201FF88DB9805F4DDED861C09569BC8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B5164E764D5EE64AB2AD861C09566293" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8AEE811165B5A809280E861C09564061" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B5164E764D5EE64AB2AD861C09566293" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8AEE811165B5A809280E861C09564061" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_InProcessResearchandDevelopmentImmuneModulatorsMember" xlink:label="loc_abus_InProcessResearchandDevelopmentImmuneModulatorsMember_A99D041156780CADF0F0861C0956947B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8AEE811165B5A809280E861C09564061" xlink:to="loc_abus_InProcessResearchandDevelopmentImmuneModulatorsMember_A99D041156780CADF0F0861C0956947B" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_InProcessResearchandDevelopmentAntigenInhibitorsMember" xlink:label="loc_abus_InProcessResearchandDevelopmentAntigenInhibitorsMember_B81325253BD72BDDD8A4861C0956E34B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8AEE811165B5A809280E861C09564061" xlink:to="loc_abus_InProcessResearchandDevelopmentAntigenInhibitorsMember_B81325253BD72BDDD8A4861C0956E34B" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_InProcessResearchandDevelopmentcccDNASterilizersMember" xlink:label="loc_abus_InProcessResearchandDevelopmentcccDNASterilizersMember_208AB80B486BE4BE9F37861C0956D644" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8AEE811165B5A809280E861C09564061" xlink:to="loc_abus_InProcessResearchandDevelopmentcccDNASterilizersMember_208AB80B486BE4BE9F37861C0956D644" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_FE5744E90A273EB2D1DA861C09566BAB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F201FF88DB9805F4DDED861C09569BC8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_FE5744E90A273EB2D1DA861C09566BAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0DF39D9CE21C182C0F1B861C09568AE7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_FE5744E90A273EB2D1DA861C09566BAB" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0DF39D9CE21C182C0F1B861C09568AE7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ImpairmentEvaluationsForIntangibleAssetsAndGoodwillTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5FF35585818263AD5CD7861C08B12E71" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_1C019CA9B112BB672617861C08B10B25" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5FF35585818263AD5CD7861C08B12E71" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_1C019CA9B112BB672617861C08B10B25" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_A9DD312DEEE21BD22D84FE9957B079F8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_757D4943DE22536BCA71FE9957B0CE8B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_A9DD312DEEE21BD22D84FE9957B079F8" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_757D4943DE22536BCA71FE9957B0CE8B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_528146A0B04A7F398A3CCED59E88E547" xlink:type="locator" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ComponentsofDeferredTaxAssetsTable" xlink:label="loc_abus_ComponentsofDeferredTaxAssetsTable_E675B1F7A17BADDE4B61CED59E88AF18" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_528146A0B04A7F398A3CCED59E88E547" xlink:to="loc_abus_ComponentsofDeferredTaxAssetsTable_E675B1F7A17BADDE4B61CED59E88AF18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_94DC8768BD10ECC2DAA0CED59E88C801" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsTable_E675B1F7A17BADDE4B61CED59E88AF18" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_94DC8768BD10ECC2DAA0CED59E88C801" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_4E0F34F9B511914672F6CED59E88CCC4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_94DC8768BD10ECC2DAA0CED59E88C801" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_4E0F34F9B511914672F6CED59E88CCC4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_FCCA6D210CB67420BDA1CED59E8823B6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4E0F34F9B511914672F6CED59E88CCC4" xlink:to="loc_us-gaap_DomesticCountryMember_FCCA6D210CB67420BDA1CED59E8823B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_BD3006AE2FB49E27280FCED59E88CF39" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4E0F34F9B511914672F6CED59E88CCC4" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_BD3006AE2FB49E27280FCED59E88CF39" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ComponentsofDeferredTaxAssetsLineItems" xlink:label="loc_abus_ComponentsofDeferredTaxAssetsLineItems_349EBE79E6D0BBCA5162CED59E884B78" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsTable_E675B1F7A17BADDE4B61CED59E88AF18" xlink:to="loc_abus_ComponentsofDeferredTaxAssetsLineItems_349EBE79E6D0BBCA5162CED59E884B78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_655B1EAC130A9EF10837CED59E88F1EE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_349EBE79E6D0BBCA5162CED59E884B78" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_655B1EAC130A9EF10837CED59E88F1EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_79CA439F6A394578F406CED59E88DA6A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_349EBE79E6D0BBCA5162CED59E884B78" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_79CA439F6A394578F406CED59E88DA6A" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_DeferredTaxAssetBookAmortizationInExcessOfTax" xlink:label="loc_abus_DeferredTaxAssetBookAmortizationInExcessOfTax_F47BF283788EDC8D2433CED59E889ACA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_349EBE79E6D0BBCA5162CED59E884B78" xlink:to="loc_abus_DeferredTaxAssetBookAmortizationInExcessOfTax_F47BF283788EDC8D2433CED59E889ACA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_CA0E5A0FCD11B043A1E6CED59E88EB69" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_349EBE79E6D0BBCA5162CED59E884B78" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_CA0E5A0FCD11B043A1E6CED59E88EB69" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_DeferredTaxAssetRevenueRecognizedForTaxPurposesInExcessOfRevenueRecognizedForAccountingPurposes" xlink:label="loc_abus_DeferredTaxAssetRevenueRecognizedForTaxPurposesInExcessOfRevenueRecognizedForAccountingPurposes_12EB7815B7F332C3B8FECED59E889F2D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_349EBE79E6D0BBCA5162CED59E884B78" xlink:to="loc_abus_DeferredTaxAssetRevenueRecognizedForTaxPurposesInExcessOfRevenueRecognizedForAccountingPurposes_12EB7815B7F332C3B8FECED59E889F2D" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_DeferredTaxAssetTaxValueInExcessOfAccountingValueInLeaseInducements" xlink:label="loc_abus_DeferredTaxAssetTaxValueInExcessOfAccountingValueInLeaseInducements_7A1BE1EAD9E059A68942CED59E89D432" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_349EBE79E6D0BBCA5162CED59E884B78" xlink:to="loc_abus_DeferredTaxAssetTaxValueInExcessOfAccountingValueInLeaseInducements_7A1BE1EAD9E059A68942CED59E89D432" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsInvestments" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_C40DD74396B5A87DCBB2CED59E89ADD3" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_349EBE79E6D0BBCA5162CED59E884B78" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_C40DD74396B5A87DCBB2CED59E89ADD3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_1AE4F96CCE44854D0B4BCED59E891FD6" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_349EBE79E6D0BBCA5162CED59E884B78" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_1AE4F96CCE44854D0B4BCED59E891FD6" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_DeferredTaxAssetUpfrontLicenseFees" xlink:label="loc_abus_DeferredTaxAssetUpfrontLicenseFees_4E395B58A9D0CAB54B7FCED59E89D2EC" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_349EBE79E6D0BBCA5162CED59E884B78" xlink:to="loc_abus_DeferredTaxAssetUpfrontLicenseFees_4E395B58A9D0CAB54B7FCED59E89D2EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_CA5ABFC88B86BF7CA455CED59E890D46" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_349EBE79E6D0BBCA5162CED59E884B78" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_CA5ABFC88B86BF7CA455CED59E890D46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1CC4616CAEC679346819CEF1D5B1FE77" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_349EBE79E6D0BBCA5162CED59E884B78" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_1CC4616CAEC679346819CEF1D5B1FE77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_5FAAFABAB0DFDEC4FFBFCED59E89527A" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_349EBE79E6D0BBCA5162CED59E884B78" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_5FAAFABAB0DFDEC4FFBFCED59E89527A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_BF3A83DE0CC8012923A6CED59E8950F7" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_349EBE79E6D0BBCA5162CED59E884B78" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_BF3A83DE0CC8012923A6CED59E8950F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_EF1C2F7B1A8E06AC6B34CED59E89A13B" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_349EBE79E6D0BBCA5162CED59E884B78" xlink:to="loc_us-gaap_DeferredTaxLiabilities_EF1C2F7B1A8E06AC6B34CED59E89A13B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_50DF77582775A622CF368714984D5735" xlink:type="locator" />
    <link:loc xlink:href="abus-20161231.xsd#abus_IncomeTaxesTable" xlink:label="loc_abus_IncomeTaxesTable_81E75252F521CD83DABF8714984DA99A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_50DF77582775A622CF368714984D5735" xlink:to="loc_abus_IncomeTaxesTable_81E75252F521CD83DABF8714984DA99A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_A2D837CD85566209910B8714984D841E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesTable_81E75252F521CD83DABF8714984DA99A" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_A2D837CD85566209910B8714984D841E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_9DE10352AAC7E240613A8714984D912C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_A2D837CD85566209910B8714984D841E" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_9DE10352AAC7E240613A8714984D912C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentCreditMember" xlink:label="loc_us-gaap_InvestmentCreditMember_66D70B9A3C24A32B71E38714984D743D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_9DE10352AAC7E240613A8714984D912C" xlink:to="loc_us-gaap_InvestmentCreditMember_66D70B9A3C24A32B71E38714984D743D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchMember" xlink:label="loc_us-gaap_ResearchMember_F2C46CEF6FEADE8519618714984D31A3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_9DE10352AAC7E240613A8714984D912C" xlink:to="loc_us-gaap_ResearchMember_F2C46CEF6FEADE8519618714984D31A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_1878BD017F39A28C72858714984DA8C5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesTable_81E75252F521CD83DABF8714984DA99A" xlink:to="loc_us-gaap_RangeAxis_1878BD017F39A28C72858714984DA8C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_0902DAE7C34E99781B8B8714984D6A12" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_1878BD017F39A28C72858714984DA8C5" xlink:to="loc_us-gaap_RangeMember_0902DAE7C34E99781B8B8714984D6A12" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_8E5765949ED63A62F2098714984DD1CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_0902DAE7C34E99781B8B8714984D6A12" xlink:to="loc_us-gaap_MaximumMember_8E5765949ED63A62F2098714984DD1CD" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_IncomeTaxesDetailsLineItems" xlink:label="loc_abus_IncomeTaxesDetailsLineItems_87AA969619406A3D4E628714984D352E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesTable_81E75252F521CD83DABF8714984DA99A" xlink:to="loc_abus_IncomeTaxesDetailsLineItems_87AA969619406A3D4E628714984D352E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3817ECCDDAAD8908928D8714984D7C6C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesDetailsLineItems_87AA969619406A3D4E628714984D352E" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3817ECCDDAAD8908928D8714984D7C6C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_2730AA0F3D6D0DEB918F8714984D30F5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesDetailsLineItems_87AA969619406A3D4E628714984D352E" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_2730AA0F3D6D0DEB918F8714984D30F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_B9B24CFC706AE85A5A498714984DBB18" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesDetailsLineItems_87AA969619406A3D4E628714984D352E" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_B9B24CFC706AE85A5A498714984DBB18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_392797D5DAE74D19516B8714984DE1D1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesDetailsLineItems_87AA969619406A3D4E628714984D352E" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_392797D5DAE74D19516B8714984DE1D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_AA30B2E3ADCEEAFB336B8714984D6620" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesDetailsLineItems_87AA969619406A3D4E628714984D352E" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_AA30B2E3ADCEEAFB336B8714984D6620" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_E509EB054D758C68FD978714984D835F" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesDetailsLineItems_87AA969619406A3D4E628714984D352E" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_E509EB054D758C68FD978714984D835F" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_PatentTaxRefundPercentage" xlink:label="loc_abus_PatentTaxRefundPercentage_B0A5B3CE7D91C30761FC8714984D5462" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesDetailsLineItems_87AA969619406A3D4E628714984D352E" xlink:to="loc_abus_PatentTaxRefundPercentage_B0A5B3CE7D91C30761FC8714984D5462" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIncomeTaxRefunds" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds_0414293223287CECF1E18714984DF804" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesDetailsLineItems_87AA969619406A3D4E628714984D352E" xlink:to="loc_us-gaap_ProceedsFromIncomeTaxRefunds_0414293223287CECF1E18714984DF804" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/IncomeTaxesIncomeTaxReconciliationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5745CFA5A14DB646F977CED59E8C1FCF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_D41CCCB83963794DC556CED59E8C0F2C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5745CFA5A14DB646F977CED59E8C1FCF" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_D41CCCB83963794DC556CED59E8C0F2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_8A1223160B878CDD4953CED59E8CF52E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5745CFA5A14DB646F977CED59E8C1FCF" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_8A1223160B878CDD4953CED59E8CF52E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_68A8A8699685273C2B40CED59E8C59F2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5745CFA5A14DB646F977CED59E8C1FCF" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_68A8A8699685273C2B40CED59E8C59F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_45BBE173935B16E85388CED59E8C33AC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5745CFA5A14DB646F977CED59E8C1FCF" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_45BBE173935B16E85388CED59E8C33AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_941EC91F9A1CD2E4A1EECED59E8DC72C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5745CFA5A14DB646F977CED59E8C1FCF" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_941EC91F9A1CD2E4A1EECED59E8DC72C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_02F4AB6B206396A68673CED59E8DDA14" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5745CFA5A14DB646F977CED59E8C1FCF" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_02F4AB6B206396A68673CED59E8DDA14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_50FFAE8549DBC95D6EC9CED59E8D2E93" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5745CFA5A14DB646F977CED59E8C1FCF" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_50FFAE8549DBC95D6EC9CED59E8D2E93" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_C3AE74ED77BC82D8C94BFE995798AC68" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_D3D58965FF356B51E382FE995799580C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_C3AE74ED77BC82D8C94BFE995798AC68" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_D3D58965FF356B51E382FE995799580C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_D700ECA99B43CDC05318FE9957993938" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_C3AE74ED77BC82D8C94BFE995798AC68" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_D700ECA99B43CDC05318FE9957993938" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/InterimFinancialDataUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_EDF937D4893E3F84323F879247DA199C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_50F12404B75EC36FCE1E879247DA5A12" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_EDF937D4893E3F84323F879247DA199C" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_50F12404B75EC36FCE1E879247DA5A12" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/InterimFinancialDataUnauditedDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_852A7F3656DF43B5BE5E4806DAAB3868" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_B512C5E4F70519EAF1B04806DAABC525" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_852A7F3656DF43B5BE5E4806DAAB3868" xlink:to="loc_us-gaap_Revenues_B512C5E4F70519EAF1B04806DAABC525" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_E9078DBD20E1A412B3684806DAABE755" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_852A7F3656DF43B5BE5E4806DAAB3868" xlink:to="loc_us-gaap_OperatingIncomeLoss_E9078DBD20E1A412B3684806DAABE755" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_B02BDC5A7800B5FEA9E34806DAAB4591" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_852A7F3656DF43B5BE5E4806DAAB3868" xlink:to="loc_us-gaap_NetIncomeLoss_B02BDC5A7800B5FEA9E34806DAAB4591" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_336A43F076A3F09D0DD24806DAABE3C4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_852A7F3656DF43B5BE5E4806DAAB3868" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_336A43F076A3F09D0DD24806DAABE3C4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/InterimFinancialDataUnauditedTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_FAD9787FA210BF7AB6C1FE9956EBFDAD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_4319C237034FEE9F1C4EFE9956EB5982" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_FAD9787FA210BF7AB6C1FE9956EBFDAD" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_4319C237034FEE9F1C4EFE9956EB5982" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/LoanPayable" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_D0F62B704924205D24FD879247C13D42" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_43E7D0EF451ED120BF69879247C14A0F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_D0F62B704924205D24FD879247C13D42" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_43E7D0EF451ED120BF69879247C14A0F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/LoanPayableDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2B088D29E3CCA5A1678AC8206FD72F01" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_F5718795852D7B38F7CBC8206FD7FC83" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2B088D29E3CCA5A1678AC8206FD72F01" xlink:to="loc_us-gaap_DebtInstrumentTable_F5718795852D7B38F7CBC8206FD7FC83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="loc_us-gaap_CounterpartyNameAxis_43885A2B5FBB2D011051C8206FD74346" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F5718795852D7B38F7CBC8206FD7FC83" xlink:to="loc_us-gaap_CounterpartyNameAxis_43885A2B5FBB2D011051C8206FD74346" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_6F81446DA30D27D1D8D4C8206FD70B95" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CounterpartyNameAxis_43885A2B5FBB2D011051C8206FD74346" xlink:to="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_6F81446DA30D27D1D8D4C8206FD70B95" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_WellsFargoMember" xlink:label="loc_abus_WellsFargoMember_C72A4A076264187C8874C8206FD7AA3E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_6F81446DA30D27D1D8D4C8206FD70B95" xlink:to="loc_abus_WellsFargoMember_C72A4A076264187C8874C8206FD7AA3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_ECCA9ADD1DDCB73264B2C8206FD71B0D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F5718795852D7B38F7CBC8206FD7FC83" xlink:to="loc_us-gaap_VariableRateAxis_ECCA9ADD1DDCB73264B2C8206FD71B0D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_F0461D3C32D700E5D9CFC8206FD7B4A8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_ECCA9ADD1DDCB73264B2C8206FD71B0D" xlink:to="loc_us-gaap_VariableRateDomain_F0461D3C32D700E5D9CFC8206FD7B4A8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_F2AC276950E661708D4AC8206FD838D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_F0461D3C32D700E5D9CFC8206FD7B4A8" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_F2AC276950E661708D4AC8206FD838D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4F90ABD51C7619AE63BCC8206FD86920" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F5718795852D7B38F7CBC8206FD7FC83" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4F90ABD51C7619AE63BCC8206FD86920" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_B743DE27915A72D5277BC8206FD82E31" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4F90ABD51C7619AE63BCC8206FD86920" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_B743DE27915A72D5277BC8206FD82E31" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="loc_us-gaap_LoansPayableMember_415903496281528EA451C8206FD85143" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_B743DE27915A72D5277BC8206FD82E31" xlink:to="loc_us-gaap_LoansPayableMember_415903496281528EA451C8206FD85143" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_8ABB860039BD6910A6A5C8206FD817BA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F5718795852D7B38F7CBC8206FD7FC83" xlink:to="loc_us-gaap_DebtInstrumentAxis_8ABB860039BD6910A6A5C8206FD817BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_39727343D5695FAED314C8206FD825C5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8ABB860039BD6910A6A5C8206FD817BA" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_39727343D5695FAED314C8206FD825C5" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_PromissoryNoteMember" xlink:label="loc_abus_PromissoryNoteMember_BAAACAE85C13B3C11B53C8206FD8A81F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_39727343D5695FAED314C8206FD825C5" xlink:to="loc_abus_PromissoryNoteMember_BAAACAE85C13B3C11B53C8206FD8A81F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8BAB9CD0D08F6B2FBAE5C8206FD886C8" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F5718795852D7B38F7CBC8206FD7FC83" xlink:to="loc_us-gaap_DebtInstrumentLineItems_8BAB9CD0D08F6B2FBAE5C8206FD886C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1331E139CD46226B3C48C826775A166A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8BAB9CD0D08F6B2FBAE5C8206FD886C8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1331E139CD46226B3C48C826775A166A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_574876F67F69D8B05A78C8206FD88985" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8BAB9CD0D08F6B2FBAE5C8206FD886C8" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_574876F67F69D8B05A78C8206FD88985" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedInvestmentsNoncurrent" xlink:label="loc_us-gaap_RestrictedInvestmentsNoncurrent_A7B33A3A62D528B76051C8206FD87820" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8BAB9CD0D08F6B2FBAE5C8206FD886C8" xlink:to="loc_us-gaap_RestrictedInvestmentsNoncurrent_A7B33A3A62D528B76051C8206FD87820" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_RestrictedInvestmentTerm" xlink:label="loc_abus_RestrictedInvestmentTerm_105F07A1B0CFE4CA5AD7C8206FD851DB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8BAB9CD0D08F6B2FBAE5C8206FD886C8" xlink:to="loc_abus_RestrictedInvestmentTerm_105F07A1B0CFE4CA5AD7C8206FD851DB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/NatureOfBusinessAndFutureOperations" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_021E996C59F698E46835FE9957F1A260" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_1745E2EFEBB90A29DA39FE9957F17A03" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_021E996C59F698E46835FE9957F1A260" xlink:to="loc_us-gaap_NatureOfOperations_1745E2EFEBB90A29DA39FE9957F17A03" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/PropertyAndEquipment" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_A64D88990A15192F89A8FE9957CBEDE9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_41089441D740017FCABDFE9957CB71EA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_A64D88990A15192F89A8FE9957CBEDE9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_41089441D740017FCABDFE9957CB71EA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/PropertyAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_BC5DDA6F059B26252CBAFE99580C9E72" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_92A4A00BDE77B26C6E34FE99580C4E0B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_BC5DDA6F059B26252CBAFE99580C9E72" xlink:to="loc_us-gaap_AssetImpairmentCharges_92A4A00BDE77B26C6E34FE99580C4E0B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/PropertyAndEquipmentPropertyAndEquipmentSummaryDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_012CC5C4B902C684995391DE2AF40F83" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5EDAE33CEC18E09C769A91DE2AF4FEA0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_012CC5C4B902C684995391DE2AF40F83" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5EDAE33CEC18E09C769A91DE2AF4FEA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_61263F60A4AB9B0C0F9391DE2AF5DAC0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5EDAE33CEC18E09C769A91DE2AF4FEA0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_61263F60A4AB9B0C0F9391DE2AF5DAC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_A1FA7E51D5024390FA5391DE2AF53495" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_61263F60A4AB9B0C0F9391DE2AF5DAC0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_A1FA7E51D5024390FA5391DE2AF53495" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_LaboratoryEquipmentMember" xlink:label="loc_abus_LaboratoryEquipmentMember_D6DA1E8932E37DEA71DD91DE2AF57DF6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_A1FA7E51D5024390FA5391DE2AF53495" xlink:to="loc_abus_LaboratoryEquipmentMember_D6DA1E8932E37DEA71DD91DE2AF57DF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_CE3926EFC49DBE0E770B91DE2AF55781" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_A1FA7E51D5024390FA5391DE2AF53495" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_CE3926EFC49DBE0E770B91DE2AF55781" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_4EE51BA14628CFFA510B91DE2AF53661" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_A1FA7E51D5024390FA5391DE2AF53495" xlink:to="loc_us-gaap_ComputerEquipmentMember_4EE51BA14628CFFA510B91DE2AF53661" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_CF367381C98BB9703F0591DE2AF55C34" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_A1FA7E51D5024390FA5391DE2AF53495" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_CF367381C98BB9703F0591DE2AF55C34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaap_ConstructionInProgressMember_BD09EC683B57FE5B8FE391DE2AF55253" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_A1FA7E51D5024390FA5391DE2AF53495" xlink:to="loc_us-gaap_ConstructionInProgressMember_BD09EC683B57FE5B8FE391DE2AF55253" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_F15ABFDED05A629CCC6291DE2AF60C40" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5EDAE33CEC18E09C769A91DE2AF4FEA0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_F15ABFDED05A629CCC6291DE2AF60C40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_93426A9CAB61F85B3B0191DE2AF6B9A4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_F15ABFDED05A629CCC6291DE2AF60C40" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_93426A9CAB61F85B3B0191DE2AF6B9A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_C7E269EF53ECDB051FAA91DE2AF60FB4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_F15ABFDED05A629CCC6291DE2AF60C40" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_C7E269EF53ECDB051FAA91DE2AF60FB4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_290E4225C91EF397733591DE2AF6B4F6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_F15ABFDED05A629CCC6291DE2AF60C40" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_290E4225C91EF397733591DE2AF6B4F6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/PropertyAndEquipmentTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_BE3733829B1C1362D4F3FE99577542E9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_DFF3DC70CFF14DA79180FE995775038A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_BE3733829B1C1362D4F3FE99577542E9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_DFF3DC70CFF14DA79180FE995775038A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapital" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_6A68A16437BBBF7E82774D4DAF208C00" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_9FC6939E510DBADB55D14D4DAF20037E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_6A68A16437BBBF7E82774D4DAF208C00" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_9FC6939E510DBADB55D14D4DAF20037E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapitalLocationOfExpensesForStockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_9ECA5803747F1F8E6E2C8B375BD80E54" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2204DBBF24E351427B2A8B375BD8A18F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_9ECA5803747F1F8E6E2C8B375BD80E54" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2204DBBF24E351427B2A8B375BD8A18F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_BC34D0BF29434D99582F8B375BD8F171" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2204DBBF24E351427B2A8B375BD8A18F" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_BC34D0BF29434D99582F8B375BD8F171" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_BD949DF7C1DCE8017BAE8B375BD83661" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_BC34D0BF29434D99582F8B375BD8F171" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_BD949DF7C1DCE8017BAE8B375BD83661" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2C714AEBDE209C5574C78B375BD8A1C4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_BD949DF7C1DCE8017BAE8B375BD83661" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2C714AEBDE209C5574C78B375BD8A1C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_C3992176D6E67C3B76198B375BD85C14" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_BD949DF7C1DCE8017BAE8B375BD83661" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_C3992176D6E67C3B76198B375BD85C14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A076CDF223B8AAAAF9BA8B375BD8DBA8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2204DBBF24E351427B2A8B375BD8A18F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A076CDF223B8AAAAF9BA8B375BD8DBA8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_202733F1EE4149FB8DC28B67285A4BAE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A076CDF223B8AAAAF9BA8B375BD8DBA8" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_202733F1EE4149FB8DC28B67285A4BAE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapitalNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_1AE63E9F8760DEC7F894CF89C8700D15" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19EBF0AFF20983CE08DFCF89C8709C41" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_1AE63E9F8760DEC7F894CF89C8700D15" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19EBF0AFF20983CE08DFCF89C8709C41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_3C799CBD9DA5D76652CFCF89C870949A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19EBF0AFF20983CE08DFCF89C8709C41" xlink:to="loc_us-gaap_PlanNameAxis_3C799CBD9DA5D76652CFCF89C870949A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_FC39D1FDEADBBB4AD77ACF89C8706C72" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3C799CBD9DA5D76652CFCF89C870949A" xlink:to="loc_us-gaap_PlanNameDomain_FC39D1FDEADBBB4AD77ACF89C8706C72" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_A2007PlanMember" xlink:label="loc_abus_A2007PlanMember_6032D44EBFF30BB77CD5CF89C8708D95" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_FC39D1FDEADBBB4AD77ACF89C8706C72" xlink:to="loc_abus_A2007PlanMember_6032D44EBFF30BB77CD5CF89C8708D95" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_A2011PlanMember" xlink:label="loc_abus_A2011PlanMember_A4FD999D23CCE52F883ACF89C87013B6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_FC39D1FDEADBBB4AD77ACF89C8706C72" xlink:to="loc_abus_A2011PlanMember_A4FD999D23CCE52F883ACF89C87013B6" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_DesignatedPlansMember" xlink:label="loc_abus_DesignatedPlansMember_3515922A913FC8757CEFCF89C870163C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_FC39D1FDEADBBB4AD77ACF89C8706C72" xlink:to="loc_abus_DesignatedPlansMember_3515922A913FC8757CEFCF89C870163C" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ArbutusPlansMember" xlink:label="loc_abus_ArbutusPlansMember_530DAE3C08082AAA1CC5CF89C8706E17" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_FC39D1FDEADBBB4AD77ACF89C8706C72" xlink:to="loc_abus_ArbutusPlansMember_530DAE3C08082AAA1CC5CF89C8706E17" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ProtivaOptionPlanMember" xlink:label="loc_abus_ProtivaOptionPlanMember_AF2A3BD317D69FECCCA5CF89C87020C8" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_FC39D1FDEADBBB4AD77ACF89C8706C72" xlink:to="loc_abus_ProtivaOptionPlanMember_AF2A3BD317D69FECCCA5CF89C87020C8" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_OnCoreOptionPlanMember" xlink:label="loc_abus_OnCoreOptionPlanMember_33436317A011B5AE850FCF89C8709004" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_FC39D1FDEADBBB4AD77ACF89C8706C72" xlink:to="loc_abus_OnCoreOptionPlanMember_33436317A011B5AE850FCF89C8709004" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_CBEB1CC6D248C1A2B25DCF89C8701AE9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19EBF0AFF20983CE08DFCF89C8709C41" xlink:to="loc_us-gaap_AwardTypeAxis_CBEB1CC6D248C1A2B25DCF89C8701AE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65D067E9B2C13EA87222CF89C870F601" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_CBEB1CC6D248C1A2B25DCF89C8701AE9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65D067E9B2C13EA87222CF89C870F601" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EmployeeStockOptionLiabilityClassifiedMember" xlink:label="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_739295EF05354B11BA96CF89C8704737" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65D067E9B2C13EA87222CF89C870F601" xlink:to="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_739295EF05354B11BA96CF89C8704737" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_CashlessExerciseProvisionMember" xlink:label="loc_abus_CashlessExerciseProvisionMember_99B2B3BA346B09CB08D3CF89C870BB8F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65D067E9B2C13EA87222CF89C870F601" xlink:to="loc_abus_CashlessExerciseProvisionMember_99B2B3BA346B09CB08D3CF89C870BB8F" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_RevisedNewCommonSharesMember" xlink:label="loc_abus_RevisedNewCommonSharesMember_C2E3C54E08EEF780DBE7CF89C870ACC4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65D067E9B2C13EA87222CF89C870F601" xlink:to="loc_abus_RevisedNewCommonSharesMember_C2E3C54E08EEF780DBE7CF89C870ACC4" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ProtivaShareOptionsMember" xlink:label="loc_abus_ProtivaShareOptionsMember_5CD68FF63D343DC5B01FCF89C87003CD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65D067E9B2C13EA87222CF89C870F601" xlink:to="loc_abus_ProtivaShareOptionsMember_5CD68FF63D343DC5B01FCF89C87003CD" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EquivalentNumberOfCompanyCommonSharesMember" xlink:label="loc_abus_EquivalentNumberOfCompanyCommonSharesMember_9DFA33AB7A335B5CCF25CF89C870E8BC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65D067E9B2C13EA87222CF89C870F601" xlink:to="loc_abus_EquivalentNumberOfCompanyCommonSharesMember_9DFA33AB7A335B5CCF25CF89C870E8BC" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_UnexpiredRepurchaseRightsOnSharesIssuedtoArbutusInc.Member" xlink:label="loc_abus_UnexpiredRepurchaseRightsOnSharesIssuedtoArbutusInc.Member_9C3A9D68A47695321713CF89C870B879" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65D067E9B2C13EA87222CF89C870F601" xlink:to="loc_abus_UnexpiredRepurchaseRightsOnSharesIssuedtoArbutusInc.Member_9C3A9D68A47695321713CF89C870B879" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ExpiredRepurchaseRightsOnSharesIssuedtoArbutusInc.Member" xlink:label="loc_abus_ExpiredRepurchaseRightsOnSharesIssuedtoArbutusInc.Member_873202F69128184F5120CF947CB599B4" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65D067E9B2C13EA87222CF89C870F601" xlink:to="loc_abus_ExpiredRepurchaseRightsOnSharesIssuedtoArbutusInc.Member_873202F69128184F5120CF947CB599B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_00E04A6969F72CBE48DCCF89C873A5FB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19EBF0AFF20983CE08DFCF89C8709C41" xlink:to="loc_us-gaap_RangeAxis_00E04A6969F72CBE48DCCF89C873A5FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_6EF7377AF54DCEA6C403CF89C8737EED" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_00E04A6969F72CBE48DCCF89C873A5FB" xlink:to="loc_us-gaap_RangeMember_6EF7377AF54DCEA6C403CF89C8737EED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_34F4B6127B850E97AE0FCF89C8737C8E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_6EF7377AF54DCEA6C403CF89C8737EED" xlink:to="loc_us-gaap_MaximumMember_34F4B6127B850E97AE0FCF89C8737C8E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_8039D9ECA8E2B31FBF0ACF89C8736225" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19EBF0AFF20983CE08DFCF89C8709C41" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_8039D9ECA8E2B31FBF0ACF89C8736225" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_E6F92D012EF201ED01ABCF89C873D946" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_8039D9ECA8E2B31FBF0ACF89C8736225" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_E6F92D012EF201ED01ABCF89C873D946" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_E6F92D012EF201ED01ABCF89C873D946" xlink:to="loc_abus_CashlessExerciseProvisionMember_99B2B3BA346B09CB08D3CF89C870BB8F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19EBF0AFF20983CE08DFCF89C8709C41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_F67DABC1CF578FBC1E91CF89C87388B5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_F67DABC1CF578FBC1E91CF89C87388B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_D99F5D655084974DB11ACF89C8733340" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_D99F5D655084974DB11ACF89C8733340" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_7FCB3E38FEA7CA656EE1CF89C8730120" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_7FCB3E38FEA7CA656EE1CF89C8730120" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_C5EF8141F1358A424803CF89C8737273" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_C5EF8141F1358A424803CF89C8737273" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_NumberOfAdditionalSharesAuthorized" xlink:label="loc_abus_NumberOfAdditionalSharesAuthorized_F584897E94AE02D991DDCF89C873E6DB" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_abus_NumberOfAdditionalSharesAuthorized_F584897E94AE02D991DDCF89C873E6DB" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_PotentialProceedsOfAdditionalSharesAuthorized" xlink:label="loc_abus_PotentialProceedsOfAdditionalSharesAuthorized_F12971A000DDBDEC1944CF89C8730126" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_abus_PotentialProceedsOfAdditionalSharesAuthorized_F12971A000DDBDEC1944CF89C8730126" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_7CBB070469C8332C8849CF89C8731B10" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_7CBB070469C8332C8849CF89C8731B10" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ProceedsFromIssuanceOfCommonStockNet" xlink:label="loc_abus_ProceedsFromIssuanceOfCommonStockNet_2C1D9873500F87847024CF89C8732F3A" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_abus_ProceedsFromIssuanceOfCommonStockNet_2C1D9873500F87847024CF89C8732F3A" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_WarrantsExercised" xlink:label="loc_abus_WarrantsExercised_74D78277E094F0F4682CCF89C87375BC" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_abus_WarrantsExercised_74D78277E094F0F4682CCF89C87375BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_6E47FADEE2D18894B10FCF89C873BA3A" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_6E47FADEE2D18894B10FCF89C873BA3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_336D76AF733F2256F723CF89C873200B" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_336D76AF733F2256F723CF89C873200B" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ClassofWarrantorRightExpired" xlink:label="loc_abus_ClassofWarrantorRightExpired_A8057675F7D75184228CCF89C873CD1C" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_abus_ClassofWarrantorRightExpired_A8057675F7D75184228CCF89C873CD1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_0EA298A9EE4304CD3067CF89C87359C7" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_0EA298A9EE4304CD3067CF89C87359C7" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_NumberofShareBasedCompensationPlans" xlink:label="loc_abus_NumberofShareBasedCompensationPlans_DA428FE6950CA8A6D74BCF89C87381F6" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_abus_NumberofShareBasedCompensationPlans_DA428FE6950CA8A6D74BCF89C87381F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_C340B49D3516291BBAA9CF89C8737C90" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_C340B49D3516291BBAA9CF89C8737C90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_AB89F1B02931B7E1AD45CF89C8730159" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_AB89F1B02931B7E1AD45CF89C8730159" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_525385279A62AF789E30CF89C8730D3F" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_525385279A62AF789E30CF89C8730D3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_6FD21DD21769693FCBA2CF89C8737EED" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_6FD21DD21769693FCBA2CF89C8737EED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_716470CACD42D5886214CF89C873702F" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_716470CACD42D5886214CF89C873702F" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_NumberOfExecutiveOfficersGrantedOptionsWithNewAppointments" xlink:label="loc_abus_NumberOfExecutiveOfficersGrantedOptionsWithNewAppointments_C06A775FCAE525F7DEA6CF89C873F7E7" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_abus_NumberOfExecutiveOfficersGrantedOptionsWithNewAppointments_C06A775FCAE525F7DEA6CF89C873F7E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_A0881457C53A5AD79DDACF89C8734423" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_A0881457C53A5AD79DDACF89C8734423" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_DAD9E629CD6711F49731CF89C873558A" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_DAD9E629CD6711F49731CF89C873558A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_CA7B0671C55272F705DECF89C8737206" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_CA7B0671C55272F705DECF89C8737206" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_B626BFF07B9C131BE2E7CF89C8734C71" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_B626BFF07B9C131BE2E7CF89C8734C71" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_56A7BB6F78FC168415B5CF89C87323E7" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_56A7BB6F78FC168415B5CF89C87323E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_18790FE88DCF8F287AC8CF89C873195D" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_18790FE88DCF8F287AC8CF89C873195D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2AB24063A707FB69C930CF89C873BD9D" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2AB24063A707FB69C930CF89C873BD9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_FairValueAssumptionsRiskFreeInterestRate_07F1895ED6D35178FC4DCF89C873047A" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_FairValueAssumptionsRiskFreeInterestRate_07F1895ED6D35178FC4DCF89C873047A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_373D410B4C2A7F7EEC2FCF89C8730B4D" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_373D410B4C2A7F7EEC2FCF89C8730B4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_E27ACB5DE36DCC414B4FCF89C8731D22" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_E27ACB5DE36DCC414B4FCF89C8731D22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_3CBEDFA841AF04BD71D6CF89C873789F" xlink:type="locator" />
    <link:presentationArc order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_3CBEDFA841AF04BD71D6CF89C873789F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentOptionsExercisePrice" xlink:label="loc_invest_InvestmentOptionsExercisePrice_BC4AD5F9F64709665B47CF89C8735032" xlink:type="locator" />
    <link:presentationArc order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_invest_InvestmentOptionsExercisePrice_BC4AD5F9F64709665B47CF89C8735032" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_83EF26B1A8650DC64283CF89C873E86A" xlink:type="locator" />
    <link:presentationArc order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_83EF26B1A8650DC64283CF89C873E86A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8CDDACCFD330BA7B8301CF89C8732B70" xlink:type="locator" />
    <link:presentationArc order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8CDDACCFD330BA7B8301CF89C8732B70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_F06702E8183225E233D8CF89C873AD14" xlink:type="locator" />
    <link:presentationArc order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_F06702E8183225E233D8CF89C873AD14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedVolatilityRate_2165D633F874820406F5CF89C873025C" xlink:type="locator" />
    <link:presentationArc order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedVolatilityRate_2165D633F874820406F5CF89C873025C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedDividendRate_C48436A6210FA3B14023CF89C873B987" xlink:type="locator" />
    <link:presentationArc order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedDividendRate_C48436A6210FA3B14023CF89C873B987" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedTerm_6C9177EC9F42FE9CC166CF89C8732CF2" xlink:type="locator" />
    <link:presentationArc order="38" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedTerm_6C9177EC9F42FE9CC166CF89C8732CF2" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssignedAttributedAsPreCombinationServiceAndIncludedAsPartOfTotalPurchasePrice" xlink:label="loc_abus_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssignedAttributedAsPreCombinationServiceAndIncludedAsPartOfTotalPurchasePrice_336B931F4B3420C366F1CF89C8739F77" xlink:type="locator" />
    <link:presentationArc order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_abus_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssignedAttributedAsPreCombinationServiceAndIncludedAsPartOfTotalPurchasePrice_336B931F4B3420C366F1CF89C8739F77" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssignedAttributedAsPostCombinationServiceAndNotIncludedAsPartOfTotalPurchasePrice" xlink:label="loc_abus_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssignedAttributedAsPostCombinationServiceAndNotIncludedAsPartOfTotalPurchasePrice_C2B79D8D4A23CCFD538ACF89C8730A74" xlink:type="locator" />
    <link:presentationArc order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_abus_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssignedAttributedAsPostCombinationServiceAndNotIncludedAsPartOfTotalPurchasePrice_C2B79D8D4A23CCFD538ACF89C8730A74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_56D3799D44AE5DC2C08ACF89C8737052" xlink:type="locator" />
    <link:presentationArc order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_56D3799D44AE5DC2C08ACF89C8737052" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9FB681E4E39D00544C5CCF89C8731EEB" xlink:type="locator" />
    <link:presentationArc order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9FB681E4E39D00544C5CCF89C8731EEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BFD52243166F24CB1B17CF89C873C206" xlink:type="locator" />
    <link:presentationArc order="43" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BFD52243166F24CB1B17CF89C873C206" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_E6DA8B39DAA8A74E8159CF89C873451B" xlink:type="locator" />
    <link:presentationArc order="44" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_E6DA8B39DAA8A74E8159CF89C873451B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_81FFE998B13114D40DC9CF89C8758314" xlink:type="locator" />
    <link:presentationArc order="45" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_81FFE998B13114D40DC9CF89C8758314" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_BusinessCombinationAccelerationOfShareBasedCompensationExpensePerQuarter" xlink:label="loc_abus_BusinessCombinationAccelerationOfShareBasedCompensationExpensePerQuarter_44F59928B8CA313B9D9FCF89C87523F8" xlink:type="locator" />
    <link:presentationArc order="46" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_abus_BusinessCombinationAccelerationOfShareBasedCompensationExpensePerQuarter_44F59928B8CA313B9D9FCF89C87523F8" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_NumberofShareholdersWhoseDepartureAcceleratedCompensationExpense" xlink:label="loc_abus_NumberofShareholdersWhoseDepartureAcceleratedCompensationExpense_FC85AC41AC2A2AF1B944CF89C87530DA" xlink:type="locator" />
    <link:presentationArc order="47" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_abus_NumberofShareholdersWhoseDepartureAcceleratedCompensationExpense_FC85AC41AC2A2AF1B944CF89C87530DA" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_NumberofShareholdersSubjecttoRepurchaseProvision" xlink:label="loc_abus_NumberofShareholdersSubjecttoRepurchaseProvision_EC663CC93873BA927FA1CF89C8755CD3" xlink:type="locator" />
    <link:presentationArc order="48" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_abus_NumberofShareholdersSubjecttoRepurchaseProvision_EC663CC93873BA927FA1CF89C8755CD3" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_CommonSharesAttributedtoPostAcquisitionPeriodCompensationCostNotYetRecognizedOverExpiryPeriodofRepurchaseProvisionRights" xlink:label="loc_abus_CommonSharesAttributedtoPostAcquisitionPeriodCompensationCostNotYetRecognizedOverExpiryPeriodofRepurchaseProvisionRights_4A88837AC10C76E0223FCF89C87576D6" xlink:type="locator" />
    <link:presentationArc order="49" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A1F5BFA76307A3EDD5BBCF89C8738F2D" xlink:to="loc_abus_CommonSharesAttributedtoPostAcquisitionPeriodCompensationCostNotYetRecognizedOverExpiryPeriodofRepurchaseProvisionRights_4A88837AC10C76E0223FCF89C87576D6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapitalNonVestedLiabilityStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_2E177E4DEAFDF69A26D2A539313FC269" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BCFE28C6A4D03A6CAF0FA539313FADB7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_2E177E4DEAFDF69A26D2A539313FC269" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BCFE28C6A4D03A6CAF0FA539313FADB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_FB412B189F5F8E3A64F1A539313F60E0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BCFE28C6A4D03A6CAF0FA539313FADB7" xlink:to="loc_us-gaap_AwardTypeAxis_FB412B189F5F8E3A64F1A539313F60E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9D86BCA68F3A120D5B2CA539313F927D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_FB412B189F5F8E3A64F1A539313F60E0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9D86BCA68F3A120D5B2CA539313F927D" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EmployeeStockOptionLiabilityClassifiedMember" xlink:label="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_9DB2E3C97DAE621C4DE6A539313FCE35" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9D86BCA68F3A120D5B2CA539313F927D" xlink:to="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_9DB2E3C97DAE621C4DE6A539313FCE35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B348B4D5A811EDFC3958A539313F42EC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BCFE28C6A4D03A6CAF0FA539313FADB7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B348B4D5A811EDFC3958A539313F42EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_B5A35259ABDBC4436D3AA539313F79A4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B348B4D5A811EDFC3958A539313F42EC" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_B5A35259ABDBC4436D3AA539313F79A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_4CE58617D54D90CA7F66A539313F6E89" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_B5A35259ABDBC4436D3AA539313F79A4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_4CE58617D54D90CA7F66A539313F6E89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_FF85CEE947800350F5F9A539313FA484" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_B5A35259ABDBC4436D3AA539313F79A4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_FF85CEE947800350F5F9A539313FA484" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_DF2A8B77B19911E82CC5A539313FD236" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_B5A35259ABDBC4436D3AA539313F79A4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_DF2A8B77B19911E82CC5A539313FD236" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_04B00D8FC1D5BD242B8EA539313FE25F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_B5A35259ABDBC4436D3AA539313F79A4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_04B00D8FC1D5BD242B8EA539313FE25F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_CA20937F6C5E7D10AAADA53D667C6F84" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B348B4D5A811EDFC3958A539313F42EC" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_CA20937F6C5E7D10AAADA53D667C6F84" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue" xlink:label="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue_62A724F27C65EEAD8FDAA539313F3EFF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_CA20937F6C5E7D10AAADA53D667C6F84" xlink:to="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue_62A724F27C65EEAD8FDAA539313F3EFF" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodWeightedAverageFairValue" xlink:label="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodWeightedAverageFairValue_FAD6AF050E7C72CD51B8A539313FB50C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_CA20937F6C5E7D10AAADA53D667C6F84" xlink:to="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodWeightedAverageFairValue_FAD6AF050E7C72CD51B8A539313FB50C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_F07CC95CE7F26D6457CEA539313F00E1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_CA20937F6C5E7D10AAADA53D667C6F84" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_F07CC95CE7F26D6457CEA539313F00E1" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue" xlink:label="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue_1B48D3E0E15A1ACB8798A539313FB408" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_CA20937F6C5E7D10AAADA53D667C6F84" xlink:to="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue_1B48D3E0E15A1ACB8798A539313FB408" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapitalNonVestedStockOptionActivityEquityOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_AF7C88E52DA75CE7844FA53932DF8AA3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_C9ED61CCFD6BAEF4E83AA53932DF14E4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_AF7C88E52DA75CE7844FA53932DF8AA3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_C9ED61CCFD6BAEF4E83AA53932DF14E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_423033BCFB1DD599AAAFA53932DFDF60" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_C9ED61CCFD6BAEF4E83AA53932DF14E4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_423033BCFB1DD599AAAFA53932DFDF60" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsNonvestedReclassificationtoLiabilityNumberofShares" xlink:label="loc_abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsNonvestedReclassificationtoLiabilityNumberofShares_2317C46BC01203538C34A53932DFA8B1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_C9ED61CCFD6BAEF4E83AA53932DF14E4" xlink:to="loc_abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsNonvestedReclassificationtoLiabilityNumberofShares_2317C46BC01203538C34A53932DFA8B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6CED0EFE79FE0BA8D508A53932DFD515" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_C9ED61CCFD6BAEF4E83AA53932DF14E4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6CED0EFE79FE0BA8D508A53932DFD515" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_C301874932834D9B6A35A53932DF88D5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_C9ED61CCFD6BAEF4E83AA53932DF14E4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_C301874932834D9B6A35A53932DF88D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_84CBAC0F93FA4EF2C3D9A53932DFBD52" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_C9ED61CCFD6BAEF4E83AA53932DF14E4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_84CBAC0F93FA4EF2C3D9A53932DFBD52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_D6D23A372742CDCF0FDFA53932DF5765" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_C9ED61CCFD6BAEF4E83AA53932DF14E4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_D6D23A372742CDCF0FDFA53932DF5765" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_220A4211C44F88AA6443A53C83D83B0D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_AF7C88E52DA75CE7844FA53932DF8AA3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_220A4211C44F88AA6443A53C83D83B0D" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue" xlink:label="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue_82D695C0E7D4027808AEA53932DF124A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_220A4211C44F88AA6443A53C83D83B0D" xlink:to="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue_82D695C0E7D4027808AEA53932DF124A" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsReclassificationtoLiabilityNonvestedWeightedAverageFairValue" xlink:label="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsReclassificationtoLiabilityNonvestedWeightedAverageFairValue_35359052D1E5A5A147E3A53932DFDD40" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_220A4211C44F88AA6443A53C83D83B0D" xlink:to="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsReclassificationtoLiabilityNonvestedWeightedAverageFairValue_35359052D1E5A5A147E3A53932DFDD40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_AB4B18C54F1253BA379BA53932DFF284" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_220A4211C44F88AA6443A53C83D83B0D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_AB4B18C54F1253BA379BA53932DFF284" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodWeightedAverageFairValue" xlink:label="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodWeightedAverageFairValue_EA418542DFB9B4DF5060A53932DF4FF9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_220A4211C44F88AA6443A53C83D83B0D" xlink:to="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodWeightedAverageFairValue_EA418542DFB9B4DF5060A53932DF4FF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_CE0FDC9CFA2B5C464FE4A53932DFC66D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_220A4211C44F88AA6443A53C83D83B0D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_CE0FDC9CFA2B5C464FE4A53932DFC66D" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue" xlink:label="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue_E5880D9D67F0EF5000DDA53932DF0C14" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_220A4211C44F88AA6443A53C83D83B0D" xlink:to="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue_E5880D9D67F0EF5000DDA53932DF0C14" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapitalNonVestedStockOptionActivityOncoreOptionPlanDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_5E944C991364B6928F7FA53FE51E1AA4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DF390C3B9465897E8BF4A53FE52F7964" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_5E944C991364B6928F7FA53FE51E1AA4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DF390C3B9465897E8BF4A53FE52F7964" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_B95B787197BB3AD01894A53FE52FAFEB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DF390C3B9465897E8BF4A53FE52F7964" xlink:to="loc_us-gaap_AwardTypeAxis_B95B787197BB3AD01894A53FE52FAFEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_00BD9B1C7015B1DEA8F4A53FE52FF71E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_B95B787197BB3AD01894A53FE52FAFEB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_00BD9B1C7015B1DEA8F4A53FE52FF71E" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EquivalentNumberOfCompanyCommonSharesMember" xlink:label="loc_abus_EquivalentNumberOfCompanyCommonSharesMember_650F59554EC582510342A53FE52FE08D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_00BD9B1C7015B1DEA8F4A53FE52FF71E" xlink:to="loc_abus_EquivalentNumberOfCompanyCommonSharesMember_650F59554EC582510342A53FE52FE08D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_A13C496E71452E0B9DF1A53FE530B8A5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DF390C3B9465897E8BF4A53FE52F7964" xlink:to="loc_us-gaap_PlanNameAxis_A13C496E71452E0B9DF1A53FE530B8A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_9BEFAC9441C59BC1A476A53FE5301A0D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_A13C496E71452E0B9DF1A53FE530B8A5" xlink:to="loc_us-gaap_PlanNameDomain_9BEFAC9441C59BC1A476A53FE5301A0D" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_OnCoreOptionPlanMember" xlink:label="loc_abus_OnCoreOptionPlanMember_29E317C6710540E677B2A53FE53014E0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9BEFAC9441C59BC1A476A53FE5301A0D" xlink:to="loc_abus_OnCoreOptionPlanMember_29E317C6710540E677B2A53FE53014E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_667EE0AF3F6CB1AA0929A53FE5309D84" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DF390C3B9465897E8BF4A53FE52F7964" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_667EE0AF3F6CB1AA0929A53FE5309D84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_F3BF3A62A7514268C7F3A53FE530B915" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_667EE0AF3F6CB1AA0929A53FE5309D84" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_F3BF3A62A7514268C7F3A53FE530B915" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_6FA4568A8A17CE80BFBDA53FE530281D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_F3BF3A62A7514268C7F3A53FE530B915" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_6FA4568A8A17CE80BFBDA53FE530281D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_3ECAE65E40B19430791BA53FE5306506" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_F3BF3A62A7514268C7F3A53FE530B915" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_3ECAE65E40B19430791BA53FE5306506" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_DF3D73D11C2A7B386046A53FE530531D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_F3BF3A62A7514268C7F3A53FE530B915" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_DF3D73D11C2A7B386046A53FE530531D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_891E7174560E4B6BDF81A53FE53012F1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_F3BF3A62A7514268C7F3A53FE530B915" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_891E7174560E4B6BDF81A53FE53012F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_C4CD8D972FBD62DA59A8A5422A9A47C9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_667EE0AF3F6CB1AA0929A53FE5309D84" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_C4CD8D972FBD62DA59A8A5422A9A47C9" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue" xlink:label="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue_8C51A256478CBBA13CFEA53FE5308AA0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_C4CD8D972FBD62DA59A8A5422A9A47C9" xlink:to="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue_8C51A256478CBBA13CFEA53FE5308AA0" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodWeightedAverageFairValue" xlink:label="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodWeightedAverageFairValue_9E2F34FBFD47363DF86EA53FE530D09B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_C4CD8D972FBD62DA59A8A5422A9A47C9" xlink:to="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodWeightedAverageFairValue_9E2F34FBFD47363DF86EA53FE530D09B" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue" xlink:label="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue_4D280FF32E27EA8DB493A53FE530ABA4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_C4CD8D972FBD62DA59A8A5422A9A47C9" xlink:to="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageFairValue_4D280FF32E27EA8DB493A53FE530ABA4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapitalOutstandingOptionsUnderOncoreOptionPlanDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_7729CBD15B3489984CAAA53FE79BA375" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5312D3CD8A1D169CEEB6A53FE79B6576" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7729CBD15B3489984CAAA53FE79BA375" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5312D3CD8A1D169CEEB6A53FE79B6576" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_6F37CE3820B553A2119AA53FE79B9579" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5312D3CD8A1D169CEEB6A53FE79B6576" xlink:to="loc_us-gaap_AwardTypeAxis_6F37CE3820B553A2119AA53FE79B9579" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AC639C9991055B113500A53FE79B6E42" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6F37CE3820B553A2119AA53FE79B9579" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AC639C9991055B113500A53FE79B6E42" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EquivalentNumberOfCompanyCommonSharesMember" xlink:label="loc_abus_EquivalentNumberOfCompanyCommonSharesMember_8C33129613E331F5E69FA53FE79B7C34" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AC639C9991055B113500A53FE79B6E42" xlink:to="loc_abus_EquivalentNumberOfCompanyCommonSharesMember_8C33129613E331F5E69FA53FE79B7C34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_351AF45FA5611DA832E6A53FE79B0CD0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5312D3CD8A1D169CEEB6A53FE79B6576" xlink:to="loc_us-gaap_PlanNameAxis_351AF45FA5611DA832E6A53FE79B0CD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_0F3EA8896962127828D4A53FE79BFBB9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_351AF45FA5611DA832E6A53FE79B0CD0" xlink:to="loc_us-gaap_PlanNameDomain_0F3EA8896962127828D4A53FE79BFBB9" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_OnCoreOptionPlanMember" xlink:label="loc_abus_OnCoreOptionPlanMember_12D544F1A2D9CCC73B42A53FE79BFDE8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_0F3EA8896962127828D4A53FE79BFBB9" xlink:to="loc_abus_OnCoreOptionPlanMember_12D544F1A2D9CCC73B42A53FE79BFDE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1B3A4E4AF69DD50E16F4A53FE79B640B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5312D3CD8A1D169CEEB6A53FE79B6576" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1B3A4E4AF69DD50E16F4A53FE79B640B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_B7A1BB9058EEFF880B12A53FE79B1B77" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1B3A4E4AF69DD50E16F4A53FE79B640B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_B7A1BB9058EEFF880B12A53FE79B1B77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_B526FB70BEBD47E6B1EDA53FE79BD878" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_B7A1BB9058EEFF880B12A53FE79B1B77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_B526FB70BEBD47E6B1EDA53FE79BD878" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_040CED2CFA65E375F310A53FE79BF990" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_B7A1BB9058EEFF880B12A53FE79B1B77" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_040CED2CFA65E375F310A53FE79BF990" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_A107D37AA004F3ECD78CA53FE79BA6DE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_B7A1BB9058EEFF880B12A53FE79B1B77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_A107D37AA004F3ECD78CA53FE79BA6DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_D073F6EA29CDA88A21B6A53FE79B63E7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_B7A1BB9058EEFF880B12A53FE79B1B77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_D073F6EA29CDA88A21B6A53FE79B63E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_531ACAC3068B837A6A5AA53FE79B19FB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1B3A4E4AF69DD50E16F4A53FE79B640B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_531ACAC3068B837A6A5AA53FE79B19FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_957EFD6C02BDF5AF0CACA53FE79B0B51" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_531ACAC3068B837A6A5AA53FE79B19FB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_957EFD6C02BDF5AF0CACA53FE79B0B51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_BD4FA5FA8172D7155E0EA53FE79BD97D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_531ACAC3068B837A6A5AA53FE79B19FB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_BD4FA5FA8172D7155E0EA53FE79BD97D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapitalOutstandingOptionsUnderProtivaOptionPlanDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_1A903ED7EC6B47657EACA4C773170CDF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6D967007B27957F90A8BA4C773171F09" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_1A903ED7EC6B47657EACA4C773170CDF" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6D967007B27957F90A8BA4C773171F09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_85A1E9436E881ECC8E8AA4C77317565C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6D967007B27957F90A8BA4C773171F09" xlink:to="loc_us-gaap_AwardTypeAxis_85A1E9436E881ECC8E8AA4C77317565C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A66C9D6A775D574C1B3EA4C773174D7C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_85A1E9436E881ECC8E8AA4C77317565C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A66C9D6A775D574C1B3EA4C773174D7C" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EquivalentNumberOfCompanyCommonSharesMember" xlink:label="loc_abus_EquivalentNumberOfCompanyCommonSharesMember_95D3EB24801A2832C727A4C77317E506" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A66C9D6A775D574C1B3EA4C773174D7C" xlink:to="loc_abus_EquivalentNumberOfCompanyCommonSharesMember_95D3EB24801A2832C727A4C77317E506" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_B272234B3B98723E2D6FA4C77317D5F9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6D967007B27957F90A8BA4C773171F09" xlink:to="loc_us-gaap_PlanNameAxis_B272234B3B98723E2D6FA4C77317D5F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_2D728653332C6C27E6AFA4C773175EBF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_B272234B3B98723E2D6FA4C77317D5F9" xlink:to="loc_us-gaap_PlanNameDomain_2D728653332C6C27E6AFA4C773175EBF" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ProtivaShareOptionsMember" xlink:label="loc_abus_ProtivaShareOptionsMember_F4349F1F299C026A8408A4C773176372" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_2D728653332C6C27E6AFA4C773175EBF" xlink:to="loc_abus_ProtivaShareOptionsMember_F4349F1F299C026A8408A4C773176372" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6716DD865815886603A2A4C773174575" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6D967007B27957F90A8BA4C773171F09" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6716DD865815886603A2A4C773174575" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1A05C5B9FE2DA3EC0267A4C773175F9C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6716DD865815886603A2A4C773174575" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1A05C5B9FE2DA3EC0267A4C773175F9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3FB0A4B773C9F4F101EDA4C77317B3D8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1A05C5B9FE2DA3EC0267A4C773175F9C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3FB0A4B773C9F4F101EDA4C77317B3D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_A0B22ED289A6E96FBF93A4C77317730E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1A05C5B9FE2DA3EC0267A4C773175F9C" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_A0B22ED289A6E96FBF93A4C77317730E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_429A2FBB9D6E7CA6EEAEA4C77317D062" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1A05C5B9FE2DA3EC0267A4C773175F9C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_429A2FBB9D6E7CA6EEAEA4C77317D062" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_FF831C629D6CE61E0D52A4C773174717" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1A05C5B9FE2DA3EC0267A4C773175F9C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_FF831C629D6CE61E0D52A4C773174717" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4E7B353C6F89F174FFC3A4D58E030B31" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6716DD865815886603A2A4C773174575" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4E7B353C6F89F174FFC3A4D58E030B31" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_81DAB4E37F09CE6C0D5AA4C77317FA31" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4E7B353C6F89F174FFC3A4D58E030B31" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_81DAB4E37F09CE6C0D5AA4C77317FA31" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_90DB9987C31105D17861A4C773175F25" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4E7B353C6F89F174FFC3A4D58E030B31" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_90DB9987C31105D17861A4C773175F25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_EA82EABD1FB06CA699A9A4C77317B514" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4E7B353C6F89F174FFC3A4D58E030B31" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_EA82EABD1FB06CA699A9A4C77317B514" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ED8A1E4AD94575640902A4C773173E2E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4E7B353C6F89F174FFC3A4D58E030B31" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ED8A1E4AD94575640902A4C773173E2E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapitalStockOptionActivityForLiabilityClassifiedOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_513D27E420A43DD5BD83A4C77327FF1D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_23061346A5551DC11A7FA4C773274AF3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_513D27E420A43DD5BD83A4C77327FF1D" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_23061346A5551DC11A7FA4C773274AF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_3F3BFDEEC4DF19667806A4C773277705" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_23061346A5551DC11A7FA4C773274AF3" xlink:to="loc_us-gaap_AwardTypeAxis_3F3BFDEEC4DF19667806A4C773277705" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_C4BE51D9FE04B13A640AA4C7732746A3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3F3BFDEEC4DF19667806A4C773277705" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_C4BE51D9FE04B13A640AA4C7732746A3" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EmployeeStockOptionLiabilityClassifiedMember" xlink:label="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_A6EC78F55C087F6D299BA4C77327549B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_C4BE51D9FE04B13A640AA4C7732746A3" xlink:to="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_A6EC78F55C087F6D299BA4C77327549B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_DA1691CAFC2BFEC3ED7AA4C77327F8DA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_23061346A5551DC11A7FA4C773274AF3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_DA1691CAFC2BFEC3ED7AA4C77327F8DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_34E2C649ED965C7002E0A4CDA59ADDAC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_DA1691CAFC2BFEC3ED7AA4C77327F8DA" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_34E2C649ED965C7002E0A4CDA59ADDAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_A06B87263DA29C976F31A4C773276EA7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_34E2C649ED965C7002E0A4CDA59ADDAC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_A06B87263DA29C976F31A4C773276EA7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_B98F7AE8CB3099D15694A4C7732728C2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_34E2C649ED965C7002E0A4CDA59ADDAC" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_B98F7AE8CB3099D15694A4C7732728C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_84B033FBCCFCE5FC9C9CA4C773277F91" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_34E2C649ED965C7002E0A4CDA59ADDAC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_84B033FBCCFCE5FC9C9CA4C773277F91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_345933C0366630013995A4C77327CC8F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_34E2C649ED965C7002E0A4CDA59ADDAC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_345933C0366630013995A4C77327CC8F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_D22BB578C2D3C6D77DBAA4CEEA7158E6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_DA1691CAFC2BFEC3ED7AA4C77327F8DA" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_D22BB578C2D3C6D77DBAA4CEEA7158E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0B708A54913B61AF5C86A4C77327E158" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_D22BB578C2D3C6D77DBAA4CEEA7158E6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0B708A54913B61AF5C86A4C77327E158" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_178F9BBFD723502497AAA4C773273686" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_D22BB578C2D3C6D77DBAA4CEEA7158E6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_178F9BBFD723502497AAA4C773273686" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_9E9F79855504E2BF4B57A4C773274B65" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_D22BB578C2D3C6D77DBAA4CEEA7158E6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_9E9F79855504E2BF4B57A4C773274B65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2E747B78F5A5F0A41684A4C773272C93" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_D22BB578C2D3C6D77DBAA4CEEA7158E6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2E747B78F5A5F0A41684A4C773272C93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_E7369D8C54B0B7528A74A4CFD6E3EA9B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_DA1691CAFC2BFEC3ED7AA4C77327F8DA" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_E7369D8C54B0B7528A74A4CFD6E3EA9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_02ECC934CEDACE6A47D4A4C77327DF6F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_E7369D8C54B0B7528A74A4CFD6E3EA9B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_02ECC934CEDACE6A47D4A4C77327DF6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_E571C9835EA9E33E4C91A4C773271ACB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_E7369D8C54B0B7528A74A4CFD6E3EA9B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_E571C9835EA9E33E4C91A4C773271ACB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F673D60A2C4D792166D3A4C77327A524" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_E7369D8C54B0B7528A74A4CFD6E3EA9B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F673D60A2C4D792166D3A4C77327A524" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapitalStockOptionsOutstandingEquityOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_A1FBCD6517817DF2D7BCA53FE380BD18" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_67062F78EFF4C3DDCCB8A53FE38172F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_A1FBCD6517817DF2D7BCA53FE380BD18" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_67062F78EFF4C3DDCCB8A53FE38172F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_CFFD31BC7915549784B2A53FE3811795" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_67062F78EFF4C3DDCCB8A53FE38172F4" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_CFFD31BC7915549784B2A53FE3811795" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_142C493219D962891C62A53FE381CA7C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_CFFD31BC7915549784B2A53FE3811795" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_142C493219D962891C62A53FE381CA7C" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_Range1Member" xlink:label="loc_abus_Range1Member_D258FEBB0ACBD615D510A53FE381187C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_142C493219D962891C62A53FE381CA7C" xlink:to="loc_abus_Range1Member_D258FEBB0ACBD615D510A53FE381187C" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_Range2Member" xlink:label="loc_abus_Range2Member_31877C8D9FF4CE8F8A4EA53FE3812CAB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_142C493219D962891C62A53FE381CA7C" xlink:to="loc_abus_Range2Member_31877C8D9FF4CE8F8A4EA53FE3812CAB" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_Range3Member" xlink:label="loc_abus_Range3Member_59A698CD21CCA0FA61FDA53FE381D023" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_142C493219D962891C62A53FE381CA7C" xlink:to="loc_abus_Range3Member_59A698CD21CCA0FA61FDA53FE381D023" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_Range4Member" xlink:label="loc_abus_Range4Member_F3ABC11512A9347D87D1A53FE38129CF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_142C493219D962891C62A53FE381CA7C" xlink:to="loc_abus_Range4Member_F3ABC11512A9347D87D1A53FE38129CF" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_Range5Member" xlink:label="loc_abus_Range5Member_C4B0D731CA9D4A4FC3E3A53FE38121D2" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_142C493219D962891C62A53FE381CA7C" xlink:to="loc_abus_Range5Member_C4B0D731CA9D4A4FC3E3A53FE38121D2" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_Range6Member" xlink:label="loc_abus_Range6Member_E12A4CA1E99EE7736EE0A53FE38149D2" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_142C493219D962891C62A53FE381CA7C" xlink:to="loc_abus_Range6Member_E12A4CA1E99EE7736EE0A53FE38149D2" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_Range7Member" xlink:label="loc_abus_Range7Member_4A45A793973471C11918A53FE38136AD" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_142C493219D962891C62A53FE381CA7C" xlink:to="loc_abus_Range7Member_4A45A793973471C11918A53FE38136AD" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_TotalRangeMember" xlink:label="loc_abus_TotalRangeMember_63DA98EFA793940363AEA53FE3817293" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_142C493219D962891C62A53FE381CA7C" xlink:to="loc_abus_TotalRangeMember_63DA98EFA793940363AEA53FE3817293" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_689259B43132594805FAA53FE381C0ED" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_67062F78EFF4C3DDCCB8A53FE38172F4" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_689259B43132594805FAA53FE381C0ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_76A67C3ABC0846FC4172A53FE382E25F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_689259B43132594805FAA53FE381C0ED" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_76A67C3ABC0846FC4172A53FE382E25F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_1479C2A6F4161D1C41E9A53FE3825697" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_689259B43132594805FAA53FE381C0ED" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_1479C2A6F4161D1C41E9A53FE3825697" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_8A39074274565CA21583A53FE3825327" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_689259B43132594805FAA53FE381C0ED" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_8A39074274565CA21583A53FE3825327" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6CE5361D050F5C15F12FA53FE3825194" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_689259B43132594805FAA53FE381C0ED" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6CE5361D050F5C15F12FA53FE3825194" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4023CCA39F98E71FDD10A53FE38200E3" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_689259B43132594805FAA53FE381C0ED" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4023CCA39F98E71FDD10A53FE38200E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_23F6612FC1552B34C329A53FE382D134" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_689259B43132594805FAA53FE381C0ED" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_23F6612FC1552B34C329A53FE382D134" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_83479BB542273D19EB24A53FE3823487" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_689259B43132594805FAA53FE381C0ED" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_83479BB542273D19EB24A53FE3823487" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapitalSummaryOfInformationEquityOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_ED33F2A1E92657329ABC94DF61C5E97B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E8E6E0BE3AAE5F71E87B94DF61C6B651" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_ED33F2A1E92657329ABC94DF61C5E97B" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E8E6E0BE3AAE5F71E87B94DF61C6B651" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_B337720518E5EFDD836C94DF61CB7200" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E8E6E0BE3AAE5F71E87B94DF61C6B651" xlink:to="loc_us-gaap_PlanNameAxis_B337720518E5EFDD836C94DF61CB7200" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_98D0343F383520B59AF894DF61CC4A66" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_B337720518E5EFDD836C94DF61CB7200" xlink:to="loc_us-gaap_PlanNameDomain_98D0343F383520B59AF894DF61CC4A66" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ArbutusPlansMember" xlink:label="loc_abus_ArbutusPlansMember_D5F39EAD6BCB1FC92FB294DF61CCF92B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_98D0343F383520B59AF894DF61CC4A66" xlink:to="loc_abus_ArbutusPlansMember_D5F39EAD6BCB1FC92FB294DF61CCF92B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9D3C994AEC5DEE3B19D994DF61CC43C7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E8E6E0BE3AAE5F71E87B94DF61C6B651" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9D3C994AEC5DEE3B19D994DF61CC43C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8D1AC9A185F6B25FEBC094DF61CCF650" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9D3C994AEC5DEE3B19D994DF61CC43C7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8D1AC9A185F6B25FEBC094DF61CCF650" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_72B1F335754D34368FC894DF61CC1C7B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8D1AC9A185F6B25FEBC094DF61CCF650" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_72B1F335754D34368FC894DF61CC1C7B" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsReclassificationstoLiabilityinPeriod" xlink:label="loc_abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsReclassificationstoLiabilityinPeriod_8549BB0869B2605B3F8C94DF61CC0D03" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8D1AC9A185F6B25FEBC094DF61CCF650" xlink:to="loc_abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsReclassificationstoLiabilityinPeriod_8549BB0869B2605B3F8C94DF61CC0D03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_A060073287A6F8A6DF4994DF61CC2CC4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8D1AC9A185F6B25FEBC094DF61CCF650" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_A060073287A6F8A6DF4994DF61CC2CC4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4DE77F8E58154E73C50294DF61CC896E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8D1AC9A185F6B25FEBC094DF61CCF650" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4DE77F8E58154E73C50294DF61CC896E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_5219D6B06C19EBD64A8694DF61CC4A81" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8D1AC9A185F6B25FEBC094DF61CCF650" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_5219D6B06C19EBD64A8694DF61CC4A81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_545EBD6E88AD825D988094DF61CDA7FB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8D1AC9A185F6B25FEBC094DF61CCF650" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_545EBD6E88AD825D988094DF61CDA7FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_368CDA4BB589A09CC51994DF61CD99C6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9D3C994AEC5DEE3B19D994DF61CC43C7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_368CDA4BB589A09CC51994DF61CD99C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_D425E5547BF0DC7FCDD294DF61CD214D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_368CDA4BB589A09CC51994DF61CD99C6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_D425E5547BF0DC7FCDD294DF61CD214D" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsReclassificationstoLiabilityinPeriodWeightedAverageExercisePrice" xlink:label="loc_abus_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsReclassificationstoLiabilityinPeriodWeightedAverageExercisePrice_B6A52E3993ED57A2F11594DF61CD2077" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_368CDA4BB589A09CC51994DF61CD99C6" xlink:to="loc_abus_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsReclassificationstoLiabilityinPeriodWeightedAverageExercisePrice_B6A52E3993ED57A2F11594DF61CD2077" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_144F504EA12444A11E5E94DF61CDC1F6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_368CDA4BB589A09CC51994DF61CD99C6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_144F504EA12444A11E5E94DF61CDC1F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_400FFA945FCA39619E8394DF61CD7C7E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_368CDA4BB589A09CC51994DF61CD99C6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_400FFA945FCA39619E8394DF61CD7C7E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_FE624A7687EAAD7035FB94DF61CDEAF5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_368CDA4BB589A09CC51994DF61CD99C6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_FE624A7687EAAD7035FB94DF61CDEAF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6E2E277F9BA89AB8D31994DF61CDA864" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_368CDA4BB589A09CC51994DF61CD99C6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6E2E277F9BA89AB8D31994DF61CDA864" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_AADE5D1513F4AF5F580294DF61CDF495" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9D3C994AEC5DEE3B19D994DF61CC43C7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_AADE5D1513F4AF5F580294DF61CDF495" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_AA125C31C2F2D6B897BB94DF61CD3653" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_AADE5D1513F4AF5F580294DF61CDF495" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_AA125C31C2F2D6B897BB94DF61CD3653" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8DAC27ED03F925FD992E94DF61CD766A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_AADE5D1513F4AF5F580294DF61CDF495" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8DAC27ED03F925FD992E94DF61CD766A" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsReclassificationstoLiabilityinPeriodIntrinsicValue" xlink:label="loc_abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsReclassificationstoLiabilityinPeriodIntrinsicValue_8B6DE8C4001EFFE2DFD994DF61CD96CD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_AADE5D1513F4AF5F580294DF61CDF495" xlink:to="loc_abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsReclassificationstoLiabilityinPeriodIntrinsicValue_8B6DE8C4001EFFE2DFD994DF61CD96CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_4DA0AB52F90131EF57C094DF61CEF8AD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_AADE5D1513F4AF5F580294DF61CDF495" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_4DA0AB52F90131EF57C094DF61CEF8AD" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapitalSummaryOfInformationLiabilityClassifiedOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_126B0C73A8F3BAA933F6A53FE85F2928" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D78B6E8AA89EEFF034BAA53FE860280A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_126B0C73A8F3BAA933F6A53FE85F2928" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D78B6E8AA89EEFF034BAA53FE860280A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_D2DF649E8E2C0EA01528A53FE860153F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D78B6E8AA89EEFF034BAA53FE860280A" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_D2DF649E8E2C0EA01528A53FE860153F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_D34EC5424D6BF14DE5CAA53FE861F5FD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_D2DF649E8E2C0EA01528A53FE860153F" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_D34EC5424D6BF14DE5CAA53FE861F5FD" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_Range1Member" xlink:label="loc_abus_Range1Member_AA3C31417C4AAC3E7663A53FE8610AE3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_D34EC5424D6BF14DE5CAA53FE861F5FD" xlink:to="loc_abus_Range1Member_AA3C31417C4AAC3E7663A53FE8610AE3" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_Range2Member" xlink:label="loc_abus_Range2Member_68BFBD4DADAED03FCCACA53FE8615A9A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_D34EC5424D6BF14DE5CAA53FE861F5FD" xlink:to="loc_abus_Range2Member_68BFBD4DADAED03FCCACA53FE8615A9A" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_Range3Member" xlink:label="loc_abus_Range3Member_137C242869C55DD2F83FA53FE861D7A7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_D34EC5424D6BF14DE5CAA53FE861F5FD" xlink:to="loc_abus_Range3Member_137C242869C55DD2F83FA53FE861D7A7" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_Range4Member" xlink:label="loc_abus_Range4Member_ECCA41F8BD88F263350AA53FE8614EEE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_D34EC5424D6BF14DE5CAA53FE861F5FD" xlink:to="loc_abus_Range4Member_ECCA41F8BD88F263350AA53FE8614EEE" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_Range5Member" xlink:label="loc_abus_Range5Member_A57A7CB3E5B070C4EA04A53FE861210B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_D34EC5424D6BF14DE5CAA53FE861F5FD" xlink:to="loc_abus_Range5Member_A57A7CB3E5B070C4EA04A53FE861210B" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_Range6Member" xlink:label="loc_abus_Range6Member_5CE086615164300986C5A53FE861FB72" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_D34EC5424D6BF14DE5CAA53FE861F5FD" xlink:to="loc_abus_Range6Member_5CE086615164300986C5A53FE861FB72" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_TotalRangeMember" xlink:label="loc_abus_TotalRangeMember_DEA69DE21A2930669640A53FE8615797" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_D34EC5424D6BF14DE5CAA53FE861F5FD" xlink:to="loc_abus_TotalRangeMember_DEA69DE21A2930669640A53FE8615797" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_5A967F92DB6A520EDCB4A53FE8612E93" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D78B6E8AA89EEFF034BAA53FE860280A" xlink:to="loc_us-gaap_AwardTypeAxis_5A967F92DB6A520EDCB4A53FE8612E93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_91C775E3C2BAF50BDC60A53FE861F721" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5A967F92DB6A520EDCB4A53FE8612E93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_91C775E3C2BAF50BDC60A53FE861F721" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EmployeeStockOptionLiabilityClassifiedMember" xlink:label="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_366C20EA5DEA30F28CB2A53FE861A6E9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_91C775E3C2BAF50BDC60A53FE861F721" xlink:to="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_366C20EA5DEA30F28CB2A53FE861A6E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90FB2D79A378778B7D24A53FE8613416" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D78B6E8AA89EEFF034BAA53FE860280A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90FB2D79A378778B7D24A53FE8613416" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_3F68B9361A8390E67AEDA53FE8612715" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90FB2D79A378778B7D24A53FE8613416" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_3F68B9361A8390E67AEDA53FE8612715" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_54FEB4FE6869BD778601A53FE861A57E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90FB2D79A378778B7D24A53FE8613416" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_54FEB4FE6869BD778601A53FE861A57E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_37B12F2B202F901C0C5AA53FE862CDD5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90FB2D79A378778B7D24A53FE8613416" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_37B12F2B202F901C0C5AA53FE862CDD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_E6571D2DF2DCAC5EA8C2A53FE8625A25" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90FB2D79A378778B7D24A53FE8613416" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_E6571D2DF2DCAC5EA8C2A53FE8625A25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3D958082C43C8886A6DBA53FE86706B1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90FB2D79A378778B7D24A53FE8613416" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3D958082C43C8886A6DBA53FE86706B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_1DC7941670ECB7A2EE7DA53FE867350D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90FB2D79A378778B7D24A53FE8613416" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_1DC7941670ECB7A2EE7DA53FE867350D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_3DFC40E195CB328A3D71A53FE8679DF5" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90FB2D79A378778B7D24A53FE8613416" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_3DFC40E195CB328A3D71A53FE8679DF5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapitalSummaryOfWarrantActivityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_A558893ED76790E130D8A579F6F3C53D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_85311D2EE4B1EC139065A579F6F40564" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_A558893ED76790E130D8A579F6F3C53D" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_85311D2EE4B1EC139065A579F6F40564" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_BD05A0A0CBB26FC4D55CA579F6F4288A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_85311D2EE4B1EC139065A579F6F40564" xlink:to="loc_us-gaap_RangeAxis_BD05A0A0CBB26FC4D55CA579F6F4288A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_5EC1489C37C400E485B5A579F6F49AC9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_BD05A0A0CBB26FC4D55CA579F6F4288A" xlink:to="loc_us-gaap_RangeMember_5EC1489C37C400E485B5A579F6F49AC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_36D6AAA1AE0170ADEAE0A579F6F43A8A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_5EC1489C37C400E485B5A579F6F49AC9" xlink:to="loc_us-gaap_MinimumMember_36D6AAA1AE0170ADEAE0A579F6F43A8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_532A1A5A28B97D11759BA579F6F49C36" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_5EC1489C37C400E485B5A579F6F49AC9" xlink:to="loc_us-gaap_MaximumMember_532A1A5A28B97D11759BA579F6F49C36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_E6EBA8E74E3294640682A579F6F4E292" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_85311D2EE4B1EC139065A579F6F40564" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_E6EBA8E74E3294640682A579F6F4E292" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward" xlink:label="loc_abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward_1310C6741D34F291FD3EA579F6F42108" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_E6EBA8E74E3294640682A579F6F4E292" xlink:to="loc_abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward_1310C6741D34F291FD3EA579F6F42108" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_D9A55D4DF74C418FB3E2A579F6F48867" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward_1310C6741D34F291FD3EA579F6F42108" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_D9A55D4DF74C418FB3E2A579F6F48867" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ClassOfWarrantOrRightExercisedDuringPeriod" xlink:label="loc_abus_ClassOfWarrantOrRightExercisedDuringPeriod_DD67ABF1A22A40BE10FAA579F6F43C6B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward_1310C6741D34F291FD3EA579F6F42108" xlink:to="loc_abus_ClassOfWarrantOrRightExercisedDuringPeriod_DD67ABF1A22A40BE10FAA579F6F43C6B" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ClassofWarrantorRightExpired" xlink:label="loc_abus_ClassofWarrantorRightExpired_2EC85450AAD5D0A3995AA579F6F4E949" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward_1310C6741D34F291FD3EA579F6F42108" xlink:to="loc_abus_ClassofWarrantorRightExpired_2EC85450AAD5D0A3995AA579F6F4E949" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_CC115E0BD44E02ABC46BA579F6F4195E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward_1310C6741D34F291FD3EA579F6F42108" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_CC115E0BD44E02ABC46BA579F6F4195E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_42F93777F7B5159C36E1A579F6F4D236" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward_1310C6741D34F291FD3EA579F6F42108" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_42F93777F7B5159C36E1A579F6F4D236" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice" xlink:label="loc_abus_ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice_EAC491CBEFF53CC521ADA579F6F419EB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward_1310C6741D34F291FD3EA579F6F42108" xlink:to="loc_abus_ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice_EAC491CBEFF53CC521ADA579F6F419EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_F771ADCAFCC859B0058FA579F6F5B79E" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward_1310C6741D34F291FD3EA579F6F42108" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_F771ADCAFCC859B0058FA579F6F5B79E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2D16AC81AC8EC5194D4AA579F6F59323" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward_1310C6741D34F291FD3EA579F6F42108" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2D16AC81AC8EC5194D4AA579F6F59323" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ClassOfWarrantorRightOutstandExcercisePriceRange" xlink:label="loc_abus_ClassOfWarrantorRightOutstandExcercisePriceRange_4B00A7523A5BF3363A0AA579F6F50DE2" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward_1310C6741D34F291FD3EA579F6F42108" xlink:to="loc_abus_ClassOfWarrantorRightOutstandExcercisePriceRange_4B00A7523A5BF3363A0AA579F6F50DE2" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ClassOfWarrantsOrRightsExcercisedPriceRange" xlink:label="loc_abus_ClassOfWarrantsOrRightsExcercisedPriceRange_53A5C52B304EAD9D6987A579F6F59BF5" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward_1310C6741D34F291FD3EA579F6F42108" xlink:to="loc_abus_ClassOfWarrantsOrRightsExcercisedPriceRange_53A5C52B304EAD9D6987A579F6F59BF5" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ClassofWarrantsorRightsExpiredPriceRange" xlink:label="loc_abus_ClassofWarrantsorRightsExpiredPriceRange_0D589501523B5D363528A579F6F58C50" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward_1310C6741D34F291FD3EA579F6F42108" xlink:to="loc_abus_ClassofWarrantsorRightsExpiredPriceRange_0D589501523B5D363528A579F6F58C50" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ClassOfWarrantorRightOutstandExcercisePriceRange" xlink:label="loc_abus_ClassOfWarrantorRightOutstandExcercisePriceRange_91D659B437F005B569D7A579F6F5828C" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward_1310C6741D34F291FD3EA579F6F42108" xlink:to="loc_abus_ClassOfWarrantorRightOutstandExcercisePriceRange_91D659B437F005B569D7A579F6F5828C" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_BalanceWeightedaverageremainingcontractuallife" xlink:label="loc_abus_BalanceWeightedaverageremainingcontractuallife_C66AC5DDF0FB54083018A579F6F5B4AB" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward_1310C6741D34F291FD3EA579F6F42108" xlink:to="loc_abus_BalanceWeightedaverageremainingcontractuallife_C66AC5DDF0FB54083018A579F6F5B4AB" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ClassOfWarrantOrRightPriceOfWarrantsOrRightsIntrinsicValue" xlink:label="loc_abus_ClassOfWarrantOrRightPriceOfWarrantsOrRightsIntrinsicValue_38A97C374BBABB05F211A579F6F5758F" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsRollForward_1310C6741D34F291FD3EA579F6F42108" xlink:to="loc_abus_ClassOfWarrantOrRightPriceOfWarrantsOrRightsIntrinsicValue_38A97C374BBABB05F211A579F6F5758F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapitalTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_DF8233FD816B87532B52871498AFDBF6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_643E93ED2F404CDF8499871498AFDA44" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_DF8233FD816B87532B52871498AFDBF6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_643E93ED2F404CDF8499871498AFDA44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_0BE63069391E6F64F396876EE8485EAB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_643E93ED2F404CDF8499871498AFDA44" xlink:to="loc_us-gaap_AwardTypeAxis_0BE63069391E6F64F396876EE8485EAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0DB96F49F12D37BC576E876EE84826CE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0BE63069391E6F64F396876EE8485EAB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0DB96F49F12D37BC576E876EE84826CE" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EmployeeStockOptionLiabilityClassifiedMember" xlink:label="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_6F7DCE6D299396C0E96D876F5616BF7A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0DB96F49F12D37BC576E876EE84826CE" xlink:to="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_6F7DCE6D299396C0E96D876F5616BF7A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_7A46C65EFCEFC66C14E2871498B07BAE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_643E93ED2F404CDF8499871498AFDA44" xlink:to="loc_us-gaap_PlanNameAxis_7A46C65EFCEFC66C14E2871498B07BAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_235E169402C33F2A62ED871498B0CBB5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_7A46C65EFCEFC66C14E2871498B07BAE" xlink:to="loc_us-gaap_PlanNameDomain_235E169402C33F2A62ED871498B0CBB5" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ProtivaOptionPlanMember" xlink:label="loc_abus_ProtivaOptionPlanMember_0C85A812ECB94D7E80EF871498B07C23" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_235E169402C33F2A62ED871498B0CBB5" xlink:to="loc_abus_ProtivaOptionPlanMember_0C85A812ECB94D7E80EF871498B07C23" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_OnCoreOptionPlanMember" xlink:label="loc_abus_OnCoreOptionPlanMember_A80854A8F77915350445871498B00BEE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_235E169402C33F2A62ED871498B0CBB5" xlink:to="loc_abus_OnCoreOptionPlanMember_A80854A8F77915350445871498B00BEE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_F2E86BFC34B3D3CFEBA5871498B00A39" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_643E93ED2F404CDF8499871498AFDA44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_F2E86BFC34B3D3CFEBA5871498B00A39" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_DE132343EB9FC46E5F04871498B05C0E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_F2E86BFC34B3D3CFEBA5871498B00A39" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_DE132343EB9FC46E5F04871498B05C0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6D1C4F28E90F4E224492871498B03790" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_F2E86BFC34B3D3CFEBA5871498B00A39" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6D1C4F28E90F4E224492871498B03790" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_26E4FAB4F20C389A23FF871498B0C1F7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_F2E86BFC34B3D3CFEBA5871498B00A39" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_26E4FAB4F20C389A23FF871498B0C1F7" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_TemporalDiagramOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" xlink:label="loc_abus_TemporalDiagramOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock_58653F9383B79DD64C4D871498B03530" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_F2E86BFC34B3D3CFEBA5871498B00A39" xlink:to="loc_abus_TemporalDiagramOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock_58653F9383B79DD64C4D871498B03530" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_149A72E6EC82281BABCE871498B08ED1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_F2E86BFC34B3D3CFEBA5871498B00A39" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_149A72E6EC82281BABCE871498B08ED1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_3FA671989269A26FC25F871498B0096C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_F2E86BFC34B3D3CFEBA5871498B00A39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_3FA671989269A26FC25F871498B0096C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_F2ED3CCF16CBEF4CCCF1871498B08762" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_F2E86BFC34B3D3CFEBA5871498B00A39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_F2ED3CCF16CBEF4CCCF1871498B08762" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_55B73235D708F724471C871498B1BD50" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_F2E86BFC34B3D3CFEBA5871498B00A39" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_55B73235D708F724471C871498B1BD50" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapitalValuationAssumptionsAssumptionsWarrantsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_8FB8602DB477AAA59C6E8A72BBB22085" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedDividendRate_0ED597228AE005CF85E18A72BBB2E1DD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8FB8602DB477AAA59C6E8A72BBB22085" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedDividendRate_0ED597228AE005CF85E18A72BBB2E1DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedVolatilityRate_1A180F174E25521CB9CF8A72BBB2EB0E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8FB8602DB477AAA59C6E8A72BBB22085" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedVolatilityRate_1A180F174E25521CB9CF8A72BBB2EB0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_FairValueAssumptionsRiskFreeInterestRate_4B14153C9CC22A15596E8A72BBB2F6E6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8FB8602DB477AAA59C6E8A72BBB22085" xlink:to="loc_us-gaap_FairValueAssumptionsRiskFreeInterestRate_4B14153C9CC22A15596E8A72BBB2F6E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedTerm_323A787A136A5404DF488A72BBB290DC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8FB8602DB477AAA59C6E8A72BBB22085" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedTerm_323A787A136A5404DF488A72BBB290DC" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_FairValueOfWarrantsOutstandingPerWarrant" xlink:label="loc_abus_FairValueOfWarrantsOutstandingPerWarrant_3098F184535CAE6E67988A72BBB2D8E9" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8FB8602DB477AAA59C6E8A72BBB22085" xlink:to="loc_abus_FairValueOfWarrantsOutstandingPerWarrant_3098F184535CAE6E67988A72BBB2D8E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_36D9C2DF57CB6DDBA7CB8A72BBB2E921" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8FB8602DB477AAA59C6E8A72BBB22085" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_36D9C2DF57CB6DDBA7CB8A72BBB2E921" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_45E68765D84E9B47F8FF8A72BBB2EEFA" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8FB8602DB477AAA59C6E8A72BBB22085" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_45E68765D84E9B47F8FF8A72BBB2EEFA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapitalValuationAssumptionsEquityOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_AC3759865AD6454579085CF7AACE7C44" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6EC64AC744BA5B6C5E5A5CF7AACEEDFE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_AC3759865AD6454579085CF7AACE7C44" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6EC64AC744BA5B6C5E5A5CF7AACEEDFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_3EFA9814F6E8F39E67735CF7AACE5CD7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6EC64AC744BA5B6C5E5A5CF7AACEEDFE" xlink:to="loc_us-gaap_PlanNameAxis_3EFA9814F6E8F39E67735CF7AACE5CD7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_F6261BE32075180A4F745CF7AACE4193" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3EFA9814F6E8F39E67735CF7AACE5CD7" xlink:to="loc_us-gaap_PlanNameDomain_F6261BE32075180A4F745CF7AACE4193" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ArbutusPlansMember" xlink:label="loc_abus_ArbutusPlansMember_F4FC09D4B64A30B0B57E5CF7AACF220E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_F6261BE32075180A4F745CF7AACE4193" xlink:to="loc_abus_ArbutusPlansMember_F4FC09D4B64A30B0B57E5CF7AACF220E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0262D48F3660BE6EB0275CF7AACF6509" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6EC64AC744BA5B6C5E5A5CF7AACEEDFE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0262D48F3660BE6EB0275CF7AACF6509" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_FF0ABDDEFD26472FBC325CF7AACF4FD2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0262D48F3660BE6EB0275CF7AACF6509" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_FF0ABDDEFD26472FBC325CF7AACF4FD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_CF0FD508ED5A7C64D61D5CF7AACF0994" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0262D48F3660BE6EB0275CF7AACF6509" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_CF0FD508ED5A7C64D61D5CF7AACF0994" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_92A9DA162AE7ECBE2E925CF7AACF6160" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0262D48F3660BE6EB0275CF7AACF6509" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_92A9DA162AE7ECBE2E925CF7AACF6160" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_BFE77183D3BEE91A17155CF7AACF63B0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0262D48F3660BE6EB0275CF7AACF6509" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_BFE77183D3BEE91A17155CF7AACF63B0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareCapitalValuationAssumptionsLiabilityClassifiedOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_5D11E28121E526BD99F8A53FE84F7972" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68B42EFB0C28A394D9EFA53FE850544E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_5D11E28121E526BD99F8A53FE84F7972" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68B42EFB0C28A394D9EFA53FE850544E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_5B4D495658F134B5721FA53FE850EEA3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68B42EFB0C28A394D9EFA53FE850544E" xlink:to="loc_us-gaap_AwardTypeAxis_5B4D495658F134B5721FA53FE850EEA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_94545745B8D8ADE95272A53FE851D8D1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5B4D495658F134B5721FA53FE850EEA3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_94545745B8D8ADE95272A53FE851D8D1" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EmployeeStockOptionLiabilityClassifiedMember" xlink:label="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_DEB3DC2C2DB419FCBC64A53FE851A5AE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_94545745B8D8ADE95272A53FE851D8D1" xlink:to="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_DEB3DC2C2DB419FCBC64A53FE851A5AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4692A7015DB3650CCD49A53FE851D1FC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68B42EFB0C28A394D9EFA53FE850544E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4692A7015DB3650CCD49A53FE851D1FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5BE9D4D056EC3B9727B9A53FE851B3FC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4692A7015DB3650CCD49A53FE851D1FC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5BE9D4D056EC3B9727B9A53FE851B3FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_28F09F5CFD12A97A978BA53FE8519FF2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4692A7015DB3650CCD49A53FE851D1FC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_28F09F5CFD12A97A978BA53FE8519FF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_308AF99D351FAAC527F7A53FE85172A5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4692A7015DB3650CCD49A53FE851D1FC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_308AF99D351FAAC527F7A53FE85172A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_80157DCA5C1C88F51E3AA53FE85117E3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4692A7015DB3650CCD49A53FE851D1FC" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_80157DCA5C1C88F51E3AA53FE85117E3" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingFairValuePrice" xlink:label="loc_abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingFairValuePrice_CF2BAB3936E2F66AEC1BA53FE851DF24" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4692A7015DB3650CCD49A53FE851D1FC" xlink:to="loc_abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingFairValuePrice_CF2BAB3936E2F66AEC1BA53FE851DF24" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure" xlink:label="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_95488655AAD07118801DA54CA63BC361" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4692A7015DB3650CCD49A53FE851D1FC" xlink:to="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_95488655AAD07118801DA54CA63BC361" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_F599BE4B2A93E6E5B0D0FE9956F3462A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_4423B74596F0422825D9FE9956F381DE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_F599BE4B2A93E6E5B0D0FE9956F3462A" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_4423B74596F0422825D9FE9956F381DE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_A6074F9ACF972B82452AB8B1DF568A57" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_310DAD9DB94CC5FED59AB8B1DF57DD35" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_A6074F9ACF972B82452AB8B1DF568A57" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_310DAD9DB94CC5FED59AB8B1DF57DD35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_FD6477ADB6FFAC4A92BBB8B1DF574EF4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_310DAD9DB94CC5FED59AB8B1DF57DD35" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_FD6477ADB6FFAC4A92BBB8B1DF574EF4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_B223357470820EE2BA4CB8B1DF570142" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_FD6477ADB6FFAC4A92BBB8B1DF574EF4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_B223357470820EE2BA4CB8B1DF570142" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_C58ECCF9D3CE6425A3D3B8B1DF57D900" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_B223357470820EE2BA4CB8B1DF570142" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_C58ECCF9D3CE6425A3D3B8B1DF57D900" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6A3EA68235DF36D4C964B8B1DF57AC60" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_B223357470820EE2BA4CB8B1DF570142" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6A3EA68235DF36D4C964B8B1DF57AC60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_2E7DDF36AB7780D4ACE5B8B1DF5C9604" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_310DAD9DB94CC5FED59AB8B1DF57DD35" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_2E7DDF36AB7780D4ACE5B8B1DF5C9604" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_A965E0EB19BD381D303EB8B1DF5D89D2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_2E7DDF36AB7780D4ACE5B8B1DF5C9604" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_A965E0EB19BD381D303EB8B1DF5D89D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_42C8A0661A7EDF6E433FB8B1DF5DB6D9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A965E0EB19BD381D303EB8B1DF5D89D2" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_42C8A0661A7EDF6E433FB8B1DF5DB6D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_C6787ED268B83D541F2BB8B1DF5D8B6B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A965E0EB19BD381D303EB8B1DF5D89D2" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_C6787ED268B83D541F2BB8B1DF5D8B6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedInvestmentsAtFairValue" xlink:label="loc_us-gaap_RestrictedInvestmentsAtFairValue_95CF739DDCAE66CE65FEB8B1DF5D6B43" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A965E0EB19BD381D303EB8B1DF5D89D2" xlink:to="loc_us-gaap_RestrictedInvestmentsAtFairValue_95CF739DDCAE66CE65FEB8B1DF5D6B43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermInvestments" xlink:label="loc_us-gaap_LongTermInvestments_CE57309C4CD8F51E2EC2B8B1DF5D46A5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A965E0EB19BD381D303EB8B1DF5D89D2" xlink:to="loc_us-gaap_LongTermInvestments_CE57309C4CD8F51E2EC2B8B1DF5D46A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_92AAB0802D7FE89C7E9CB8B1DF5D105E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A965E0EB19BD381D303EB8B1DF5D89D2" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_92AAB0802D7FE89C7E9CB8B1DF5D105E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_3F4AD5C082D8534C4A24B8B1DF5D1C94" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_2E7DDF36AB7780D4ACE5B8B1DF5C9604" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_3F4AD5C082D8534C4A24B8B1DF5D1C94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_F42C56C40169443AA07EB8B1DF5D4493" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_3F4AD5C082D8534C4A24B8B1DF5D1C94" xlink:to="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_F42C56C40169443AA07EB8B1DF5D4493" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure" xlink:label="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_4EB1EAD55311FFFE89EBB8B1DF5EC2EA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_3F4AD5C082D8534C4A24B8B1DF5D1C94" xlink:to="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_4EB1EAD55311FFFE89EBB8B1DF5EC2EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_58930A08318A6241F02FB8B1DF5EACDB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_3F4AD5C082D8534C4A24B8B1DF5D1C94" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_58930A08318A6241F02FB8B1DF5EACDB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureRecurring" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureRecurring_2B6EF99DE51BEDF6FA49B8B1DF5E7A77" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_3F4AD5C082D8534C4A24B8B1DF5D1C94" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureRecurring_2B6EF99DE51BEDF6FA49B8B1DF5E7A77" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesChangesInFairValueOfCompanysWarrantsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_38CAD92D887CEFAC49268A72BC5AD179" xlink:type="locator" />
    <link:loc xlink:href="abus-20161231.xsd#abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward" xlink:label="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_CF7C512376103F98ED828A72BC5A66AC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_38CAD92D887CEFAC49268A72BC5AD179" xlink:to="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_CF7C512376103F98ED828A72BC5A66AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_3B74896BF7EC40806B7D8A72BC5AF797" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_CF7C512376103F98ED828A72BC5A66AC" xlink:to="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_3B74896BF7EC40806B7D8A72BC5AF797" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_FairValueOfWarrantsExercisedInThePeriod" xlink:label="loc_abus_FairValueOfWarrantsExercisedInThePeriod_6696C866F92DFA74CA378A72BC5AE4E5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_CF7C512376103F98ED828A72BC5A66AC" xlink:to="loc_abus_FairValueOfWarrantsExercisedInThePeriod_6696C866F92DFA74CA378A72BC5AE4E5" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_IncreaseDecreaseInValueOfWarrants" xlink:label="loc_abus_IncreaseDecreaseInValueOfWarrants_50EAB3D6AAAF4A02232E8A72BC5A2BC5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_CF7C512376103F98ED828A72BC5A66AC" xlink:to="loc_abus_IncreaseDecreaseInValueOfWarrants_50EAB3D6AAAF4A02232E8A72BC5A2BC5" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_FairValueWarrantsForeignExchangeGainLoss" xlink:label="loc_abus_FairValueWarrantsForeignExchangeGainLoss_061BB7119649D937D1868A72BC5AF372" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_CF7C512376103F98ED828A72BC5A66AC" xlink:to="loc_abus_FairValueWarrantsForeignExchangeGainLoss_061BB7119649D937D1868A72BC5AF372" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_8E3F54B19D9561A613F88A72BC5A78D6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_CF7C512376103F98ED828A72BC5A66AC" xlink:to="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_8E3F54B19D9561A613F88A72BC5A78D6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesChangesInFairValueOfContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_E87B4D7F173B3E63CD4F87D3ADA27ECC" xlink:type="locator" />
    <link:loc xlink:href="abus-20161231.xsd#abus_BusinessCombinationContingentConsiderationArrangementsChangeinAmountofContingentConsiderationFairValueLiabilityRollForward" xlink:label="loc_abus_BusinessCombinationContingentConsiderationArrangementsChangeinAmountofContingentConsiderationFairValueLiabilityRollForward_1E7AF9A82CBBB0A3136187D3ADA2BB9D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_E87B4D7F173B3E63CD4F87D3ADA27ECC" xlink:to="loc_abus_BusinessCombinationContingentConsiderationArrangementsChangeinAmountofContingentConsiderationFairValueLiabilityRollForward_1E7AF9A82CBBB0A3136187D3ADA2BB9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_3F715F2C060992E2350B87D3ADA2BB64" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_BusinessCombinationContingentConsiderationArrangementsChangeinAmountofContingentConsiderationFairValueLiabilityRollForward_1E7AF9A82CBBB0A3136187D3ADA2BB9D" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_3F715F2C060992E2350B87D3ADA2BB64" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_23CBF7438D7A809B5CFB87D3ADA26095" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_BusinessCombinationContingentConsiderationArrangementsChangeinAmountofContingentConsiderationFairValueLiabilityRollForward_1E7AF9A82CBBB0A3136187D3ADA2BB9D" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_23CBF7438D7A809B5CFB87D3ADA26095" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_38D2239DC8388B72B9CC87D3ADA27F4B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_BusinessCombinationContingentConsiderationArrangementsChangeinAmountofContingentConsiderationFairValueLiabilityRollForward_1E7AF9A82CBBB0A3136187D3ADA2BB9D" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_38D2239DC8388B72B9CC87D3ADA27F4B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesChangesInFairValueOfLiabilityClassifiedStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_D18AEF5083831F8A99FCA5432EDE5D90" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_B4C88812F000EFBFA19CA5432EDECE67" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_D18AEF5083831F8A99FCA5432EDE5D90" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_B4C88812F000EFBFA19CA5432EDECE67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2B7F594482A7B2717D30A5432EDEFF85" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_B4C88812F000EFBFA19CA5432EDECE67" xlink:to="loc_us-gaap_AwardTypeAxis_2B7F594482A7B2717D30A5432EDEFF85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B78A912537B7EE4CD111A5432EDEE0A6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2B7F594482A7B2717D30A5432EDEFF85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B78A912537B7EE4CD111A5432EDEE0A6" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EmployeeStockOptionLiabilityClassifiedMember" xlink:label="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_4231F70F70B5B0EC692FA5432EDE5E8A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B78A912537B7EE4CD111A5432EDEE0A6" xlink:to="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_4231F70F70B5B0EC692FA5432EDE5E8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_523E576242340C40B971A5432EDEAE7F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_B4C88812F000EFBFA19CA5432EDECE67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_523E576242340C40B971A5432EDEAE7F" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward" xlink:label="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_C0DD3A627A81E67A1293A5432EDEC462" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_523E576242340C40B971A5432EDEAE7F" xlink:to="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_C0DD3A627A81E67A1293A5432EDEC462" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure" xlink:label="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_F32D41A7688229CA75D4A54AF13410CF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_C0DD3A627A81E67A1293A5432EDEC462" xlink:to="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_F32D41A7688229CA75D4A54AF13410CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_035985C23F67AA696018A5432EDE589F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_C0DD3A627A81E67A1293A5432EDEC462" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_035985C23F67AA696018A5432EDE589F" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_IncreaseDecreaseinFairValueofLiabilityClassifiedOptions" xlink:label="loc_abus_IncreaseDecreaseinFairValueofLiabilityClassifiedOptions_E0AE89E5FD8A13C1C919A5432EDE71DA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_C0DD3A627A81E67A1293A5432EDEC462" xlink:to="loc_abus_IncreaseDecreaseinFairValueofLiabilityClassifiedOptions_E0AE89E5FD8A13C1C919A5432EDE71DA" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure" xlink:label="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_9125097C04912E0346FDA54B4947AE17" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_C0DD3A627A81E67A1293A5432EDEC462" xlink:to="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_9125097C04912E0346FDA54B4947AE17" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesComputationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_78B9069F84B035CAC8D187D3AD82814D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_04ADE8F64A56F0065E8287D3AD826530" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78B9069F84B035CAC8D187D3AD82814D" xlink:to="loc_us-gaap_NetIncomeLoss_04ADE8F64A56F0065E8287D3AD826530" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_885E3321480554304E5087D3AD82FEDB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78B9069F84B035CAC8D187D3AD82814D" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_885E3321480554304E5087D3AD82FEDB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_509FF23F3FECED013AA687D3AD82246F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78B9069F84B035CAC8D187D3AD82814D" xlink:to="loc_us-gaap_EarningsPerShareBasic_509FF23F3FECED013AA687D3AD82246F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_925157AC58EF8193F6F187D3AD8272C2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78B9069F84B035CAC8D187D3AD82814D" xlink:to="loc_us-gaap_EarningsPerShareDiluted_925157AC58EF8193F6F187D3AD8272C2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesEstimatedUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_842A57888564EF22687BFE995645EAFF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_77254C8A9DCF84C181CFFE995646ED2A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_842A57888564EF22687BFE995645EAFF" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_77254C8A9DCF84C181CFFE995646ED2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1CA3DFFD88BCDD3758ADFE995646346C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_77254C8A9DCF84C181CFFE995646ED2A" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1CA3DFFD88BCDD3758ADFE995646346C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_BE6739FEFFDF5517070CFE9956466C0B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1CA3DFFD88BCDD3758ADFE995646346C" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_BE6739FEFFDF5517070CFE9956466C0B" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_LaboratoryEquipmentMember" xlink:label="loc_abus_LaboratoryEquipmentMember_432C6330966238520252FE995646058F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_BE6739FEFFDF5517070CFE9956466C0B" xlink:to="loc_abus_LaboratoryEquipmentMember_432C6330966238520252FE995646058F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_B74C3E34262DC7D2E92CFE995646BCE6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_BE6739FEFFDF5517070CFE9956466C0B" xlink:to="loc_us-gaap_ComputerEquipmentMember_B74C3E34262DC7D2E92CFE995646BCE6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_2306BB98BCE8114311DFFE9956462A14" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_BE6739FEFFDF5517070CFE9956466C0B" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_2306BB98BCE8114311DFFE9956462A14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_0789E3FEE0B179DEA400FE9956463A45" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_77254C8A9DCF84C181CFFE995646ED2A" xlink:to="loc_us-gaap_RangeAxis_0789E3FEE0B179DEA400FE9956463A45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_432D1487CC277627EDC5FE995647BD6C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_0789E3FEE0B179DEA400FE9956463A45" xlink:to="loc_us-gaap_RangeMember_432D1487CC277627EDC5FE995647BD6C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_732EABE4374EF3C51F8FFE99564779DD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_432D1487CC277627EDC5FE995647BD6C" xlink:to="loc_us-gaap_MinimumMember_732EABE4374EF3C51F8FFE99564779DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_D795CD37A442F35CBFD9FE99564780C9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_432D1487CC277627EDC5FE995647BD6C" xlink:to="loc_us-gaap_MaximumMember_D795CD37A442F35CBFD9FE99564780C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_428B263B51FAA4AE42D1FE995647FB54" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_77254C8A9DCF84C181CFFE995646ED2A" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_428B263B51FAA4AE42D1FE995647FB54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_E8C2657D44703C099B70FE9956477031" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_428B263B51FAA4AE42D1FE995647FB54" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_E8C2657D44703C099B70FE9956477031" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7D75671CD76BEA1FEC888F837E6107D6" xlink:type="locator" />
    <link:loc xlink:href="abus-20161231.xsd#abus_WhollyOwnedSubsidiariesIncludedinFinancialStatements" xlink:label="loc_abus_WhollyOwnedSubsidiariesIncludedinFinancialStatements_4253BF898D54D4DEAB898F837E61F7FC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7D75671CD76BEA1FEC888F837E6107D6" xlink:to="loc_abus_WhollyOwnedSubsidiariesIncludedinFinancialStatements_4253BF898D54D4DEAB898F837E61F7FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ACD9A0173C2633EE37248F837E61ABF3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7D75671CD76BEA1FEC888F837E6107D6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ACD9A0173C2633EE37248F837E61ABF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_E6D1DFB452DA1EA2D0C98F837E61079B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ACD9A0173C2633EE37248F837E61ABF3" xlink:to="loc_dei_LegalEntityAxis_E6D1DFB452DA1EA2D0C98F837E61079B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_295CF974BE9EE1200B158F837E618D73" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_E6D1DFB452DA1EA2D0C98F837E61079B" xlink:to="loc_dei_EntityDomain_295CF974BE9EE1200B158F837E618D73" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_MonsantoMember" xlink:label="loc_abus_MonsantoMember_051F81B4C458F74114138F837E61C92D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_295CF974BE9EE1200B158F837E618D73" xlink:to="loc_abus_MonsantoMember_051F81B4C458F74114138F837E61C92D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0C61B3FD8D9EE320746F8F837E61F8BF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ACD9A0173C2633EE37248F837E61ABF3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0C61B3FD8D9EE320746F8F837E61F8BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F74C5C7FA1E00AF29E158F837E6143F2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0C61B3FD8D9EE320746F8F837E61F8BF" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F74C5C7FA1E00AF29E158F837E6143F2" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_PADCo.Member" xlink:label="loc_abus_PADCo.Member_F4395B064C58B9531AB18F837E61B31A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F74C5C7FA1E00AF29E158F837E6143F2" xlink:to="loc_abus_PADCo.Member_F4395B064C58B9531AB18F837E61B31A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_475A1EF7ED828390667B8F837E61BE39" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ACD9A0173C2633EE37248F837E61ABF3" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_475A1EF7ED828390667B8F837E61BE39" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9F79913288C2CFF466198F837E616979" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475A1EF7ED828390667B8F837E61BE39" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9F79913288C2CFF466198F837E616979" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_RestrictedInvestmentTerm" xlink:label="loc_abus_RestrictedInvestmentTerm_5F2251E65D55E5E531588F837E612D64" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7D75671CD76BEA1FEC888F837E6107D6" xlink:to="loc_abus_RestrictedInvestmentTerm_5F2251E65D55E5E531588F837E612D64" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentInterestRate" xlink:label="loc_invest_InvestmentInterestRate_1F5AB000CA30CD60EC088F837E618C24" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7D75671CD76BEA1FEC888F837E6107D6" xlink:to="loc_invest_InvestmentInterestRate_1F5AB000CA30CD60EC088F837E618C24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_A78DE43AB419AB27E7978F837E619A96" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7D75671CD76BEA1FEC888F837E6107D6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_A78DE43AB419AB27E7978F837E619A96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_0B8E089B6950196330C68F837E62B662" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7D75671CD76BEA1FEC888F837E6107D6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_0B8E089B6950196330C68F837E62B662" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_06D39F8E4ED435EDF03E8F837E62DB9F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7D75671CD76BEA1FEC888F837E6107D6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_06D39F8E4ED435EDF03E8F837E62DB9F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_D650F6E89A26CADF48A9A5432EED50C8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_D650F6E89A26CADF48A9A5432EED50C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_8B44C69AD4DFFD1BB3D0A5432EED17E9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_8B44C69AD4DFFD1BB3D0A5432EED17E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_1322BBD1042A63DF13B6A5432EED17F5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_UseOfEstimates_1322BBD1042A63DF13B6A5432EED17F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_18152C155BCE3CA50341A5432EEDDEFD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_18152C155BCE3CA50341A5432EEDDEFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_C06C40F30BD01AEA3EB5A5432EED8015" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_C06C40F30BD01AEA3EB5A5432EED8015" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_DebtandRestrictedCashInvestmentPolicyPolicyTextBlock" xlink:label="loc_abus_DebtandRestrictedCashInvestmentPolicyPolicyTextBlock_618422EA796A3368F47CA5432EED8FC3" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_abus_DebtandRestrictedCashInvestmentPolicyPolicyTextBlock_618422EA796A3368F47CA5432EED8FC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_68F1BBA3E8F58CD38D61A5432EED1E33" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_68F1BBA3E8F58CD38D61A5432EED1E33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_39DD1BDA945EE616F8FEA5432EEDB219" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_39DD1BDA945EE616F8FEA5432EEDB219" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_62267A024AA988215EB5A5432EEDCBD1" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_62267A024AA988215EB5A5432EEDCBD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_B97E992C0DD2A430F539A5432EED1CDA" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_B97E992C0DD2A430F539A5432EED1CDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_93618112AB1AB519A81DA5432EEDEFAD" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_93618112AB1AB519A81DA5432EEDEFAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasePolicyTextBlock" xlink:label="loc_us-gaap_LeasePolicyTextBlock_42D4DB76CC24166872D5A5432EED3487" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_LeasePolicyTextBlock_42D4DB76CC24166872D5A5432EED3487" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_84E9CC0009B012ED8CD7A5432EED20D4" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_84E9CC0009B012ED8CD7A5432EED20D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_A6C69FDC7C44C6BDDE99A5432EEDA983" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_A6C69FDC7C44C6BDDE99A5432EEDA983" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_GovernmentGrantsAndRefundableInvestmentTaxCreditsPolicyTextBlock" xlink:label="loc_abus_GovernmentGrantsAndRefundableInvestmentTaxCreditsPolicyTextBlock_9B0315F355AAF30E1FD2A5432EED06E6" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_abus_GovernmentGrantsAndRefundableInvestmentTaxCreditsPolicyTextBlock_9B0315F355AAF30E1FD2A5432EED06E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_FD47288C9C6BAEC7D7E7A5432EEDB76F" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_FD47288C9C6BAEC7D7E7A5432EEDB76F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_6CD09F4E7FBF0B01A041A5432EED0525" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_6CD09F4E7FBF0B01A041A5432EED0525" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ReplacementAwardsPolicyTextBlock" xlink:label="loc_abus_ReplacementAwardsPolicyTextBlock_739F41FFCC481906EFFCA5432EEDC7AB" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_abus_ReplacementAwardsPolicyTextBlock_739F41FFCC481906EFFCA5432EEDC7AB" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_WarrantsPolicyTextBlock" xlink:label="loc_abus_WarrantsPolicyTextBlock_15C0963B7784FF354EC1A5432EEDBB17" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_abus_WarrantsPolicyTextBlock_15C0963B7784FF354EC1A5432EEDBB17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_44FF9D47469C4E6DFFD2A5432EEDC06B" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_44FF9D47469C4E6DFFD2A5432EEDC06B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_11038B6AF8E7E3480D72A5432EEDEB7C" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_091397A6FD15C9F53905A5432EEDDAC4" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_11038B6AF8E7E3480D72A5432EEDEB7C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_52AE870D6E547310B8D886FC9B49D154" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_E82DA95CB383A28BB5C786FC9B499157" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_52AE870D6E547310B8D886FC9B49D154" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_E82DA95CB383A28BB5C786FC9B499157" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ChangesInFairValueOfWarrantsTableTextBlock" xlink:label="loc_abus_ChangesInFairValueOfWarrantsTableTextBlock_D8E40735DBA7AD10033086FC9B498419" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_52AE870D6E547310B8D886FC9B49D154" xlink:to="loc_abus_ChangesInFairValueOfWarrantsTableTextBlock_D8E40735DBA7AD10033086FC9B498419" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_ChangesInFairValueofLiabilityOptionTableTextBlock" xlink:label="loc_abus_ChangesInFairValueofLiabilityOptionTableTextBlock_D66D93B53E847EC2CC3F86FC9B49563D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_52AE870D6E547310B8D886FC9B49D154" xlink:to="loc_abus_ChangesInFairValueofLiabilityOptionTableTextBlock_D66D93B53E847EC2CC3F86FC9B49563D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_00B567CFC391CA157C4E86FC9B4A5000" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_52AE870D6E547310B8D886FC9B49D154" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_00B567CFC391CA157C4E86FC9B4A5000" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:label="loc_abus_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_EFDD597DE128A0F9C96686FC9B4A27D1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_52AE870D6E547310B8D886FC9B49D154" xlink:to="loc_abus_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_EFDD597DE128A0F9C96686FC9B4A27D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_D1C9701CDAC8A0E4FF4C86FC9B4ACBAD" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_52AE870D6E547310B8D886FC9B49D154" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_D1C9701CDAC8A0E4FF4C86FC9B4ACBAD" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_18989F025E5081DD9A15879247D2D5F7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_82A60901738BD2E9927D879247D32000" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_18989F025E5081DD9A15879247D2D5F7" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_82A60901738BD2E9927D879247D32000" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SubsequentEventsSubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_C667BF22D3CD4683232AEC93F74789AA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_1DBF76C97752C9EDD1ECEC93F7471102" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_C667BF22D3CD4683232AEC93F74789AA" xlink:to="loc_us-gaap_SubsequentEventTable_1DBF76C97752C9EDD1ECEC93F7471102" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="loc_us-gaap_CounterpartyNameAxis_795D163E92698B4DABC8EC94704ACBC1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1DBF76C97752C9EDD1ECEC93F7471102" xlink:to="loc_us-gaap_CounterpartyNameAxis_795D163E92698B4DABC8EC94704ACBC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_F8FEF7DCE9901E78E844EC94718A1A6C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CounterpartyNameAxis_795D163E92698B4DABC8EC94704ACBC1" xlink:to="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_F8FEF7DCE9901E78E844EC94718A1A6C" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_AlexionMember" xlink:label="loc_abus_AlexionMember_193B0BBA921A9886C68FEC950176AAF6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_F8FEF7DCE9901E78E844EC94718A1A6C" xlink:to="loc_abus_AlexionMember_193B0BBA921A9886C68FEC950176AAF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5CDB0237824AAC00E8EFEC93F748F927" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1DBF76C97752C9EDD1ECEC93F7471102" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5CDB0237824AAC00E8EFEC93F748F927" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_569C324DCF0723F14383EC93F7489E58" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5CDB0237824AAC00E8EFEC93F748F927" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_569C324DCF0723F14383EC93F7489E58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_5CBCE1FB6F989758D7EFEC94389D7274" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_569C324DCF0723F14383EC93F7489E58" xlink:to="loc_us-gaap_SubsequentEventMember_5CBCE1FB6F989758D7EFEC94389D7274" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_AE0F0724EEB7A0B0544AEC93F748598C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1DBF76C97752C9EDD1ECEC93F7471102" xlink:to="loc_us-gaap_SubsequentEventLineItems_AE0F0724EEB7A0B0544AEC93F748598C" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_LicenseUpfrontPayment" xlink:label="loc_abus_LicenseUpfrontPayment_B6B42B66D4AE3FE0B57CEC93F748BDD1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_AE0F0724EEB7A0B0544AEC93F748598C" xlink:to="loc_abus_LicenseUpfrontPayment_B6B42B66D4AE3FE0B57CEC93F748BDD1" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_PotentialContractFundingAmount" xlink:label="loc_abus_PotentialContractFundingAmount_6176397DCE8DF81201CFEC93F7485442" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_AE0F0724EEB7A0B0544AEC93F748598C" xlink:to="loc_abus_PotentialContractFundingAmount_6176397DCE8DF81201CFEC93F7485442" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SupplementaryInformation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_4A0AF30B7C854B2C8B5B879247E4A898" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_55319A836BF6C57A626B879247E46E53" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_4A0AF30B7C854B2C8B5B879247E4A898" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_55319A836BF6C57A626B879247E46E53" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SupplementaryInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_F2E60B7C0D3F51F888AD877B8C88A888" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_8E8A68B130D4EE4A9403877B8C880FE6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_F2E60B7C0D3F51F888AD877B8C88A888" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_8E8A68B130D4EE4A9403877B8C880FE6" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_AccruedResearchandDevelopmentCurrent" xlink:label="loc_abus_AccruedResearchandDevelopmentCurrent_BF211E429AC353837E2E877B8C898C75" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_F2E60B7C0D3F51F888AD877B8C88A888" xlink:to="loc_abus_AccruedResearchandDevelopmentCurrent_BF211E429AC353837E2E877B8C898C75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_79BD1285EA8B1F65A51E877B8C897A09" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_F2E60B7C0D3F51F888AD877B8C88A888" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_79BD1285EA8B1F65A51E877B8C897A09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseIncentivePayableCurrent" xlink:label="loc_us-gaap_LeaseIncentivePayableCurrent_A15183A14576E544900C877B8C89F7D6" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_F2E60B7C0D3F51F888AD877B8C88A888" xlink:to="loc_us-gaap_LeaseIncentivePayableCurrent_A15183A14576E544900C877B8C89F7D6" xlink:type="arc" />
    <link:loc xlink:href="abus-20161231.xsd#abus_AccruedPayrollCurrent" xlink:label="loc_abus_AccruedPayrollCurrent_A8C59262731537F033C8877B8C894F89" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_F2E60B7C0D3F51F888AD877B8C88A888" xlink:to="loc_abus_AccruedPayrollCurrent_A8C59262731537F033C8877B8C894F89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_CA0116814E7E8FCDB4D4877B8C891C71" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_F2E60B7C0D3F51F888AD877B8C88A888" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_CA0116814E7E8FCDB4D4877B8C891C71" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_25F8E7FB6B5FA036880D877B8C892C9B" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_F2E60B7C0D3F51F888AD877B8C88A888" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_25F8E7FB6B5FA036880D877B8C892C9B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SupplementaryInformationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_7A61C80AE1A85BA3D9EDFE9956FCFDA8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_BA5A87ED59B3CED990A4FE9956FD68D3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7A61C80AE1A85BA3D9EDFE9956FCFDA8" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_BA5A87ED59B3CED990A4FE9956FD68D3" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>